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Abstract
The practical application of deep learning methods in the medical domain
has many challenges. Pathologies are diverse and very few examples may
be available for rare cases. Where data is collected it may lie in multiple
institutions and cannot be pooled for practical and ethical reasons. Deep
learning is powerful for image segmentation problems but ultimately its output
must be interpretable at the patient level. Although clearly not an exhaustive
list, these are the three problems tackled in this thesis.
To address the rarity of pathology I investigate novelty detection algorithms
to find outliers from normal anatomy. The problem is structured as first finding
a low-dimension embedding and then detecting outliers in that embedding
space. I evaluate for speed and accuracy several unsupervised embedding and
outlier detection methods. Data consist of Magnetic Resonance Imaging (MRI)
for interstitial lung disease for which healthy and pathological patches are
available; only the healthy patches are used in model training.
I then explore the clinical interpretability of a model output. I take related
work by the Canon team — a model providing voxel-level detection of acute
ischemic stroke signs — and deliver the Alberta Stroke Programme Early CT
Score (ASPECTS, a measure of stroke severity). The data are acute head
computed tomography volumes of suspected stroke patients. I convert from
the voxel level to the brain region level and then to the patient level through a
series of rules. Due to the real world clinical complexity of the problem, there
are at each level — voxel, region and patient — multiple sources of “truth”; I
evaluate my results appropriately against these truths.
Finally, federated learning is used to train a model on data that are divided
between multiple institutions. I introduce a novel evolution of this algorithm
— dubbed “soft federated learning” — that avoids the central coordinating
2
3authority, and takes into account domain shift (covariate shift) and dataset
size. I first demonstrate the key properties of these two algorithms on a series
of MNIST (handwritten digits) toy problems. Then I apply the methods to the
BraTS medical dataset, which contains MRI brain glioma scans from multiple
institutions, to compare these algorithms in a realistic setting.
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Healthcare is facing the perfect storm of staff shortages and aging popula-
tions. In 2020 the number of people aged 60+ will outnumber children under
5 globally, and by 2050 they will make up 22% of the global population [237].
The elderly are more likely to be frail or suffer chronic health problems than
a younger population, which leads to an increased burden on healthcare ser-
vices. By the age of 65, most people will have at least one chronic health
illness and by 75 they will have two [24], and yet, there is a shortage of seven
million health workers worldwide [169, 253, 295]. In the UK the gap between
the number of healthcare staff needed and the number being recruited is un-
sustainable [196, 216, 244], leading to a national emergency [25] with staff
shortages looking to double between 2019 and 2024 without radical change
[134].
Artificial intelligence (AI) — a broad term for machine learning — has
the potential to have a profound, positive, and transformative impact on the
health of European and worldwide populations [106] with its use within the
National Health Service (NHS) [217] saving up to £12.5 billion a year worth in
staff time — or about 10% of the NHS budget [102] — easing the pressures of
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staff shortages [113]. AI could change healthcare as we know it with machines
making critical decisions on behalf of clinical staff [66]. Hospitals produce 50
petabytes of data every year with 90% of this being medical imaging, but 97%
of this goes unused [185]. AI can process these data faster than a radiologist
and thus save them time and extract more use from the data.
Machine learning provides a way of automating or aiding in clinical work,
but this too faces its own set of challenges. For instance, both pathological and
healthy anatomy are highly diverse and, in the case of rare or new diseases,
prior examples can be difficult to come across. Medical data are highly sensitive
and cannot be easily pooled for machine learning training. Outputs from
machine learning methods are often not understandable by humans and must
be converted into a form that is. This can be done by distilling the high-
dimensional output into a simple, small set of outcomes. This thesis aims to
demonstrate solutions to these problems.
For common pathology where many imaging examples from varied sources
exist, a wide range of machine learning techniques are available with neural
networks providing state-of-the-art in image analysis [123]. There are many
neural network methods focusing within the medical field [13, 82, 86, 107, 150,
160, 181, 208, 298]. However, the existence of sufficient data and suitable ma-
chine learning algorithms does not equal easy application development. The
data are controlled within a clinical environment. Technical and ethical is-
sues prevent the data leaving for a research environment. Laws such as the
Data Protection Act 2018 [284], General Data Protection Regulation 2016 [54],
and, in some cases, the Health Insurance Portability and Accountability Act
1996 [225] prevent sharing or use of the data without costly and complicated
contracts. Despite an increasing regulatory environment, in 2019 the NHS fi-
nancially encouraged the use of artificial intelligence systems to replace clinical
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tasks conventionally performed by humans [141].
1.1 Medical Imaging Data
Through its complexity and size, medical imaging data are a difficult but rich
and rewarding type of data to work with due to the extensive information they
contain. This thesis focuses on the use of CT and MRI data in the exploration
of the aforementioned problems. This section provides an overview of these
imaging techniques.
1.1.1 CT
Computed tomography (CT) is a technique to form slicewise volume rendering
of organs and structures within the body. It does this by passing x-rays through
the body from multiple angles and recording their absorption. The projections
from multiple angles are captured in a sinogram where the projection there is
the Radon transform of the volume. This projection can then be converted
back into a volume by the inverse Radon transform [243, 242]. The voxel sizes
in the resulting volume are dependent on the number of angles sampled and
the resolution of the x-ray detector.
The Hounsfield scale is used to measure absorption in Hounsfield Units
(HU), which are standardised against the absorption of air and distilled water
at standard temperature and pressure. Air is defined as -1000 HU and water
as zero HU. Thus one HU represents a change of 0.1% of the attenuation coef-
ficient of water. Table 1.1 defines the HU range for common medical materials
and Figure 1.1 displays an example CT lung axial slice — note how the bone
is bright and air spaces are dark.
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Substance HU Range
Fat -120 to -90
Cancellous Bone +300 to +400
Cortical Bone +1800 to +1900
Unclotted Bood +13 to +50
Clotted Blood +50 to +75
Pleural Effusion +2 to +33
Cerebrospinal Fluid +15
Lung -700 to -600
Kidney +20 to +45
Liver +54 to +66
Lymph Nodes +10 to +20
Muscle +35 to +55
Brain White Matter +20 to +30
Brain Grey Matter +37 to +45
Glass (foreign body) +500
Rocks (foreign body) +2100 to +2300
Copper (foreign body) +14 000
Steel (foreign body) +30 000
Table 1.1: The HU ranges of various structures found within the human body.
Data from a range of sources: [64, 88, 91, 148, 168, 176, 188, 228, 305].
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Figure 1.1: Example of a CT axial slice of diseased lungs. The lungs are
the darker regions on either side of the centre of the image, the white regions
surrounding are bone with the spine at the bottom, and the dark outer region is
the region outside of the body (air). The presence of brighter regions (non-air)
within the lungs is indicative of disease. Chapter 3 expands on this further.
1.1.2 MRI
MRI — magnetic resonance imaging — utilises the magnetisation properties
of atoms within the patient. A powerful magnetic field (3 or 7 Tesla in modern
scanners) is applied that aligns the spins of protons along the direction of the
applied field. These protons are normally oriented randomly. Most protons
are aligned in the direction of the field, however some are aligned opposing
it. A second, weaker magnetic field is applied to produce a magnetic gradient
across the imaging axis of the patient.
A third energy field - usually electromagnetic radiation in the radio fre-
quency spectrum - is then applied in the form of a short pulse with the fre-
quency of the waves being set to the resonant frequency of the protons in a
specific slice of the imaging axis. This frequency, also known as the Larmor
frequency, is the product of the magnetic field strength and the gyromagnetic
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ratio (a constant for each particle) [78], and hence the gradient of the field al-
lows localisation of the slice. Protons whose spin is aligned with the magnetic
field can absorb this energy to flip to become aligned against the field in a
higher energy state. The energy of the pulse is set to flip enough protons such
that 50% are aligned with the field and 50% oppose it. The application of this
field also aligns the spins of all protons, such that they are now in phase.
The result of these two effects is a transverse magnetisation that can be
detected. As the pulse ends, the protons gradually fall back into their original
state. This happens in two ways. First the protons’ spins fall out of phase.
This is due to the positive charge of protons repelling each other. This is called
the T2 or spin-spin relaxation. As this happens the transverse magnetisation
decreases to zero. Next the protons in the high energy flipped state flip back
to being aligned with the magnetic field. This is called T1 or spin-lattice
relaxation.
To measure the T1 and T2 properties of materials and thus differentiate
them, the time between pulses and the delay before measure of the transverse
magnetisation is varied. To measure T1 properties, a second pulse is applied
shortly after the first pulse, and then the transverse magnetisation signal is
recorded almost immediately after this. Molecules whose protons have been
able to relax fully in the time between the pulses will absorb the new pulse to
create a strong transverse magnetisation (due to 50% of the spins being aligned
each way). However, if the protons are still in the excited state when the new
pulse arrives, more unexcited protons will absorb the energy and flip to the
excited state. This leads to there being more than 50% of the protons now
spin-aligned against the magnetic field, which weakens the overall transverse
signal.
To measure T2 properties no second pulse is used. Instead the transverse
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signal is measured after some time after the original pulse. The strength of the
signal informs how in phase the spins are and therefore their T2 properties.
Figure 1.2: Examples of MRI brain slices of a patient with low-grade glioma
(a type of brain tumour). From left: FLAIR, T1, T1 contrast enhanced, and
T2 imaging. Each modality shows the same slice with the glioma located in
the lower left portion. See Chapter 5 for further details.
T1 imaging can be enhanced with the use of a contrast agent — a param-
agnetic agent administered to modify the T1 properties of protons to improve
the signal.
A third type of imaging exists called FLAIR (fluid-attenuated inversion
recovery). This uses a long delay between pulses and between the pulse and
recording the signal. Its purpose is to suppress the signal from water and
cerebrospinal fluid (CSF) for clearer imaging in organs such as the brain.








CSF Dark Bright Dark
White Matter Light Dark Grey Dark Grey
Grey Matter Grey Light Grey Light Grey
Bone Marrow Fat Bright Light Light
Demylinated Tissue Dark Bright Bright
Table 1.2: The general appearance of head tissue for T1, T2, and FLAIR MRI
scans [258].
1.2 Machine Learning
Machine learning is a wide collection of techniques that take a dataset and
produce some output of useful information about the data [97]. This is called
training. Once trained, the technique is able to take novel data (not seen be-
fore) and provide information about it based on what it has learned during
training. In this work I cover unsupervised clustering and supervised classifi-
cation machine learning.
In the unsupervised approach, the machine learning technique learns to
cluster its training data in the sample space. Then, novel data samples are
compared to their nearest cluster to determine how similar or different each
sample is. This is useful for abnormality detection.
For my supervised approaches, the training data is fed in with ground truth
for each sample. This ground truth is some accurate set of information about
the sample and is manually added to the data by a human. For instance, in a
CT scan it could be a label attached to each voxel indicating the presence or
absence of a disease; or for a sampled region, it could be a single label covering
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the entire region stating if a disease is present or not.
During training in a supervised approach, the machine learning technique
learns to map the data samples to the ground truth. Then, as novel data are
fed in (without ground truth), the trained technique can provide the ground
truth for them, and thus from this allows us to understand what the data is
showing. For instance, the technique could tell us the region of disease within
a CT dataset. The technique chooses the ground truth by comparing the
samples to the training data to see what ground truth is the best match.
1.3 Research History
Research into machine learning for medical imaging data has existed since the
late 1980s and 1990s [33, 147, 173, 193, 203, 210, 286], although it was around
2006 that deep models suitable for complex medical data were designed [127].
Over the past 5 – 10 years advancements in graphical processing units have
allowed for rapid prototyping of models of sufficient capacity for medical data
thus reducing barriers to development.
With this overcoming of major barriers, the field has experienced a rapid
increase in the number of publications of medical imaging data. Figure 1.3
shows the number of matches on Google Scholar [104] for the search term
<<“medical imaging” “machine learning”>> over the past 30 years from 1988
to 2019. The number of publications exceeded 10 000 in 2018 and has increased
at a rate of an order of magnitude every ten years during this time period.
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Figure 1.3: Log scale of the number of publications found on Google Scholar
[104] for the search term ‘“medical imaging” “machine learning”’ each year
from 1988 to 2019.
1.4 Taking it Further
This thesis has three key contributions that advance machine learning in med-
ical imaging further by tackling the challenges at the beginning of this section.
This section explains the high level contributions in overview, while Section
1.5 discusses the chapters in detail.
1. I test five abnormality detection machine learning methods on weakly
labelled medical data (CT interstitial lung disease) to compare their
speed and accuracy and derive useful results that could be applicable to
other medical imaging problems (Chapters 2 and 3). This addresses the
issue of dealing with rare pathology where training examples for that
pathology do not exist.
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2. I next take a supervised classifier’s voxel-level output on acute ischemic
stroke head CT and process this into a form suitable for a medical ap-
plication — the noting of presence/absence of ischemic stroke signs in
different regions in the brain — in Chapter 4. This form effectively dis-
tills the information from the classifier’s output, and thus the output
becomes interpretable at a patient level. This addresses distillation of a
model output.
3. Finally, I explore ways around some of the data sharing laws by removing
the need to move data around. This is achieved using a federated learn-
ing training algorithm in Chapter 5. This enables wider access to data
and therefore easier development of machine learning applications in the
industry. I introduce soft federated learning, a novel evolution of the con-
ventional federated learning algorithm, and compare it to conventional
federated learning and a number of baseline measures.
Where work has been previously published, it has been reproduced in this
thesis with permission from the publisher.
1.5 Chapter Overview
This section provides a detailed overview of each research chapter of this thesis,
starting from the first research chapter introducing the Novelty Forest and
progressing in order through to the chapter on Federated Learning near the
end of the thesis.
Chapter 2: Here I introduce the novelty forest, a novel form of the decision
forest — a binary tree ensemble approach — which efficiently clusters
data by using a subset of the features within the dataset. This is per-
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formed in an unsupervised manner for abnormality detection. I scruti-
nise the behaviour of the novelty forest using Gaussian distributions and
the Modified National Institute of Standard and Technology (MNIST)
handwritten digits dataset to demonstrate its strengths and weaknesses,
particularly with regards to its node division and growing behaviour.
Success and failure examples are discussed and I show that the novelty
forest is susceptible to noise.
Chapter 3: This chapter takes the novelty forest along with four other unsu-
pervised classification techniques and using CT interstitial lung disease
data extracted as either healthy or pathological patches — an abnormal-
ity detection problem — I compare the accuracy and runtime speed of
these five methods on a range of data embeddings.
The new methods are the one-class support vector machine, isolation
forest, local outlier factor, and fast-minimum covariance determinant
estimator, which each represent a different family of techniques. The
embeddings I use are the salient components from principal component
analysis and its kernel form, and the embeddings from the condensed
layer of a flat autoencoder and a convolutional autoencoder. The data
consist of patches of healthy, emphysema, fibrosis, ground glass opacity,
and micronodule pathology.
Chapter 4: I explore a specialised convolutional neural network model on
non-contrast head CT of suspected ischemic stroke patients. This model
aims to highlight areas of early ischemic change. Non-contrast CT (NCCT)
is often the first scan that gets taken of a patient due to its speed and
availability in ambulances (particularly, mobile stroke units). Therefore
being able to classify it accurately is crucially important.
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The model produces voxel-level confidence masks of ischemic stroke by
comparing the brain hemispheres. Then I use a brain region atlas to
deliver the Alberta Stroke Programme Early CT Score (ASPECTS) (a
clinically meaningful measure of stroke severity) from the predictions.
The atlas is a typical brain volume with the ASPECTS regions overlaid
and is rigidly aligned to my other samples. I use rules saying for a region
to be classed as ischemic it requires either a certain fraction of its volume
as ischemic prediction or it requires an ischemic prediction of any size in
any one region. This ensures an accurate conversion from the prediction
masks to regions.
This chapter focuses on the conversion of predictions to this score and
compares the scores the model’s predictions provide to those provided
clinically, those from the ground truth segmentations used to train the
model, and those by visual examination of the CT volumes by the creator
of the ground truth segmentation. This is done at both the volume level
and region level.
Chapter 5: I expand on neural network training by using a series of model
copies in a federated setup. In this setup, each model copy sees a subset
of the total data and can only communicate that data to the other copies
through its learned parameters. A regular sharing of parameters is used
to develop all models over training cycles. This happens by periodically
aggregating the shared parameters into a new model and then replacing
all of the current model copies with copies from this new model.
After introducing the concept of federated learning, I evolve it to a new
algorithm called soft federated learning that is able to recognise when
there are differences between the data each network sees (covariate shift)
and can adjust the parameter sharing accordingly to account for these
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differences. Soft federated learning does this in two steps. First it dis-
covers how similar these data subsets are by training a model within each
one and evaluating it on each subset, including its own. The evaluation
happens on data not seen during training and the performance provides
a measure of similarity. The second step involves adjusting the parame-
ter aggregation step to now create a unique model for each data subset
based on how similar that subset is to others — models from similar
subsets are weighted higher than those from dissimilar.
I demonstrate the ability of this new method on transformed MNIST
data, and then compare both methods on the Brain Tumour Segmenta-
tion (BraTS) medical dataset, which contains Magnetic Resonance Imag-
ine (MRI) brain glioma scans from multiple institutions. The tranformed
MNIST data takes the MNIST dataset and applies one of a range of affine
transformations or noise to each sample in a data subset, such that each
subset has one transformation applied to all of its data. For the BraTS
dataset, its splits in source institution provide the model training data
subsets.
I show that soft federated learning is effective in a range of crafted sce-
narios and is able to match the accuracy performance of conventional
federated learning on the BraTS medical dataset.
Chapter 2





The novelty forest, an evolution of the decision forest, is a decision tree ensem-
ble approach for efficient abnormality detection in imaging data. It sparsely
evaluates the features in a sample to allow for efficient clustering using a spec-
ified information gain. Features in this case are the pixel intensities in a set of
images. Once clustered, each sample delivers an abnormality score indicating
how well it fits within its cluster. I introduce the novelty forest and explore
its behaviour on the MNIST dataset divided into even and odd digits repre-
senting normality and abnormality. We discuss issues surrounding the use of
its information function and edge cases involving singular covariance matrices
53
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and a large Mahalanobis distance relative to the number of data dimensions.
Success and failure examples are shown and I explore the novelty forest on a
simple imaging dataset of handwritten digits to discover how the node division
during growth and the stopping criteria affect the accuracy when tested on
clean and noisy versions of the images. The noisey versions are generated by
adding Gaussian noise to the original images on a per pixel basis. A more
detailed evaluation of the novelty forest occurs in the next chapter (Chapter
3).
2.2 Introduction
In this chapter I introduce the Novelty Tree — a novelty (abnormality) detec-
tion method based on decision trees [128, 61] and use it as an ensemble method
called the Novelty Forest. This efficient method seeks to operate at a low com-
putational cost while not sacrificing accuracy, especially on high-dimensional
medical imaging datasets. It does this by utilising a narrow range of features
in a dataset — the fewer features, the higher the efficiency. The Novelty Forest
is introduced in this chapter and demonstrated on a simple problem. In the
next chapter I evaluate it against four common novelty methods.
This chapter starts with an introduction to the concept of decision trees
and decision forests (Section 2.3) and a literature overview (Section 2.4) before
introducing the Novelty Forest in Section 2.5. Following this, specific design
details of the Novelty Forest and its pseudocode are described in Section 2.6,
and a proof of concept on simple artificial data is found in Section 2.7. Section
2.8 then notes weaknesses of the Novelty Forest. I then introduce a set of data
in Section 2.9 and record the performance of the novelty forest with various
growing and stopping criteria on this data in Section 2.10. Finally, discussion
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and conclusions are in Sections 2.11 and 2.12.1
The novelty forest is used in this chapter on MNIST data to highlight its
strengths and shortcomings, and then used in the next chapter (Chapter 3)
for medical dataset evaluation alongside several other methods.
2.3 Decision Forests
A decision tree is a structure made up of nodes, each of which make some
decision. The nodes can be branch nodes, which connect to two or more deeper
nodes — called child nodes; or they can be leaf nodes, which are the terminal
points of a tree and do not perform any decision making. The first node of
the tree is called the root node, although it will also be a branch node or a
leaf node. Figure 2.1 illustrates a simple decision tree with each branch node
leading to two child nodes. While a decision tree’s branch nodes can feature
two or more child nodes, the novelty tree introduced later focuses on binary
branching as it is convenient and the most common way of designing a decision
tree. Decision trees have been shown to have a better overall performance than
a conventional single-stage classifier with the same number of features because
the different feature subsets can be selected at different levels within a tree
[308].
1Acknowledgement: The original idea and theory presented in the section introducing
the novelty forest (Section 2.5) and the content in Section 2.6.1 was devised solely by Dr.
Poole, my industrial supervisor, and was adapted from an internal report written by Dr.
Poole [236]. My contribution to this work is the remainder of this chapter.
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Figure 2.1: A simple 7-node binary decision tree showing the root node, branch
nodes with two child nodes each, and leaf nodes. Example decision choices
are displayed in the branch nodes where a feature (represented by a or b) is
compared against a threshold. The Y/N labels show the Yes/No path to follow
based on whether or not a sample follows the decision in that node. The leaf
nodes show the set of all decisions that lead to that node. Data samples enter
through the root node and are individually processed down the tree until a
leaf node is reached.
Decision trees are used to sort and classify data. A data sample begins at
the root node and, if this node is a branch node, will be passed to one of the
child nodes based on a simple decision. The root node itself can be a leaf node,
in which case a data cohort is not divided. This decide-and-pass-on method
is applied at every branch node the sample encounters until a leaf node is
reached.
Decision trees feature a growth stage followed by a prediction stage. During
the growth stage, the tree is created from a set of training data and some pre-
determined rules on how to process this data. A tree grows from its root node
to its leaf nodes. The rules may include the information gain of a decision, or
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restrictions on depth, sample size, or tree complexity, and so on. During the
prediction stage, samples of unseen data (i.e. data not used during the growth
stage) are fed individually into a grown tree, where they then are processed
into a leaf node and evaluated.
Decision trees can be collated into an ensemble called a decision forest
[175]. Each tree in the forest gets a random subset of samples from the training
cohort, and so it grows differently. These differences can be structural in the
number of nodes and depth of the tree, or decisional in the decision rules the
nodes learn2. See Figure 2.2 for an example of different (fictional) trees in a
forest.
When the forest is used for prediction, each sample is fed through each tree
and the outputs — the leaf nodes the samples ends up in — are aggregated
for the final result.
2To expand on this, the structural differences can also include factors such as the number
of child nodes per branch, tree truncation, or any other factor that is outside a node.
Decisional differences focus on the nodes themselves, changing how the exact node behaves
and processes the data. These two types capture all possible differences between trees.
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Figure 2.2: A forest consists of multiple trees, which may have a varying
structure. Six example trees are shown here, but a forest may have any number.
A large forest may be comutationally inefficient, while a small one may risks
bias or poor accuracy.
2.4 Previous Work
Decision trees are a effective algorithm for multistage decision making. Com-
mon alternatives are table look-up rules [119], which can be inefficient due to
checking redundant choices, optimal decision trees [35, 29, 121, 152, 204, 303]
that use the final objective of the decision tree to choose its form (as opposed
to growing the tree one node at a time maximising the division), but require
additional complexity in finding the optimal form, and sequential approaches
that evolve on samples one at a time [100, 288].
Optimality criteria for tree design include: minimising the error, having
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min-max path length (minimising the maximum number of nodes in path to a
decision), achieving a minimum number of nodes or expected length of path,
and maximising the information gain [251]. Some trees only use a priori knowl-
edge and do not optimise via any other means. For example, Argentiero et al.
used a set of 2D canonical transforms and Bayes table look-up decision rules
based on a priori information [9]. Similar approaches can be found for noisily
printed Chinese character recognition [112], and white blood cell classification
[170]. Casey and Nagy used characters with some pixels within each character
either on or off (black or white) with some probability. They then used these
a priori class probabilities and number of black (on) bits in each pixel position
in each class to design the tree to yield a prescribed error probability [46].
Other methods of designing the tree have been proposed. Diday and
Moreau used a nearest neighbours hierarchical algorithm that served to cluster
nearby (similar) samples into a node, and then clustered nearby nodes into a
higher level node, and repeated until all samples were contained within a single
node, effectively building the tree from the leaf nodes up to root [75]. Payne
and Meisel designed their tree from root to leaf by optimising min-max path
length, minimum number of nodes in the tree, and expected path length at
each node [230]. The Kolmogorov-Smirnov criterion [155] was used by Rounds
to optimise the classification decision at each tree node [248], while Sethi and
Sarvarayudu maximised mutual information gain at each node [267]. Scheur-
mann and Doster showed how using a soft (probabilistic) decision strategy
could be used to build a tree [259].
Other interesting research related to decision trees include Sethi who showed
the equivalence of a decision tree and a neural network and how to convert
from a tree to a neural network [266], Wang and Suen who analysed a range
of theories for constructing a tree top-down using entropy as the node opti-
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misation task [289], and Criminisi et al. provide a good overview of different
decision forest designs and optimisations in [60].
2.5 An Introduction to the Novelty Forest
The novelty tree is inspired by the density tree (introduced in [59]; see also
Section 2.5.1) and seeks to sparsely evaluate the features in a sample to allow
for efficient clustering and evaluation speed. A feature here refers to a single
parameter in a data sample — for example, a pixel in an image. Each node
looks at a single feature to make a decision. A novelty tree seeks to cluster the
training data using as few features as possible to minimise memory usage and
improve speed.
The novelty forest – an ensemble of novelty trees – can be thought of as a
clustering algorithm followed by abnormality detection.
During test time, an unseen sample is fed through a forest, passing through
each tree and, within each, being channeled to the nearest cluster of training
data. A z-score distance metric (explained shortly in Section 2.5.2) is deter-
mined based on how close the novel sample is to the training cluster, which
gives a measure of abnormality. The Novelty Forest is implemented in the
Python programming language (version 3.6) [93].
2.5.1 The Density Tree
The density tree is a binary decision tree that learns nodes that maximise
some form of information gain at each node to classify the sample space by
sample density. All features are evaluated at each node. At each leaf node the
samples are modelled as a Gaussian distribution, such that a single density
tree can be viewed as a special case of a Gaussian mixture model. Samples
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are evaluated against the mean and variance of this Gaussian to deliver an
abnormality score.
The novelty tree differs from the density tree in its use of a minimal number
of features for the clustering and Gaussian evaluation, making it more efficient.
The runtime complexity of the novelty tree is not significantly affected by the
number of features in the data, while the density forest has a O(fn) relation
where f is the number of features and n is the number of nodes. This is
because each additional feature causes an additional calculation in each node.
2.5.2 Defining the Novelty Tree
The novelty tree’s branch nodes learn a threshold-feature pair that seeks to
optimise the information gain3 (Equation 2.1) of the data division between








where Ij is the information gain of a split at node j, |S ij| is the number of
samples in the left or right (i = L or R) child node, |Sj| is the total number of
samples in the node, and H being the entropy — defined as the log determinant
of the covariance matrix:
H(S) = log(|Λ(S)|) (2.2)
where Λ is the covariance matrix — in my case this collapses down to the
standard deviation as I only evaluate one feature at a time. Since |Λ(S)| is
related to the volume occupied by a Gaussian distribution, the above criteria
partitions a dataset into tight distributions.
3“Information gain” is a broad term and the form I use here should not be confused with
other common forms - see [96].
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During the prediction stage, each sample is fed down a tree to end in a leaf
node. The training data in that leaf node is used to deliver an abnormality
score. The abnormality score is a measure of how outlying a sample is relative
to the others in its leaf node. My abnormality score is the z-score, which is the
number of standard deviations a sample is from the mean of all samples within
that cluster [161]. Although the z-score can take negative values denoting a
sample is below the mean, throughout this work I use the z-score as a distance





where z is the z-score, x is a data value being evaluated against a distribution,
µ is the distribution’s mean, and σ the distribution’s standard deviation.
The novelty forest aims to deliver a z-score from the leaf nodes computed
by assuming Gaussian distributions for only the features used in the path
from the root node to leaf node — all other features are ignored for efficiency
purposes. A novelty tree requires only a single feature to be measured at each
branch node as opposed to the full feature vector used in decision trees [35].
As the z-score is strictly 1D and the novelty tree will usually deliver mul-
tidimensional clusters, I use the multidimensional equivalent of the z-score:
Mahalanobis distance [194], and later convert it to the z-score (Section 2.5.3).
At each leaf node, the Mahalanobis distance is calculated based on the set of
unique features measured in the path from the root node to that leaf node.
Equation 2.4 shows the Mahalanobis distance where x is a sample, µ is the
mean vector for a multivariate Gaussian (MVG), and Λ−1 is the inverse of
the covariance matrix for the MVG. T is the transpose [297]. The covariance
matrix in the case of the novelty forest consists of only the features used in
the path from the root to the leaf node.
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D(x;µ,Λ) =
√
(x− µ)TΛ−1(x− µ) (2.4)
The novelty tree has one key advantage over the density tree.
 The full mean vector and covariance matrix need not be estimated at
all nodes of the novelty tree. The use of every feature dimension in a
sample is computationally costly. There is also likely to be redundancy
between features. One feature’s value may be correlated strongly with
another feature. Hence evaluating every feature is an inefficient use of
resources. A node should only evaluate the most important features.
2.5.3 Converting from Mahalanobis Distance to Z-Score
via χ2
The Mahalanobis distance is itself a measure of abnormality and works with
any number of dimensions. However, its interpretation is dependent on the
number of dimensions it is calculated in. I convert it to a z-score via the χ2
distribution to provide comparable distances. The z-score for a test sample
is the mean of the z-score produced by the trees in the novelty forest. The
χ2 distribution comes about because it is the Euclidean distance of normally-
distributed independent random variables from the origin for a given number
of degrees of freedom.
A k-dimensional MVG distribution with respect to D2 follows a χ2k distri-
bution, where k is the degrees of freedom parameter — the number of features
in my case. I denote the cumulative χ2 distribution as Fk(). The interpre-
tation of Fk(D2) is: the proportion of the probability mass lying inside the
hyper-ellipsoid defined by Mahalanobis distance D.
By using the inverse of this, it is possible to transform a Mahalanobis
distance measured in k-dimensional feature space, Dk, into an equivalent 1-
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1. A (squared) Mahalanobis distance Dk is obtained for some k-dimensional
pattern vector of interest, based on µ and Λ, as in equation 2.4.
2. I convert this to a cumulative distribution percentile via Fk().
3. Then convert back to a (squared) Mahalanobis distance appropriate to
a 1D Gaussian, via F−11 ().
4. I obtain a z-score by taking the square root.
The above expression allows us to convert a Mahalanobis distance measured
in any number of dimensions into a z-score.
2.6 Design Parameters
2.6.1 Growing a Novelty Forest
Information Gain: The objective function used during the growth stage is
a form of information gain that we defined in Equation 2.1. The gain is
based on the single feature being tested. This encourages splits which,
along the feature being tested, result in child nodes having small standard
deviations compared with the parent.
Division Method: We have two division methods for finding the optimal
split in a branch node: the best of a selection of random feature/threshold
pairs, and an optimised random feature split. The randomness creates a
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large degree of diversity between trees in the forest, which is beneficial
for the ensemble approach. In my experiments, we trial both to learn
their effectiveness.
Random Feature/Threshold : A set of 1000 randomly chosen feature-
threshold pairs are evaluated for information gain. The highest gain
is chosen for the division.
This technique allows for a high probability of finding a high in-
formation gain split, ensuring the most relevant features are used
for growing the tree. However, the downside is that the threshold
chosen may not be the most optimal for the chosen feature.
Optimised Feature : A randomly chosen feature is evaluated across
its range with 1000 equally-spaced interval steps to identify the
optimal threshold for information gain. This threshold and feature
is selected regardless of the information gain it offers.
The benefit of this technique is that it does not require searching
the entire feature/threshold space and instead focuses on achieving a
perfect split along a single feature. Although this feature may not be
informative, across a forest of trees where each tree randomly selects
a feature, the average of all these features should approximate the
full feature space. Of course, this technique can fail if a large number
of features are uninformative.
Figure 2.3 shows an example of the Random Feature/Threshold method
of selecting features and thresholds, while Figure 2.4 shows the Optimised
Feature method.
Leaf Size Checking: A practical method of stopping tree growth is ensuring
a minimum number of samples in a leaf node. If there are too few sam-
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ples, then the covariance matrix and mean will have a large uncertainty,
which leads to problems when seeking an accurate z-score during predic-
tion. This is done by setting a minimum value for the number of samples
required in a leaf node. This value may be a constant to use throughout
the tree (e.g. 100 samples minimum per leaf), or it can be a function
of depth (e.g. d2 minimum samples in a node, where d is the depth of
the node). The choice of d2 arises from the number of values in the co-
variance matrix, which is a square of the number of features used, which
is the depth of the node. With the number of samples increasing with
the size of the covariance matrix, the sampling error of the covariance
matrix remains constant.
Sample Size and Feature Count: To grow a forest of different trees, each
tree must be grown differently. While there is some randomness intro-
duced in the division method, additional variation can be added by grow-
ing each tree with a random subsample of samples and features present
in the full data. This also reduces the growth and prediction times of
each tree as they grow smaller.
Tree Count: Finally, the number of trees in a forest can be adjusted. Having
few trees allows for speed and minimal memory usage at the cost of
accuracy, while many trees allows z-scores to be determined to higher
precision.
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Figure 2.3: An example of Random Feature/Threshold selection for a dataset
with five features whose value ranges are represented by the bars. The marks
within the bars show ten possible choices for the feature and threshold this
method might select.
Figure 2.4: An example of Optimised Feature selection for a dataset with five
features whose value ranges are represented by the bars. If this method is used
to select ten thresholds and Feature 2 was chosen, the marks within this bar
show the choices for the threshold.
2.6.2 Pseudocode
Pseudocode for growing and evaluating with a Novelty Forest can be found in
Algorithms 1 and 3.
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Algorithm 1 Novelty forest growth stage
for Tree in Forest do
Subsample samples and features
Call Algorithm 2 createNode(Data, Root Node)
Return set of Trees
Algorithm 2 createNode(Data, Node)
if Stopping criteria met then
Set node to leaf node
Return
else
Find threshold and feature to divide
Create Left Child Node
Create Right Child Node
Split Data into Left Node Data and Right Node Data
Call Algorithm 2 createNode(Left Node Data, Left Child Node)
Call Algorithm 2 createNode(Right Node Data, Right Child Node)
Algorithm 3 Novelty forest prediction stage.
for Tree in Forest do
for Sample in Test Data do
Call Algorithm 4 predictionNode(Sample, Root Node)
Return average z-score for each sample
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Algorithm 4 predictionNode(Sample, Node)
if Node is Branch Node then
if Sample at Node.divFeature ≤ Node.divThreshold then
Append Node.divFeature to Node.featurePath
Call Algorithm 4 predictionNode(Sample, Left Child Node)
else
Append Node.divFeature to Node.featurePath
Call Algorithm 4 predictionNode(Sample, Right Child Node)
else
Calculate z-score for Sample using unique Features in Node.featurePath
Return z-score
2.7 Proof of Concept
In this section I explore the behaviour of the Novelty Forest on a series of
simple artificial tests using Gaussian distributions.
2.7.1 Dividing Two Gaussians
When presented with a simple one-dimensional case of two sampled Gaussian
distributions separated by some distance such that they are fully separated
and there is space between them, the novelty forest divides these with a single
branch node, such that each child node contains a full Gaussian.
For the random feature/threshold division method, the threshold is selected
at random in the empty space between the Gaussians. For the optimised
feature method, the division is the lowest evaluated threshold in this gap as
this is the first threshold checked that produces maximal information gain.
This behaviour remains when there is a partial overlap between two Gaus-
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sians. The midway point between the peaks of the Gaussians is used for the
division.
2.7.2 Dividing N Gaussians
In the case of N Gaussians, where N > 2, each separated by an equal distance,
the novelty forest divides them as above, but the first split is between the two
most central Gaussians. The child nodes will contain the same number of
Gaussians as each other, or, if the parent data contains an odd number of
Gaussians, one child node will have one more Gaussian than the other. This is
because the information gain of dividing the Gaussians evenly is higher than
for any other division.
2.8 Issues with the Novelty Forest
This section provides an overview of problems that became apparent during
early testing of the Novelty Forest. Carefully designed examples are used to
show the failings of the algorithm.
2.8.1 Issue 1 - Impossibility of Finding Optimal Infor-
mation
An optimal feature/threshold split in a dataset can only be found if the distri-
bution for each feature is continuous. When there are gaps in a dataset, which
many datasets will have to some extent, a single optimal threshold cannot be
identified. This means that even if the optimal feature is found, the precise
threshold will be unknown. See Figure 2.5 for an emphasised example using
two sampled Gaussians.
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Figure 2.5: Two Gaussians separated by some distance will produce identical
(and maximal) information gain for any division that takes place in the space
between them - annotated by the central vertical lines.
2.8.2 Issue 2 - Singular Covariance Matrices
During the prediction stage, the covariance matrix of samples in a leaf node
may be singular in cases where there is a strong correlation between features,
which is problematic during the calculation of Mahalanobis distance (Equation
2.4) as the inverse of the covariance matrix is taken to calculate the distance
metric. A singular matrix does not have an inverse because of its zero deter-
minant.
This is resolved by using the Pseudo Inverse function [275] from the SciPy
library [264]. This allows for the inverse to be taken at a minimal cost to
overall speed and works by using a least squares generalisation to solve for the
matrix.
2.8.3 Issue 3 - Very Large Mahalanobis Distances
Upon calculating the Mahalanobis distance, this value is converted to the z-
score via Equation 2.5. If the Mahalanobis distance is large - with the definition
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of large being relative to the number of dimensions - the χ2 value saturates
and Fk(D2k) becomes one. This is due to the limited precision of floating point
numbers, leading to a value very close to one becoming rounded to one. This
causes an issue when converting this value to a z-score as the z-score becomes
infinity. This is both false and unworkable.
To resolve this, the program checks for a value of one when a Mahalanobis
distance is converted to the χ2 domain. If found, it sets the z-score to be
the highest allowed non-infinite value for a floating point number. This ap-
proximation highlights the test sample as highly abnormal while allowing for
a numerical value that can be used in the forest.
2.8.4 Issue 4 - Failure Case: Missing Unseen Features
Here I present a more complex problem. Imagine a case where there are
two classes in the training data, and each sample has two binary features
(see Figure 2.6). Referring to the figure, a novelty tree will learn that the
first (left) feature in the training data is important as it differs between the
classes, whereas the right feature does not. Thus a branch node will grow that
sends these two classes of training data to separate leaves. This is expected
behaviour.
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Figure 2.6: If the training data contains many examples of two distinct classes
of data, the novelty tree will — in this example — learn to divide the data
using the left feature as this is the descriptive feature. When using the testing
data for prediction, which has one class the same as one class different to the
training data, all of the data will be sent to the left leaf node as only the first
feature is checked. This means the novelty tree fails to separate the classes.
This failure occurs because the testing data has an unseen class within it.
However, when the two test cases are input to the tree, they will both be
channeled down the left node and evaluated against the first feature. The
first case is correctly classified as belonging to that leaf, but the second case
is incorrect as the second feature - ignored during the evaluation - is different
to the others. This failure is caused by the tree not learning to split at the
second feature, which in turn is caused by there not being any training data
with a variation with this feature.
While a lack of training examples of a certain class is an issue for most
trained classifiers4, the novelty forest is particularly vulnerable to them as it
only factors in a subset of all features during training. This makes its use as
4Other abnormality detection methods, as described in Chapter 3, are a notable excep-
tion.
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an abnormality detection method questionable.
The argument against this failure case is that the gain in efficiency by only
checking a small subset of features outweighs the cost in accuracy by potentially
mis-evaluating cases in the testing data that do not follow the patterns in the
training data. The novelty forest is designed with efficiency in mind.
2.9 Data
I use the Modified National Institute of Standards and Technology (MNIST)
dataset [306] as a simple dataset to explore the Novelty Forest’s behaviour.
This dataset is a collection of 70 000 2D images of handwritten digits. Each
image is normalised and centred to a 28 x 28 pixel area and created by applying
an anti-aliasing filter to the original black and white version of the digit. Each
digit appears in approximately equal proportions.
From this dataset I create two sets of data called MNIST Even and MNIST
Odd:
MNIST Odd Dataset: I take the odd-valued digits (1, 3, 5, 7, 9) and from
these separate out 5000 at random. The 5000 are placed in the normal
test set, while the remaining around 30 000 are put in the training set.
These are used for training and testing the novelty forest in Section 2.10.
I then take the even-valued digits (0, 2, 4, 6, 8) and form the abnormal
test set.
MNIST Even Dataset: The same as above, but with the even and odd
digits swapped. Thus the training set and normal test set consist of even
digits, while the abnormal test set holds odd digits.
The training data serves to grow the novelty forest, the normal test set pro-
vides a baseline for the forest’s performance on data similar to its training data
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(i.e. normal data samples), and the abnormal test set gives the performance
when evaluating on data different to its training data (i.e. abnormal data sam-
ples). This simulates abnormality detection where normal data are plentiful,
but some rare examples, represented by the abnormal test set here, are not
available during train time. Chapter 3 goes into more detail on abnormality
detection.
I also use a noisy variant of these datasets. With noisy, I add Gaussian
noise to each digit with the Gaussian having zero mean and a variance of
1000. The noise is sampled from this Gaussian and added to the intensity
value of each feature (pixel). The noisy data will strain the model. These four
datasets are chosen as they offer a sufficiently high complexity to explore the
behaviour of the novelty forest, but are simple enough for the results to be
easily interpreted. My results, shown later, demonstrate this.
Figure 2.7 shows examples of MNIST digits and their noise-added variants.
3 (original) 4 (original) 6 (original) 9 (original)
3 (noise added) 4 (noise added) 6 (noise added) 9 (noise added)
Figure 2.7: Examples of MNIST digits and their Gaussian noise-added vari-
ants.
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2.10 Experimentation
To understand how the novelty forest’s performance is affected by the division
method and stopping criteria on various datasets, I perform a comprehensive
evaluation under these parameters. I use the MNIST Odd and MNIST Even
datasets and the Gaussian noise-added variant of them introduced previously.
Each test digit is assigned a z-score and labelled as normal or abnormal ac-
cording to which test set it came from.
On each dataset I apply a novelty forest with either the Random Fea-
ture/Threshold division method or the Optimised Feature method, leading to
eight experiments. For each experiment the novelty forest is tested with three
stopping criteria: a minimum number of samples of 10 or 100 in each leaf node,
or a minimum number equal to the square of the node’s depth. The novelty
forest is evaluated for its area under the curves for the Receiver Operating
Characteristic (ROC) curve and the Precision-Recall (PR) curve when tested
on the normal and abnormal test data sets. The ROC curve measures the true
positive rate (TPR) against the false positive rate (FPR) (both defined below)
with 0.5 representing a performance that could be obtained by randomly as-
signing class labels to the data samples; scores range from 0 to 1 with higher
scores indicating more TPs or less FPs. The PR curve measures precision
against recall with these terms defined below. The value can be between 0 and


















where TP , TN , FP , FN represent the true positives, true negatives, false
positives, and false negatives respectively.
The forests are grown with 100 trees, each with a random 10% of the
samples and a random 10% of the features. These parameters were found in
prior tests to provide a suitable ensemble of trees in the forest without costing
excessive computational resources. Each experiment is repeated three times to
gauge the variance and the results averaged. Table 2.1 displays the accuracies.

















































































Table 2.1: The performance of the novelty forest across a variety of algorithmic
parameters. The error is the standard deviation of the three experiments of
100 trees with each tree using a random 10% subset of features and samples.
The top row in each cell is the area under the ROC curve; the bottom is the
area under the PR curve. MNIST E/O represents the even and odd datasets
respectively and the (Noisy) label represents the dataset with added Gaussian
noise.
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2.11 Discussion
My two division methods first select a feature and then choose a threshold
within this feature. This means each feature is selected with equal probability,
but the thresholds within a feature are searched inversely proportionally to the
feature’s value range.
The number of leaf samples used in the stopping criteria should not be
a constant. The covariance matrix used for the Mahalanobis distance is a
function of the depth2 as it is the number of features used squared. To estimate
the covariance matrix’s values, which is a 2D square matrix of the features used,
there should be at least as many samples as there are values to estimate. This
is where the depth2 stopping criteria comes from. This enables larger training
sets to form deeper trees, but the number of samples would need to increase
quadratically with depth. This limits the depth of a tree and thus keeps it
efficient.
Despite this, the best performing stopping criteria were the minimum 10 or
100 samples in leaf nodes. This means the increase in accuracy from forming
deeper trees and smaller clusters outweighed the loss in accuracy from uncer-
tainty in the covariance matrix. This may be because many of the features in
MNIST are uninformative, so most nodes in the tree are useless in the case of
the Optimised Feature method. With Random Feature/Threshold the number
of useful combinations found is likely to be low, so even the best found split
may not be great. I believe having more nodes in the tree is a way around this
as more feature/threshold splits will be explored, leading to a higher chance
of finding the useful combinations. This may not be an issue when using data
with a higher proportion of informative features. In general, the Random Fea-
ture/Threshold method performed stronger on the MNIST datasets. If the
proportion of useful features increased, I would expect the Optimised Fea-
Chapter 2. The Novelty Forest 80
ture method to improve because on average it will then find better splits (by
optimising features as before but having a higher chance of targeting useful
features).
The MNIST Even dataset (even training digits) had much poorer perfor-
mance than the Odd dataset with the area under the ROC curves around 0.5
in all cases, which is random chance accuracy. The features learned on the
even digits were not useful for distinguishing the even and odd digits during
test time. The even digits: 0, 2, 4, 6, 8 have lower interclass variability than
the odd digits 1, 3, 5, 7, 9. With the even digits, 0, 2, 6, and 8 all show similar
curves at the top or bottom of the digits. Only the 4 is relatively unique. The
trees will be splitting according to this digit alone, at least at the high levels,
and these splits may not be informative for distinguishing the odd digits. On
the other hand, the set of odd digits have higher interclass variability. 3, 5,
and 9 have similar structures in them, but have differences too. 1 and 7 are
incomparable to these digits. The trees will be forming more informative splits
with this data and this in turn leads to a greater discriminative power on the
test data.
2.12 Conclusions and Further Work
There is a need to explore the Novelty Forest with a wider range of data,
especially data that has a higher proportion of informative features. This will
aid in understanding the strengths of the two division methods. I would also
like to explore what would happen if every feature was equally informative. I
would expect the Optimised Feature method to perform strongly here, as each
node will be optimally thresholded. The Random Feature/Threshold method
would be unlikely to find the optimal threshold for any feature, so performance
could be lower. Likewise if there was only a single informative feature in a large
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range of features, the Random method should be able to find it and find an
acceptable split, while the Optimised method would struggle here.
There is also a case for introducing a smarter division method. One that
randomly samples the features and thresholds at first to determine which may
be the most useful and then focuses searches within these areas. This will come
with a cost during the growing stage, but will not affect the prediction stage.
It is also possible that prior knowledge about the distribution, if available,
could be used to improve the division method by providing areas to search in
or clues about finding optimal thresholds. However, as decision forests depend
on a substantial degree of randomness to search the solution space, this may
not be the best way forward.
In a similar line, the criteria for optimising (the information gain) could be
modified to better identify optimal areas. For instance, the derivative of the
information gain would provide a gradient, which could be used by the division
method to shift its search towards a likely higher gain area. Alternatively, the
criteria could be chosen specifically for the dataset at hand as the information
gain might not be the most suitable quantity for all datasets. Information gain
is about minimising the standard deviations of child nodes, which might not
be the best choice for every dataset. More research is needed here to explore
this.
Next Steps: I take the Novelty Forest, along with four soon-to-be-introduced
abnormality detection techniques, and evaluate them on medical data under a
range of embedding methods in the next chapter.
Chapter 3






Abnormality detection, also called outlier detection and novelty detection,
seeks to identify data that do not match an expected distribution. This may
be done by learning a model of normality, against which new samples are
evaluated. In this chapter the novelty forest introduced previously and four
other abnormality detection methods, each representing a different family of
techniques, are compared. These methods are local outlier factor, the one-
class support vector machine, isolation forest, and fast-minimum covariance
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determinant estimator.
Each method is evaluated on patches of CT interstitial lung disease where
the patches are encoded with one of four embedding methods: principal com-
ponent analysis, kernel principal component analysis, a flat autoencoder, or a
convolutional autoencoder. These methods seek to capture the salient trends
of the data, allowing the outlier detection method to perform with higher ac-
curacy and speed. The methods are also evaluated on the non-embedded (raw)
data for reference.
The dataset consists of 5500 healthy patches from one patient cohort defin-
ing normality, and 2970 patches from a second patient cohort with emphysema,
fibrosis, ground glass opacity, and micronodule pathology representing abnor-
mality. From this second cohort 1030 healthy patches are used in the evaluation
for a comparison to the abnormal patches.
Evaluation occurs in both the accuracy (area under the receiver-operator
curve) and runtime. The fast-minimum covariance determinant estimator
shows fair time scaling with dataset dimensionality, while the isolation for-
est and one-class support vector machine scale well with dimensionality. The
one-class support vector machine is the most accurate, closely followed by the
isolation forest and fast-minimum covariance determinant estimator. The nov-
elty forest is found to be fast with good accuracy. The embeddings from kernel
principal component analysis are the most generally useful.
3.2 Introduction
Abnormality detection – also known as outlier detection or novelty detection –
is a type of unsupervised data classification process whereby a model of normal
data is created against which unseen data samples are compared. The class
labels of the samples are not used (beyond normal/abnormal). The unseen
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samples that match the model are classed as normal, while those that do not
are classed as abnormal. Normal and abnormal samples may be referred to as
inliers and outliers respectively.
An outlier is defined by Hawkins [122] as “an observation point, which
deviates from the other observation points so much that it is caused by the
suspicion that it is generated by different mechanisms.” Barnett et al. [23]
provide a similar, but simpler, definition: “An observation (or subset of ob-
servations) which appears to be inconsistent with the remainder of that set of
data.”
Abnormality detection finds use in situations where normal data are plenti-
ful or easy to obtain and represents the space of normality well, but abnormal
data are logistically difficult, expensive, or otherwise challenging to obtain; or
where it is unreasonable to collect data on the full space of abnormality because
the space required to be sampled to capture all possibilities is large or infinite.
Abnormality detection can be used in medical imaging to, for example, find
patient data with possible pathology or, more generally, to exclude data that
are normal (healthy). Every patient is unique and being able to model the
range of healthy patients is crucial to being able to detect rare diseases that
may not appear in any training data.
There are a broad range of methods for abnormality detection. The most
popular ones fall into four categories: random forest, hyperplane separation,
Gaussian fit, and distance/density measurement. For each of these categories
I select one of the most influential algorithms for my evaluation: The Isolation
Forest [182] for the random forest, the One-Class Support Vector Machine
[256] for the hyperplane separation, Fast-Minimum Covariance Determinant
Estimator [249] for the Gaussian fit, and Local Outlier Factor [37] for the
distance/density measurement. I also take the novelty forest introduced in the
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previous chapter (Chapter 2) for comparison.
These methods ultimately assign a value to each sample that describes its
abnormality – or in other words how likely that sample is to not belong to the
normal population. I call this the abnormality score. The abnormality score is
a measure of how abnormal a sample is, with a lower score (bounded by zero)
indicating a perfectly normal sample, while an increasing abnormality score
– which has no upper bound – shows an increasingly more abnormal sample.
The abnormality score for the outlier detection methods is discussed in more
detail in Section 3.5.2. In practice, these scores are thresholded at a sensible
level, such as 95% confidence of the sample being normal, to classify samples
into normal or abnormal. The abnormality scores produced by one method
are not directly comparable with the scores produced by a different method.
In this work I do not use a single threshold to classify the samples but
instead threshold at all possible thresholds to determine the false positive rate
and true positive rate at these thresholds. These two rates then form a receiver
operating characteristic (ROC) curve from which I evaluate the performance
by the area under the curve (AUC).
My evaluation is implemented in the Python programming language (ver-
sion 3.6) [93].
3.3 Previous Work
Identifying outliers in a dataset is an active area of interest in statistical fields.
This section describes the most popular and interesting techniques for outlier
detection. These techniques broadly fall into two categories: density based
or distance based. Density-based techniques focus on using the density of
clusters within the data to determine outliers. Distance-based techniques put
less emphasis on cluster density and more on local distances between samples.
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This can be thought of as looking at the local density around a point, instead of
looking at broader density patterns. These categories are broad and arguably
have some degree of overlap, but they aim to serve a coherent structure to this
section. I also include a short section at the end for techniques that do not fit
into either of the aforementioned definitions cleanly.
The techniques introduced previously for this chapter’s experiments (Sec-
tion 3.2) are not discussed here, but are described in detail in Section 3.5.2.
3.3.1 Density Techniques
These techniques directly use the density of clusters as a means of determining
abnormality. This may involve using the density directly or by clustering the
data according to densities.
Examples of clustering algorithms that seek to omit outliers are Shared
Nearest Neighbour by Erto¨z et al. [84], DBSCAN (Density-Based Spatial
Clustering of Applications with Noise) by Ester et al. [85], and OPTICS
(Ordering Points To Identify the Clustering Structure) by Breunig et al. [36].
Other work aims to cluster data and determine the abnormality of each data
sample by its distance to the centre of its closest cluster. Kohonen used self-
organising maps [154] for this task, while Barbara´ et al. [21] designed a novel
algorithm for intrusion detection based on intersecting segments of unlabelled
data and using the intersection as the base data for clustering.
Some research has taken a more sophisticated approach where a sample’s
abnormality score factors into how its local cluster is structured, such as the
size of the cluster. He et al. proposed a technique called Find Cluster-Based
Local Outlier Factor [124] that uses the size of clusters to influence the degree
of abnormality of a sample.
The Isolation Forest I introduced earlier in this chapter has been shown
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by Hariri et al. to have issues with artifacts [120]. These are artifacts in
the abnormality score assignment in the feature space. Figures 1 – 3 of their
publication ([120]) demonstrate that the Isolation Forest is unable to pick up
intricate design within the feature space and instead acts to blur a pattern of
samples into a single cluster. It also increases the abnormality score of regions
in feature space that are perpendicular to the training samples. The authors
present two extensions to the Isolation Forest which allow for finer details to
emerge within the training set and reduces the artifacts seen perpendicular to
the training samples. The first is the Rotated Isolation Forest, which rotates
training data randomly per tree during the growing stage; the second is the
Extended Isolation Forest that rotates the hyperplane that dissects the data
within each node, essentially allowing a division to exist across any number
of features at once. Both methods are shown to reduce data artifacts in the
original Isolation Forest, but they have a higher runtime. For the purpose of
evaluating the simplest version of the Isolation Forest and with the expectation
that the artifacts mentioned here will be rare in my dataset evaluation, I will
not be using these proposed extensions in my work.
Zhou et al. take a different approach. With their CBMIR (Content-Based
Image Retrieval) method use the Isolation Forest to represent the original data
in a new form: a vector of relevance features [311]. In other words, they use
the Isolation Forest as an embedding space. This new space is shown to be
richer in information than the original space, and this in turn allows for a
higher performance on detection tasks. The authors claim CBMIR has linear
time complexity with respect to the dataset size when training, constant time
complexity for number of features in the dataset if the number of features to
use for training is fixed, and is tolerant to irrelevant features due to its use of
the Isolation Forest in determining outliers.
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Other researchers have focused on a trade-off between efficiency and accu-
racy. The SCiForest by Liu et al. is an example of this [183]. It maintains
the favourable time complexities of the Isolation Forest to allow it to out-
perform other methods in runtime, but it is also of superior performance to
the Isolation Forest in most of the tasks the authors trialled. The SCiForest
grows Isolation Trees but the authors examines the post-split dispersal for each
node during the growing stage and focus on minimising this. They do this by
introducing random hyperplanes for outliers that are undetectable by single
attributes. When the outliers depend on multiple attributes for detection, a
higher number of attributes being used in the hyperplanes yields an improved
detection performance. The authors also claim the SCiForest is particularly
good at detecting outliers that are close to the edge of normal clusters.
Ting’s et al. Mass Estimation is another example where efficiency has been
central to the method [283]. Mass Estimation uses the mass (i.e. number of
surrounding samples) samples in feature space have to perform abnormality
detection with constant time and space complexities. The mass of a sample is
independent of other characteristics of the region it occupies, such as density,
shape, and volume; such that mass is a rectangular function with the same
value for the region it is measured in. The authors show how this measure can
be used alongside a concave function to effectively cluster samples together and
provide an ordering in terms of abnormality rather than a probability density
estimation.
Ho developed the Random Decision Forest [128] that was later developed
by Barandiaran [20] and Breiman [34] into the modern version of the Random
Forest. An example of the random forest in action can be found by Peerbhay
et al. who use the random forest to map an invasive plant species from satellite
imagery data [232].
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Mu¨ller et al. present a novel outlier detection method, OUTRES (OUTlier
RElevant Subspace), for samples deviating in subspace projections of the orig-
inal data [213]. This approach computes the deviation from the local density
but only takes into account a selection of subspaces for each sample, where
subspaces that are not distributed uniformly random are used for the outlier
detection. A density measurement that adapts to each subspace is used for
comparable production of abnormality scores.
Latecki provides a method based on non-parametric density estimation
with a variable kernel to yield a robust local density estimation, which in turn
leads to outliers being revealed [172].
3.3.2 Distance Techniques
These techniques focus on the distance between samples to decide abnormality.
This is similar to the density techniques discussed previously, but these pay
less attention to the density of the overall cluster and more to local density,
which acts as a proxy for distance.
Harada et al. apply the Local Outlier Factor method , which I introduced
earlier as one of the methods I use in my evaluation, to cyber physical systems
[118]. They show that while many outliers were detected, this method also
found anomalous samples that appeared too frequently were missed (false neg-
atives), as well as featuring a number of false positives, although the authors
note that these false positives share some similarities with the anomalies.
Su et al. develop an efficient local outlier factor method that operates in two
stages [276]. The authors argue that traditional local outlier factor is inefficient
as it must evaluate every data sample, despite the majority of the samples being
inliers and therefore uninteresting to an outlier detection method. To account
for this, the authors develop E2DLOS (Efficient Density-based Local Outlier
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detection for Scattered data), a technique able to identify the most obvious
inliers and remove most of them from a dataset. The authors then perform a
modified local outlier factor to find the outliers. In this way the method only
factors in a subset of the inliers when evaluating samples. Agyemang provide
a similar technique through their LSC (Local Sparsity Coefficient) method
where non-outlying data are removed before applying a modified local outlier
factor method [4].
Jin et al. provide an improvement to the accuracy of a k-nearest neighbours
(kNN) [58, 7] method when density distributions are required to determine
outliers, for instance in the case of a sparse cluster of outliers being close to a
denser cluster of inliers [138]. The authors do this by looking at the symmetric
neighbourhood relationship to consider both the neighbours and the reverse
neighbours of an object when estimating its density distribution. Djenouri et
al. also use a kNN approach, but in this case to detect outliers within a dataset
and remove them, thus enriching the information remaining in the dataset [76].
Cai et al. adapt the kNN approach to work with time data [43]. This
adaption is called RD-kNN (Real-time Detection based on kNN). First this
method explores the historical data of the system to determine an outlier
threshold and then uses a modified kNN approach to detect outliers in real
time data.
Zhang et al. demonstrate LDOF — Local Distance-based Outlier Factor
— a distance-based outlier detection method that is particularly effective on
scattered datasets where there are implicit data patterns [309]. This method
is shown to outperform kNN and local outlier factor on such a dataset.
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3.3.3 Other Techniques
Some proposed techniques do not fit cleanly into the previous definitions. I
have kept these separate here.
Paulheim et al. take a different approach entirely for outlier detection and
effectively reformulate unsupervised outlier detection as a set of supervised
learning problems, specifically supervised regression learning problems, using
their ALSO (Attribute-wise Learning for Scoring Outliers) method [229]. The
authors create a predictive model for each feature in a dataset using the other
features as attributes. Each model learns the relations between features. The
models produce a weighting for each feature and use these alongside the differ-
ence between the predicted value and the original value for a sample feature to
determine the degree of outlierness. That is, a feature value that is very differ-
ent to what is predicted by the model based on the other features is likely to
be abnormal as it does not follow the pattern of other values for that feature.
This method comes with a significant computational cost, especially when the
number of features is large.
While most methods focus on some concept of distance between samples
(be it density, clustering, projected distances, or otherwise) to determine out-
liers, Kriegel et al. take a different approach with their ABOD (Angle-Based
Outlier Detection) technique and use the variance from angular vectors be-
tween samples to find outliers [163]. This allows them to avoid the curse of
dimensionality in high-dimensional datasets to accurately determine outliers.
In a later publication [162], Kriegel et al. formalise the process of determining
whether a sample is an outlier or inlier from its abnormality score using a
method named LoOP (Local Outlier Probabilities).
Schneider et al. propose a new kernel-based outlier detection method,
EXPoSE (EXPected Similarity Estimation) which is efficient for very large
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datasets and operates with linear time complexity during training and con-
stant time and space complexity during testing [255].
3.4 Datasets
My evaluation uses two publicly available datasets: MedGIFT [73] and the
Emphysema dataset [274]. The MedGIFT dataset is used for testing data,
while the Emphysema dataset is used to generate training data. This en-
sures there is no potential for overfitting to the evaluation dataset and mimics
training a system in a research environment and deploying it to an external
environment, such as a hospital.
MedGIFT Dataset [73]: 93 volumetric scans of interstitial lung disease (ILD)
collected at the University Hospitals of Geneva where patients had a his-
tory of ILD and radiographic evidence consistent with the diagnosis. Pa-
tients received high-resolution CT imaging of the thorax. The scan slices
are annotated by a radiologist with 2D regions of interest for pathological
lung patterns.
Emphysema Dataset [274]: High-resolution CT scans of a study group of
39 patients. The scans were acquired at the Gentofte University Hospi-
tal in an exploratory study. A set of 61 x 61 pixel patches is provided,
extracted for regions of healthy (non-pathological) tissue, centrilobular
emphysema, and paraseptal emphysema. Healthy tissue was marked only
on non-smoking patients. Patches are labelled with the leading diagno-
sis based on the consensus of an experienced chest radiologist and an
experienced CT pulmonologist.
These datasets feature segmented ground truth that is used to define sam-
pling regions. Each sampling region is either healthy tissue (representing nor-
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Figure 3.1: Left: Example of a lung scan slice from the Emphysema dataset
showing an emphysema sampling region in each lung (outlined region) and
extracted patches (squares). Right: A zoomed-in example of a small sampling
region.
mal samples) or pathological (representing abnormal samples). Regions are
defined by a single ground truth label: Healthy, Emphysema, Fibrosis, Ground
Glass Opacities, or Micronodules and samples are extracted fully within the
regions. The MedGIFT dataset has all the full range of labels while the Em-
physema dataset has Healthy and Emphysema only.
2D patches of 20 x 20 mm size are sampled at a resolution of 1 pixel/mm2
from these regions on scan slices. This means the patches have 400 pixels
(or features). Once the samples are extracted, their ground truth labels are
removed to ensure this is an unsupervised approach.
5500 healthy patches are taken from the Emphysema dataset. Due to
limited data availability, these patches are permitted to overlap by 80% to
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increase the number of samples taken. This is a form of data augmentation.
Figure 3.1 shows the sampling process. These samples are used for training
the model of normality. No samples of pathological tissue are taken from the
Emphysema dataset.
1030 healthy patches and 2970 pathological patches are taken from the
MedGIFT dataset for testing the model of normality. There is no overlap be-
tween these patches. The pathological patches consist of the following ground
truth labels: 231 emphysema, 557 fibrosis, 266 ground glass opacities, and 1916
micronodule samples. The relative proportion of these pathologies derives from
the relative abundance of the labels in the MedGIFT dataset. Figure 3.2 shows
a set of patches extracted from the MedGIFT dataset.
These patches are divided into a training set and two testing sets: normals
and abnormals. From each of these sets, a small subset is removed and placed
into a corresponding optimisation set. Figure 3.3 illustrates the division of
the data into these six sets. The optimisation sets are used for optimising the
hyperparameters of the abnormality methods only and are then discarded.






Figure 3.2: Examples of extracted patches of lung pathology windowed at a
level of -600 HU with a width of 1500 HU, as recommended by Radiopaedia
[241]. From top to bottom: a) Healthy (upper row from the training set (Em-
physema dataset) and lower row from the test set (MedGIFT)) b) Emphysema
c) Fibrosis d) Ground glass opacities e) Micronodules. Rows b-e are from the
MedGIFT dataset.

































• 42 Ground Glass
• 376 Micronodules
Figure 3.3: A training dataset is extracted from the Emphysema dataset,
and normals and abnormals testing datasets are extracted from the MedGIFT
dataset. Each of these three datasets has an optimisation version that is used
for optimising the parameters of the abnormality methods.
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3.5 Experiment Design
In this section I describe the experimental setup used starting with the embed-
ding spaces (Section 3.5.1), then the abnormality detection methods (Section
3.5.2), the optimisation of each pair of embedding and abnormality detection
method (Section 3.5.3), and the overall pipeline setup (Section 3.5.4).
3.5.1 Embedding Spaces
Each of the abnormality methods have their own strengths and weaknesses. To
highlight these a number of embedding spaces are utilised for the input data
samples, as well using the raw data (no embedding). These embeddings are:
Principal Component Analysis, Kernel Principal Component Analysis, Flat
Autoencoder, Convolutional Autoencoder. I denote the number of features
these embedding spaces produce by x, which I explain how to get and its final
values in Section 3.5.3 and Table 3.2. Each embedding space transforms the
data in a unique way and it is unclear without experimentation which will be
the best.
The parameters of each method (e.g. batch size, number of epochs) were
chosen based on prior experimentation with the optimisation datasets.
None: The data samples are not projected into a embedding space and retain
their 400 original features.
Principal Component Analysis (PCA) [140]: Principal component anal-
ysis converts a set of samples of possibly correlated features into a set
of linearly uncorrelated features called components using an orthogonal
transformation. It is a dimensionality reduction technique using a linear
mapping in such a way that the variance of the data is maximised in the
transformed domain. Each of the components explain some fraction of
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the variance seen in the original data samples. In this work the compo-
nents are sorted by the amount of variance they explain, starting with
the highest variance, and the first x components are kept for analysis.
Kernel Principal Component Analysis (kPCA) [257]: An extension of
PCA where the data samples are mapped into a higher dimensional space
using a supplied kernel. PCA is then performed in this space. A third
order polynomial kernel is used in this work as this was found to be
effective at capturing explained variance in a small number of features.
Like the PCA method, the components are sorted by explained variance
and the first x components are used in the analysis.
Flat Autoencoder (fAE): An autoencoder is an artificial neural network
whose output is learned to match its input. Thus, the input and out-
put layer dimensions must be identical. In the case of an autoencoder
for dimensionality reduction, which is the purpose of the one used in
this work, the intervening layers have a lower dimension than the in-
put/output layer. This forces the network to learn an encoding of the
data with a lower dimension than the original data such that minimal
information is lost (i.e. the data can be reconstructed accurately from
this encoding).
A simple 5-layer dense neural network is used for the autoencoder with
the central layer providing the encoded data of dimensionality x, which
is then used for abnormality method evaluation (Figure 3.4). The flat
part of this autoencoder refers to the use of dense neural layers. The fAE
is trained for 200 epochs with a batch size of 256, adadelta optimisation
[79], and the mean square error loss function.
Convolutional Autoencoder (cAE): Similar to the fAE but with 2D con-
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volutional and max pooling layers instead of dense layers. Figure 3.5
shows the structure. The constraints of this structure means the dimen-
sionality of the data extracted from the central layer (x ) is a multiple
of 25. Training is carried out identically to the fAE with 200 epochs, a
batch size of 256, adadelta optimisation [79], and mean square error loss.
The fAE and cAE are implemented through Keras [50] (version 2.1.2).
Figure 3.4: The structure of the flat autoencoder showing the number of units
in each layer and the activation function used. ReLU is the Rectified Linear
Unit. Layer 3 acts as the input to the outlier detection methods and has a
number of units that varies between the methods (see Table 3.2). The number
of extracted dimensions is labelled C.
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Figure 3.5: The structure of the convolutional autoencoder showing the di-
mensionality after each layer. The horizontal arrows represent 2D convolutions
using a filter size of 3 x 3 pixels and a padding of zero surrounding the con-
volved images (using Keras [50] padding=same). The shaded arrows represent
max pooling or up-sampling (both by a factor of 2) for downwards-facing or
upwards-facing respectively. The vertical plain arrow is the flattening of the
image for the encoded output. The flattening occurs as the outlier detection
methods require a 1D input. All layers use the rectified linear unit activation
function with the exceptions of the flatten and final layer, which use a linear
activation function. The number of extracted dimensions is labelled K.
3.5.2 Outlier Detection Methods
In addition to the novelty forest, there are a wide variety of algorithms for
abnormality detection. I utilise four of the most influential algorithms here,
each representing a different family of solutions: local outlier factor, the one-
class support vector machine, isolation forest, and fast-minimum covariance
determinant estimator. By doing this, I aim to broadly capture the strengths
and weaknesses these methods offer relative to each other and provide a useful
evaluation against the novelty forest.
Novelty Forest (NF) is a forest ensemble technique that rapidly and intel-
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ligently divides data based on a subset of features. Chapter 2 describes
the novelty forest in detail.
Local Outlier Factor (LOF) [37] is a nearest-neighbour-based approach that
determines the distance to the kth nearest neighbour for each data sam-
ple in feature space. This distance is then compared to the distances
other nearby samples gave to calculate the final abnormality score. LOF
effectively judges each sample relative to the density of its local area in
the feature space.
Mathematically speaking, the abnormality score for a sample a for the







where Nk(a) is neighbour k to sample a, |Nk(a)| is the number of neigh-
bours to a, and lrd(a) is the local reachability density of sample a as
defined as the inverse of the average reachability distance of sample a







and this reachability distance is the L2 distance [94] in feature space
between two samples bounded by a minimum of the distance to the kth
nearest neighbour from sample b:
reachability-distance(a, b) = max{k-distance(b), distance(a, b)} (3.3)
One-Class Support Vector Machine (1-SVM) [256, 235] is a support
vector machine-based method for working with one training class. It
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transforms the data samples to a higher dimensional space than they
were initially in and seeks to build a hyperplane decision boundary that
maximises the distance from this hyperplane to the origin. This is ef-
fectively building a non-linear region around the training samples. This
is not to be confused with the support vector data description by Tax
et al. [281], which is a one-class support vector machine method that
constructs a hypersphere dividing surface of minimal volume around the
training samples.
The kernel trick [282] is used to calculate the pairwise distances for the
sample vectors in the transformed space without needing an explicit pro-
jection to that space. This improves the efficiency of the method. Equa-
tion 3.4 shows how the abnormality of a sample, a, is determined. αi are
the Lagrange multipliers, also known as the supports for the machine, ρ
is related to the margin between the origin and the decision hyperplane,
n is the number of samples, K(a, a′) is the kernel function, which in my




αiK(a, ai)− ρ (3.4)







Isolation Forest (IF) [182, 49] is a binary forest approach whereby each
node randomly selects a feature, and within this feature chooses a random
threshold for splitting between the minimum and maximum value along
that feature. Equations 3.6 and 3.8 This continues until each node has
a single sample in it. These nodes form the leaf nodes. The greater the
number of nodes between a leaf node and the root node, the greater the
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abnormality score for the sample in that node. This is repeated over
an ensemble of trees (a forest) and the scores averaged on a per sample
basis. At each node that is not a leaf node:
fsplit = randint(0, |F |) (3.6)
tsplit = randfloat( min(A(fsplit)),max(A(fsplit)) ) (3.7)
where randint(n,m) selects a random integer between n and m inclu-
sively, and randfloat(n,m) selects a float between n and m exclusively.
F is the set of all features and |F | is the cardinality of this set. fsplit is
the feature corresponding to the random integer selected. A(fsplit) is
the set of sample values along feature fsplit. The min and max functions
select the minimum and maximum value in the set. tsplit is the threshold
selected for the node split, while fsplit is the feature selected for splitting.
The samples in the node are then split by evaluating each sample, a at
the chosen feature and threshold:
Child Node choice =
left if a(fsplit) < tsplitright otherwise (3.8)
The isolation forest works in a probabilistic fashion with samples not
belonging to a cluster being more likely to be separated out early in the
growing phase in the tree, and thus they will end up in leaf nodes in a
fewer number of steps than samples within a cluster. This technique is
useful if there are many useful features in the data, otherwise it can be
splitting along meaningless features and this leads the abnormality score
to be meaningless.
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Fast-Minimum Covariance Determinant Estimator (FMCD) [249] is
a Gaussian fit model that is robust to outliers in the training data, thus
leading to a robust fit centred around clusters. The mean and covariance
of the nearest fitted Gaussian to a sample provides a means of determin-
ing the abnormality score of any sample in terms of standard deviations
from the mean using the Mahalanobis distance (defined in the previous
chapter – see Section 2.5. The formulation of FMCD goes as follows
[249]:
For a dataset a of samples ai and size n, let H1 ⊂ {1, ..., n}. µ1 is the
mean and Λ1 is the covariance matrix of this subset. Define the relative
distances using the formula for Mahalanobis distance previously defined
(Equation 2.4) but restated here for completeness:
d1(i) =
√
(a− µ)TΛ−1(a− µ) (3.9)
where d1(i) is the Mahalanobis distance for sample ai.
Now a set H2 is taken such that {(d1)1:n, ..., (d1)h:n, where (d1)1:n ≤
(d1)2:n ≤ · · · ≤ (d1)n:n are the ordered distances. The covariance matrix
is calculated for this H2. It follows that Equation 3.10 holds true. The
det function is the matrix determinant.
det(Λ2) ≤ det(Λ1) (3.10)
The above step now repeats iteratively with H3 onwards until the conver-
gence criterion of the determinants being equal between two successive
iterations or the determinant reaching zero. At this point, the mean and
covariance matrix of the final subset, Hfinal, is used as the model of nor-
mality and the abnormality scores are calculated using the Mahalanobis
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distance with these parameters.
The time complexity of these methods against the number of features (f)
and samples (s) is found in Table 3.1.
Method Train Time Scaling Test Time Scaling
NF O(log(s)) O(log(s))




Table 3.1: The time complexities of the abnormality methods for the train-
ing and testing stages in terms of the number of features, f , and number of
samples, s. Worst case scenarios are shown.
With the exception of the NF, the methods are implemented by Scikit-
Learn [231] (version 0.19.1). Direct Scikit-Learn references follow: LOF [262],
1-SVM [263], IF [261], FMCD [260]. The NF is implemented in the Python
programming language (version 3.6) [93].
3.5.3 Parameter Optimisation
For every pair of data embedding with abnormality method there is a set of
parameters that must be optimised for the problem being solved. Fair and
reasonable attention to parameter optimisation is essential to be able to draw
conclusions on the relative efficacy of the methods. By having a separation
between the optimisation and experiment datasets (see Section 3.4) I prevent
overfitting to the experiment dataset. I use a gridsearch method over the
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optimisation datasets to find the optimal parameters for each pair. No cross-
validation is used during optimisation due to time constraints. The following
parameters were tuned for each abnormality method (all ranges are inclusive):
 NF: The node division method (Random Feature/Threshold vs Opti-
mised Feature) only.
 LOF: The size the leaf and the number of neighbours. The leaf size was
explored between 1 - 10 in steps of 1 and 10 - 100 in steps of 10; the
number of neighbours was explored between 1 - 10 in steps of 1 and 10
- 100 in steps of 10.
 1-SVM: The upper bound on the fraction of training errors (and lower
bound on the fraction of support vectors) and the kernel coefficient. Both
were explored between 0.1 - 0.9 in steps of 0.1.
 IF: The number of trees in forest was explored between 1 - 10 in steps
of 1 and between 10 - 100 in steps of 10.
 FMCD: The support fraction between 0.1 - 0.9 in steps of 0.1.
For the NF the stopping criteria is chosen to be the depth2, the number of
trees is 100, and the sample and feature fraction used for each tree is 0.1. These
choices were found to provide high accuracy with minimal speed trade-off in
initial research not included in this thesis.
For the encoding methods, the following output dimensionality values were
explored:
 PCA: The number of components kept after performing PCA. This was
first explored broadly from 10 to 390 in steps of 10, and then followed by
a higher precision evaluation of: y-9 to y+9 in steps of 1. y represents
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the best performing value from the initial broad search. Computational
limitations prevented searching the full range in steps of 1. The number
of components is the dimensionality of the encoded data.
 kPCA: The number of kept components and the kernel used. Identically
to the PCA method, the number of kept components for kPCA was first
explored broadly from 10 to 390 in steps of 10, and then followed by a
higher precision evaluation of: y-9 to y+9 in steps of 1. y represents
the best performing value from the initial broad search. The kernel had
five possible options: linear, poly, rbf , sigmoid, and cosine with the
poly kernel having a range of possible degrees. The degree was explored
between 2 and 10 in this case. This covers all common choices for the
kernels.
 fAE: The encoding dimension (the number of neurons in the central
layer). This was explored broadly between 10 - 90 in steps of 10, followed
a closer inspection of y-9 to y+9 in steps of 1 for the best performing
value from the broad stage, y.
 cAE: The encoding dimension (the number of neurons in the central
output). This was explored from 25-400 in steps of 25. The multiple of
25 is required due to the design restrictions of the cAE (see Figure 3.5).
Table 3.2 shows the number of features selected by the optimisation of
each method. The kernel selected for the kPCA method was the third degree
polynomial. For the NF method, the Optimised Feature division method was
chosen. Again, this choice comes from prior experimentation.
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Embedding NF LOF 1-SVM IF FMCD
None (Fixed) 400 400 400 400 400
PCA 340 5 20 237 347
kPCA 400 3 22 15 2
fAE 15 40 26 31 10
cAE (Multiple of 25) 50 25 25 50 25
Table 3.2: The number of features used (per sample) by each embedding-
method pair. With the exception of the None method, these values are from
optimising each pair on the optimisation data sets. The None method uses the
raw data and so uses the full set of features (400).
3.5.4 Experiment Pipeline
My evaluation consists of four main stages. These stages are sketched in Fig-
ure 3.6 which shows input/output of each stage. First, I take the pairs of
embedding space/abnormality detection method and determine their optimal
parameters (Section 3.5.3). Second I train a model of normality on the training
set (Section 3.4) and use this to generate a set of abnormality scores for the
testing sets (third step). Finally, these abnormality scores and the class labels
of the testing data — which were not used previously — are converted to a
ROC curve and the area under this provides the final evaluation score.
This final stage of converting from abnormality score to the ROC curve is
shown in Figure 3.7. I order the samples in terms of their abnormality score,
from lowest to highest. The class label is assigned to each sample representing
either a normal sample (0) or abnormal (1). The ROC is created by scanning
through the full range of samples and at every possible threshold making a note
of the number of true positives (TP) — normal cases below the threshold, false
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positives (FP) — abnormal cases below the threshold, true negatives (TN) —
abnormal cases above the threshold, and false negatives (FN) — normal cases
above the threshold. From these I calculate the true positive rate (TPR) and









With these two numbers, a ROC curve can be plotted and the area under
it follows [98].
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Figure 3.6: The full process of determining the performance of a method. First,
the optimisation datasets are used to find the optimal number of embedding
features and abnormality method parameters (see Section 3.5.3). Once opti-
mised, the training data can be passed through the embedding method and
then the abnormality method to develop a model of normality. This model
of normality acts upon the testing data to give an abnormality score to every
testing sample. Finally, the abnormality scores are evaluated to give overall
performance of that embedding/abnormality pair.
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Figure 3.7: An example calculation of area under the ROC on fictional results.
Each sample is assigned an abnormality score by the outlier detection method.
The samples are sorted by these scores and have a true class assigned which is
0 for a normal sample, or 1 for an abnormal sample. At each possible division
of the ordered list, the TPR and FPR is calculated. The pairs of TPR and
FPR are plotted to create an ROC curve and from this the area under the
curve is trivially determined.
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3.6 Results
The aim of this research is to demonstrate how the abnormality methods per-
form on a medical dataset when trained on normal samples taken from one
patient cohort and tested on normal and abnormal samples taken from a sec-
ond cohort. This mimics training a system in a research environment and
deploying it to an external environment such as a hospital. The objective is
to correctly distinguish abnormality from normality and to do this in a time-
efficient manner.
Each abnormality detection method is evaluated on the four embedding
methods plus the non-embedded raw data. The methods are trained with
healthy patches from one patient cohort and evaluated with a healthy test set
and a pathological test set both from a second cohort to produce an abnor-
mality score for all test samples. These scores are used to construct a ROC
curve. The test scores for the healthy (normal) samples provide the true pos-
itive rate, while the test scores for the pathological (abnormal) samples give
the false positive rate. The AUC is used for the reported accuracy (Table 3.3).
The time required for the algorithm to embed and fit to the data (training
stage) and predict abnormality scores (testing stage) is detailed in Table 3.41.
Figure 3.8 summarises my experiment pipeline.
1The predict times do not include the time taken to run the embedding method on the
data being predicted on.
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Figure 3.8: The experiment pipeline showing the order of data processing and
the fit and predict stages. The scoring function takes the abnormality scores
and produces an ROC curve from them, from which the area under the ROC
curve follows. The abnormality detection method consists of first fitting a
model of abnormality followed by testing of this model on the testing datasets.
Embedding NF LOF 1-SVM IF FMCD Average
None 0.740 0.697 0.776 0.771 0.657 0.728
PCA 0.691 0.620 0.823 0.620 0.650 0.681
kPCA 0.678 0.612 0.817 0.807 0.809 0.744
fAE 0.546 0.627 0.742 0.790 0.771 0.696
cAE 0.626 0.539 0.816 0.766 0.758 0.695
Average 0.656 0.619 0.795 0.751 0.729
Table 3.3: The AUC ROC curve for all embedding methods and outlier detec-
tion methods.
Chapter 3. A Comparison Of Abnormality Techniques 114
































































































Table 3.4: The time in seconds required for each experiment combination to fit
to the training data and predict on both test sets. Sample size is 5500 patches
for fitting and 3000 patches for predicting. The NF results are per tree to aid
comparison.
The highest accuracies are for the 1-SVM with a PCA or kPCA embedding
where the AUC ROC curve is around 0.82. The IF and FMCD achieve similar
to this with accuracies of 0.81 with the kPCA embedding. Overall the kPCA
embedding gave the best results, PCA produced the poorest on average, and
the autoencoder methods gave similar average AUC ROC. The lowest accuracy
is LOF operating on the cAE embeddings where it roughly equates to random
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chance. LOF has the poorest accuracy on average and the 1-SVM has the
highest.
For the PCA embedding, the NF, IF and FMCD methods are most accurate
when using a high number of components (>50%). kPCA used fewer than 6%
of the total components for all methods except for the NF, where it used all.
For the IF and FMCD methods, the kPCA embedding improves the accuracy
over PCA. For the NF, LOF, and 1-SVM methods there is little difference in
the two embeddings.
3.7 Discussion
My results demonstrate the key differences between the NF and four selected
unsupervised abnormality detection methods when explored in terms of accu-
racy and runtime efficiency (relative time taken to complete computation) on
CT lung data and embeddings of it. The highest accuracy for each method is:
 NF: 0.740 area under the ROC curve in 7.1 s using the raw data.
 IF: 0.807 area under the ROC curve in 21.8 s using kPCA.
 FMCD: 0.809 area under the ROC curve in 9.0 s using kPCA.
 LOF: 0.697 area under the ROC curve in 1525.6 s using the raw data.
 1-SVM: 0.823 area under the ROC curve in 3.0 s using PCA.
However, the runtimes vary greatly — by about three orders of magnitude
— between these methods. Of course, with any method there will be a trade-
off between runtime efficiency (speed) and accuracy. In some clinical settings,
such as stroke (see next chapter), speed is crucial and any method that takes
many minutes or longer may not be considered acceptable. More generally,
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these methods will be tying up compuational resource while completing, which
is a limited resource at hospitals. If a method takes too long and is run too
often, there could be a shortage of computational resource here. Other use
cases, such as in the detection of an illness that needs to be diagnosed quickly
to have a good prognosis, accuracy is highly valued and so a longer runtime is
more acceptable.
3.7.1 Accuracy
The most accurate method is the 1-SVM, closely followed by the IF and FMCD.
NF comes next and LOF has the poorest accuracy. Dimensionality reduction
methods have a positive effect on accuracy for FMCD and 1-SVM and a neg-
ative impact on LOF and NF.
LOF relies on a distance measure to points in space. If dimensionality
is reduced, information on distance between points is lost, and this has a
noticeable impact on the accuracy.
The NF on the other hand should perform well when working with fewer
features and information concentrated in these features. This appears to be
down to the choice of stopping criteria. As the trees grow to a similar depth
regardless of the number of features used, with few features I get a higher
probability of some features being split multiple times as a tree grows. This
serves to break larger clusters along one feature into smaller ones, which may
not be optimal for finding abnormality.
The PCA and kPCA embeddings selected a large number of features for
NF (340 and 400 respectively) but remained worse than using the raw data.
This could be because in the medical imaging data the information is spread
widely between the features, while in PCA and versions of it, the information
becomes concentrated in a small number of features. The random nature of
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feature selection can lead the novelty trees to have several low-information
features in its path as opposed to using the raw data where features are more
likely to be useful.
3.7.2 Speed
These times are the total of the fit and predict times. It is assumed that the
fitting stage of the methods would take place in a research environment and
the predicting stage in a clinical environment. This means the predict time is
much more critical to the successful functioning of the method, provided the
fit time remains feasible.
The time taken to complete an experiment is based on two key factors:
The speed of the embedding method and the dimensionality of the data.
PCA is the fastest of the tested embedding methods (excluding None),
followed by kPCA, then fAE, and finally cAE. For PCA, all experiments are
faster than using no embedding, meaning the speedup from the dimensionality
reduction outweighed the time increase from performing PCA. kPCA is the
most accurate, on average, of all the methods, and PCA is the least accurate.
This may be due to non-linear structure present in my data that can only
be captured effectively by kPCA. The lower or comparable number of features
selected for kPCA relative to PCA supports this idea - kPCA is more efficiently
capturing the information in the data.
The LOF method is the most affected by the number of features due to
the exponential increase in the number of calculations required with increasing
features. The IF method is the least affected as it has no dependence on the
number of features.
PCA has a substantial drop in performance for the IF method. This is
likely due to PCA focusing the variance along a small number of features.
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This affects the IF method as it relies on all features having useful variance so
it can divide the data effectively no matter which features is selected at each
node. Despite this, the IF method selected 237 features for its analysis. This
means that having fewer features was not enough to usefully split the data as
there was not sufficient information, but at the same time adding more features
failed to improve the splitting more due to the lack of useful information in
some features. This means the features of the sample patches were mostly of
useful features.
The NF is generally the fastest method, although the stated times are
normalised for the number of trees. When factoring in the use of 100 trees in
the forest, NF becomes the slowest method generally.
The fast training time for the NF is what enables its overall speed. The
IF has similar runtime as the NF for the raw data, but when the autoencoder
embeddings are used the speed reduces by 1–2 orders of magnitude for the
reasons stated above. The NF grows in the same way regardless of how useful
the features are, so its fit time is not affected.
3.8 Conclusion
This chapter reviewed the novelty forest and four of the most influential abnor-
mality detection algorithms, each representing a different family of solutions:
local outlier factor, the one-class support vector machine, isolation forest, and
fast-minimum covariance determinant estimator. These methods were evalu-
ated on CT interstitial lung pathology imaging data under five embeddings:
none (raw data), salient components from principal component analysis, salient
components from kernel principal component analysis, embeddings from a flat
autoencoder, and embeddings from a convolutional autoencoder. The aim
was to correctly distinguish abnormality from normality and to do this in a
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time-efficient manner.
Local outlier factor method had the lowest accuracy and was poorly suited
to datasets with a large number of features. This is due to it calculating
distance as a vector through all dimensions. The fast-minimum covariance
determinant estimator with its Gaussian fitting showed better scaling with the
number of features but the effect of the number of features on speed was still
noticeable. Its overall performance varied depending on the embedding from
poor to good. The isolation forest and one-class support vector machine were
the least affected by the number of features. The isolation forest uses a number
of divisions equal to the number of samples minus one, so has no significant
dependence on the number of features. Finally, the novelty forest was fast,
but the performance poor due to its inability to capture all dimensions —
even relative to the isolation forest, which is an entirely stochastic method,
the novelty forest’s accuracy was much weaker on average.
The one-class support vector machine was the most accurate, closely fol-
lowed by the isolation forest and fast-minimum covariance determinant esti-
mator, then the novelty forest and local outlier factor.
Kernel principal component analysis was the most effective embedding
technique, leading to the highest average accuracy, but the effect of each
embedding varied across the methods. The isolation forest appeared to be
well-suited to complex medical datasets. However, concern is noted over the
isolation forest’s ability to explore all features in datasets with a large number
of features relative to number of samples, which may lead to it missing small
pathologies. The novelty forest was fast with good general accuracy.
Next Steps: This chapter concludes my work on novelty. The next chap-




Analysis in Non-Contrast CT
using an ASPECTS Atlas
4.1 Abstract
Determining the severity of early ischemic stroke in non-contrast computed
tomography (CT) is critical to ensuring a patient is treated effectively and
rapidly. However, due to a low signal to noise ratio and confounding factors
from other pathologies, past events, and natural age-related changes within
the brain, this is not an easy task. These issues contribute to a variable
interpretation of the ischemic stroke severity. Incorrect or delayed treatment
can lead to an adverse outcome for the patient.
I investigate the level of agreement between four methods, including the use
of an automated system, with the aim of identifying early ischemic changes
within the brain. For the evaluation I divide the Middle Cerebral Artery
(MCA) territory of each hemisphere into ten regions defined according to the
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Alberta Stroke Programme Early CT Score (ASPECTS). These regions allow
us to calculate the ASPECTS – a score indicating the severity of the stroke – for
each method, and effectively distills the outcome into something interpretable
at the patient level.
The automatic system uses a specialised Convolutional Neural Network
(CNN) to produce voxel-level confidence masks showing which voxels are sus-
pected of showing early ischemic change. From this I compute the score. I
also obtain the score from three other methods that involve trained human
graders, and compare the level of agreement between these methods at both
a patient level and a territory level through Simultaneous Truth and Perfor-
mance Level Estimation (STAPLE) and Cohen’s kappa coefficient. I analyse
possible causes of disagreement between the methods and statistically validate
the performance of the CNN model against the performance of clinical staff
(the professional standard). I find that the CNN produces scores that corre-
late the greatest with its training data at the patient level, but the training
data could be improved to strengthen the correlation with the professional
standard. Improvements would come from improved ground truth.
4.2 Introduction
This chapter focuses on the problem of distillation in medical image analy-
sis. Using non-contrast CT (NCCT) brain scans of patients with suspected
ischemic stroke, I utilise a specially designed neural network to provide voxel-
level probability maps of the stroke-affected regions. I then distill these prob-
ability maps through a brain region mapping and processing rules to provide a
single clinically meaningful, easily interpretable, and reliable quantity for each
patient that can be used to influence that patient’s treatment.
During an ischemic stroke, blood supply is lost to a region of the brain
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due to a vessel clot. This requires immediate medical attention as the affected
tissue will die if blood flow is not promptly restored. To select the appropriate
treatment for a patient exhibiting stroke symptoms, the cause of the symp-
toms must be identified - ischemic stroke, hemorrhagic stroke, or stroke mimic
- and the severity determined [171]. Stroke symptoms include lateral weakness
manisfesting as, for example, drooping of one side of the face with the patient
having reduced ability to smile or speak clearly, inability to lift both arms
and keep them in position due to weakness or numbness in one arm, or other
unilateral symptoms. Other potential symptoms of stroke include paralysis of
one side of the body, vision loss, blurring, or double vision, dizziness, confu-
sion, difficulty interpreting speech, problems with balance and coordination,
dysphagia (swallowing difficulties), a sudden and severe headache, and loss of
consciousness [218].
A similar condition to stroke is the transient ischemic attack (TIA) [5]. This
is essentially a more minor version of a stroke resulting in similar symptoms
but that clear within minutes or hours. A TIA is a warning sign of stroke as
its root causes are the same [14].
Strokes and TIAs are considered medical emergencies requiring immediate
medical attention. There are several tests for strokes, such as FAST [223],
FASTER [224], and BE-FAST [12], which evolved from the Cincinnati scale
[159] used previously. These methods focus on the rapid identification of symp-
toms. During a stroke the average patient loses as many brain neurons per
hour as 3.6 years of normal aging would cause, and over the duration of the
stroke the patient may lose almost 2 million neurons, 14 billion synapses, and
12 km of anonal fibres [252]. 15 million people globally are affected by stroke
each year with 5 million of these resulting in death and a further 5 million
leading to permanent disability [47]. The number of stroke cases is increasing,
Chapter 4. ASPECTS For Ischemic Stroke 123
driven primarily by people living longer. The number of stroke incidents in
developed countries may double by 2050 from 2010 numbers (16.9 million [90])
with those aged 75+ contributing the most to this rise [130].
NCCT is a widely available and rapid means of imaging the brain. It is
frequently used as the first step in identifying the stroke cause and classifying
its severity [167]. However, early ischemic changes are challenging to detect
and the boundary between affected and normal brain tissue is poorly defined
[293]. A range of features with different pathophysiological bases may present
including hyperdense vessels, loss of the insular ribbon, obscuration of the
lentiform nucleus, loss of grey-white matter differentiation, sulcal effacement,
and hypoattenuation [111]. Conflation of these features contributes to variable
interpretation of stroke severity [109, 291]. This makes it difficult to compare
the performance of an external automated system for detecting early ischemic
changes to clinical diagnosis.
The Alberta Stroke Programme Early CT Score (ASPECTS) is a clinically
meaningful system of scoring stroke severity that concentrates on hypoatten-
uation as this is the most relevant indication of the severity of ischemia [233].
ASPECTS determines the presence or absence of acute hypoattenuation in ten
regions within the middle cerebral artery territory of each hemisphere and can
influence treatment choice [22] The score starts at 10 for a normal brain vol-
ume and reduces by one point for each affected territory in the symptomatic
hemisphere. Patients with a score of 7 and higher are most likely to respond
positively to treatment [126].
ASPECTS is a means of distilling down the information from a patient
NCCT brain scan into: first a brain territory level, then a patient level score.
The issue of distillation appears frequently in the field of medical imaging.
Every stroke is unique and to summarise one as a single number on a stan-
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dardised scale is not straightforward. Throughout this chapter I will present
and discuss four methods of determining ASPECTS, and statistically compare
them using Simultaneous Truth and Performance Level Estimation (STAPLE)
[294] and Cohen’s kappa [51]. The methods consist of three based on man-
ual reading, and one using an automatic method. The performance is judged
at two interpretation levels: a dichotomised patient level and an ASPECTS
territory level.
The remainder of this chapter is structured as follows: Section 4.3 provides
further details on ASPECTS. Section 4.4 details previous work on ischemic
stroke classification. Section 4.5 provides the sources and information of my
datasets. Section 4.6 explains four scoring methods. Section 4.7 shows my
performance evaluation. Sections 4.8, 4.9, and 4.10 are my results, discussion,
and conclusions respectively.
My evaluation is implemented in the Python programming language (ver-
sion 2.7) [92].
4.3 ASPECTS
The carotid arteries carry blood up from the torso to the brain, neck, and face.
Within the head they divide into the internal carotid arteries, which supply
the brain with blood. These internal carotids divide at the Circle of Willis
where a pair of major arteries called the Middle Cerebral Arteries (MCAs)
begin. The MCAs each supply blood to most of a hemisphere of the brain –
Figure 4.1 shows the areas they supply as the large central region.
ASPECTS is a clinically meaningful score from 0 to 10 in integer steps
where 10 indicates a healthy brain and 0 indicates severe lateral ischemia. It is
determined by ten regions supplied by the MCA in each hemisphere consisting
of the subganglionic nuclei, supraganglionic nuclei, and basal ganglia regions.
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These territories are given one or two character reference identifications (IDs)
detailed in Table 4.1, and marked on a NCCT brain scan in Figure 4.2.
Figure 4.1: A schematic of the brain showing the region supplied by the middle
cerebral arteries as the large central region, extending from the middle frontal
gyrus (upper left of centre) across to the inferior parietal lobule and angular
gyrus (right of centre) down to the mid temporal gyrus (lower centre). This is
the pink region on a colour print. Figure from the public domain.
To determine the ASPECTS of a patient I count the number of territories
affected by early ischemic change in each hemisphere. I then take the highest
(most affected) of the hemispheres and subtract the number of its affected
territories from ten. The result is the ASPECTS. See Equation 4.1.
ASPECTS = 10−max(Tleft, Tright) (4.1)
where Tleft is the number of ischemic territories in the left hemisphere, and
Tright is the number of ischemic territories in the right hemisphere.
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ID Region Full Clinical Name
M1 Subganglionic Nuclei Frontal Operculum
M2 Subganglionic Nuclei Anterior Temporal Lobe
M3 Subganglionic Nuclei Posterior Temporal Lobe
M4 Supraganglionic Nuclei
Anterior Cortex immediately rostal to
M1
M5 Supraganglionic Nuclei
Lateral Cortex immediately rostal to
M2
M6 Supraganglionic Nuclei
Posterior Cortex immediately rostal to
M3
C Basal Ganglia Caudate
L Basal Ganglia Lentiform Nucleus
I Basal Ganglia Insula
IC Basal Ganglia Internal Capsule
Table 4.1: The ten ASPECTS territories showing their shortened ID name,
general brain region, and full clinical name.
Figure 4.2: Two axial slices of a healthy human brain showing the ganglionic
level (left) and supraganglionic level (right) with the ASPECTS territories
labelled with their IDs.
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4.4 Previous Work
This section covers previous work in classifying stroke. I start by exploring
the 1/3 MCA rule, which is an alternative to ASPECTS. After this I detail
other work on ASPECTS and follow with other techniques for measuring stroke
severity.
4.4.1 The 1/3 MCA Rule
Prior to ASPECTS clinicians used the 1/3 MCA rule [287] to determine
whether or not to treat patients with thrombolysis (breaking down the clot
using alteplase). This rule states that one must determine if the affected vol-
ume of the MCA territory is greater than a third of the total MCA volume.
If it is, thrombolysis is not recommended as it is associated with worsened
outcome. ASPECTS on the other hand recommends thrombolysis for scores
of 8 or higher.
Contra-indications for thrombolysis include hemorrhage or history of hem-
orrhage, time of symptom onset being greater than 4.5 hours (the more time
that passes, the less effective this treatment is), neurosurgery, head trauma,
or stroke in the past three months, hypertension, endocarditis, a low blood
glucose level, and the patient taking anticoagulants (although this may be
countered by administrating coagulants). The use of thrombolysis for severe
strokes, which are usually caused by a larger blockage, leads to an increased
risk of hemorrhagic transformation (bleeding) [101], which is a serious compli-
cation that can be fatal [15].
In cases where thrombolysis is not suitable, an alternative treatment is
available: thrombectomy [219]. This involves using surgery to remove the clot.
This treatment has risks and may lead to bleeding (potentially causing death),
infection, or damage to the blood vessel at the site of the clot [202]. There is
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also a risk of the clot breaking into smaller pieces, which may in turn cause
further clots in other vessels. Research by El Tawil and Muir indicate that
using thrombolysis after thrombectomy treatment can improve outcome by
breaking down these smaller pieces [83].
A study by Mak et al. showed that the 1/3 MCA rule was more reliable
in detecting significant early ischemic change on CT brain within 6 hours of
stroke onset, whereas ASPECTS was able to detect significant early ischemic
change in a higher proportion of these scans [197]. Further research has shown
that a more systemic approach improves the reliability of the 1/3 MCA rule
[142, 270]. Dzialowski showed that for patients where the 1/3 MCA threshold
is reached, the median ASPECTS is 4 [81].
4.4.2 Work on ASPECTS
Kobkitsuksakul et al. studied interobserver agreement in 2018 and found the
ASPECTS interpretation varied among raters [153]. Using 43 patients, the
Cohen’s kappa coefficient [51, 103, 271] varied from 0.49 to 0.68 for consen-
sus between two neuroradiologists and a neuroradiology fellow, and from 0.20
to 0.49 for consensus between two neuroradiologists and a senior radiology
resident. These ranges derive from three window level settings.
Coutts et al. also studied the interobserver variation for ASPECTS [57].
They took 214 patients presenting acute ischemic stroke or transient ischemic
attack and who had a head CT scan performed within 12 hours of symptom
onset. Each scan was read by the treating physician and later by an expert
reader, and the ASPECTS determined. The Cohen’s kappa coefficient was
0.69, and the mean score difference between the two raters was 0 with a stan-
dard deviation of 1.1.
Aviv et al. took the ASPECTS of 36 patients with acute stroke and NCCT
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taken within 3 hours of symptom onset and found ASPECTS is as predictive
of radiologic outcome as cerebral blood volume from the the NCCT, however
ASPECTS may have the additional benefit of predicting patients with major
neurological improvement [16]. The ASPECTS were assigned by 3 neuroradi-
ologists.
Puetz et al. have a detailed report from 2009 titled The Alberta Stroke
Program Early CT Score in clinical practice: what have we learned? that
explains a range of practical findings related to the score. Findings include the
presence of focal brain swelling confounding the interpretation of the score, the
1/3rd rule providing similar outcomes to ASPECTS, and the lack of evidence
proving the effectiveness of using ASPECTS to inform thrombolysis treatment
[238].
4.4.3 Other Techniques for Measuring Stroke Severity
ASPECTS is one of several techniques to measure stroke severity. Here I list
other popular alternatives that are used alongside or instead of ASPECTS in
practice. These can be divided into three categories: Prehospital, Acute, and
Outcome.
Prehospital measures are assessments completed before taking a patient to
the hospital. The purpose here is to reduce the number of false stroke cases
(false positives) or categorise the severity of these cases to speed up treatment
decisions later.
Acute assessments examine patients in the acute phase of a stroke — when
it is happening or shortly after. ASPECTS is an example of an acute as-
sessment. These assessments focus on the symptoms of the stroke, which can
include physical changes immediately visible to the clinician, such as unilateral
weakness or inability to perform certain tasks, or they may focus on results
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from medical scans, such as ASPECTS.
Outcome measures look long-term into the level of disability the patient has
after recovering as much as possible. These cannot be used during the acute
phase, but can serve as input to future decisions on the patient should they
experience a further stroke. They serve as a means of translating a complex set
of symptoms into something interpretable at the patient level. This is similar
to the aims of ASPECTS.
4.4.4 Prehospital Assessments
ABCD Score [247] The ABCD — or Age, Blood pressure, Clinical features,
and Duration — score is a simple means of classifying the likelihood that
someone is having a stroke based on a small number of characteristics
[247]. These are the age and blood pressure of the patient, the presence of
any clinical features such as motor weakness or speech disturbance, and
the duration of these symptoms. This information may only display a risk
factor, but may inform clinical treatment should the risk be particularly
high or low.
Cincinnati Stroke Scale [159]: This is a short physical assignment consist-
ing of two tasks: Raising arms and speaking. The patient is assessed on
three criteria and on meeting all three is sent for stroke treatment: (1)
One side of face does not move when speaking; (2) speech is slurred, in-
appropriate, or mute; (3) one arm drifts compared to the other. A study
by Kothari et al. showed the scale had high reproducibility and validity
[159] and in earlier work showed it had high sensitivity and specificity
when identifying patients for thromolysis [158].
Los Angeles Prehospital Stroke Screen (LAPSS) [149]: LAPSS is an as-
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sessment to determine the probability that a patient is having a stroke.
It is designed around a number of risk factors and examines the lateral
asymmetry of the face, grip, and arm strength to determine if a patient
is likely having a stroke. The risk factors are an age over 45, no history
of seizures or epilepsy, symptoms present for less than 24 hours, patient
is not wheelchair bound or bedridden, and a blood glucose level between
60 and 400 [149]. Although these do not capture every possible stroke
patient, it does help to highlight contraindications to stroke that may
require further investigation.
Chen et al. reviewed the LAPSS diagnosis with 1130 patients and found
that out of the 795 patients this criteria identified as having a stroke, 782
(98.4%) were clinically determined to be stroke patients [48]. However,
out of the 335 patients it did not identify as stroke patients, 215 (64.2%)
were in fact experiencing a stroke. The Los Angeles Prehospital Stroke
Screen provides a low false positive rate, but has a high false negative
rate. The author states that if the criteria is not met, the patient should
continue to be assessed following standard medical protocol [149]. This
will allow false negative cases to be caught.
4.4.5 Acute Assessments
National Institutes of Health Stroke Scale (NIHSS) [40, 214, 296]: NIHSS
consists of 15 items that are scored on a scale of 0 to 2, 3, or 4 each,
depending on the item. The maximum score is 42. This is a largely phys-
ical assessment and features areas such as vision, speech, arm and leg
movement, sensation, and memory. It does not factor in other neurolog-
ical or physical issues into the assessment, which can lead to inaccurate
analysis. This test takes time to perform, unlike ASPECTS which can
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be automated from NCCT data in near real time.
Schlegel et al. showed that each point on NIHSS decreased the likelihood
of “excellent outcome” by 24% at one week and 17% at three months
[254]. Meyer et al. found that using a simpler scale or 11 items improved
interobserver reliability [206] over the original scale.
Six Signs and Symptoms [240]: This is a newer method from 2014 derived
from NIHSS that uses six signs of stroke to determine its score between
0 (no symptoms) and 15 (severe stroke). Its advantage over NIHSS is its
simplicity, allowing it to be carried out faster and with less prior training.
It has shown a similar performance to NIHSS [240].
European Stroke Scale [117]: The European Stroke Scale is used when a
patient has recently had a stroke involving the area of brain supplied
by the middle cerebral artery — the same as for ASPECTS. This scale
measures the impact a stroke has had on a patient’s consciousness. com-
prehension, speech, visual ability, and a range of physical activities in-
volving the face, arms, wrist, fingers, legs, feet, and gait. A final score
out of 100 captures the severity of the stroke.
Hemispheric Stroke Scale [3]: This is a comprehensive survey that, like
the European Stroke Scale, scores the patient out of 100. The areas cov-
ered range from language — such as comprehension, naming, repetition,
and fluency; to visual fields and gaze; facial expression; ability to draw
shapes; arm and leg movement; muscle tone; gait; and touch recognition
and sensitivity.
Orgogozo Stroke Scale [227]: Similar to the Hemispheric Stroke Scale, this
is a comprehensive survey covering the same general areas but separates
muscle tone into upper limb and lower limb, and does not examine mental
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capacity beyond the level of consciousness. This effectively make it a
faster, although weaker, assessment. It predates the Hemispheric Stroke
Scale by four years.
Canadian Neurological Scale [56]: This assessment measures the patient’s
mentation for levels of alertness, orientation, and speech, and then checks
for weakness or asymmetric strength in the face, arms, and legs. Cote
et al. showed the interobserver reliability on each scale item was “good”
[55]. A later study compared it to the NIHSS where Bushnell et al.
showed that for retrospectively assigned NIHSS and Canadian Neurolog-
ical Scale scores, levels of interobserver agreement were almost perfect
[42].
Hunt & Hess Scale [132, 133]: This quick survey is aimed at non-traumatic
sub-arachnoid haemorrhage patients and consists of a single evaluation.
The five-point scale ranges from mild headache and neck stiffness to
more serious symptoms such as drowsiness/confusion and focal neuro-
logic deficit and through to the most severe score for a comatosed pa-
tient.
Scandinavian Stroke Scale [110]: Focusing on ischemic stroke, the patient
is scored for level of consciousness, eye movement, and motor power of
the arms and legs. The severity of the symptoms indicates the severity
of the stroke.
4.4.6 Outcome Assessments
Modified Rankin Scale [19, 277, 285]: Introduced in 1957 by Dr. John
Rankin and modified into scale form by Van et al. [285], this seven-
point scale rates patient outcome by perceived disability from a score of
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0 meaning no symptoms, through to a score of 6 — patient is deceased.
The in-between scores are 1: No significant disability despite symptoms;
able to carry out all usual duties and activities; 2: Slight disability;
unable to carry out all previous activities, but able to look after own
affairs without assistance; 3: Moderate disability requiring some help but
can walk without assistance; 4: Moderately severe disability; unable to
walk and attend to bodily needs without assistance; 5: Severe disability;
bedridden, incontinent and requiring constant nursing care and attention.
Quinn et al. show the scale may not be reliable with significant interob-
server variability observed [239]. An average Cohen’s kappa coefficient
of 0.42 — or “moderate” correlation — is noted in interobserver agree-
ment over ten studies that range from 0.25 (“poor”) to 0.72 (“good”)
[28, 44, 115, 207, 215, 239, 285, 301, 302, 304]. Wilson et al. found that
using structured interviews to rate a patient on the scale improved the
reliability and decreased the variability and bias between observers [301].
Cohen’s kappa coefficient improved from 0.25 (“poor”) to 0.74 (“good”)
when using a structured interview [302]. Bruno et al. showed that using
a simplified set of interview questions consisting of two to three questions
before determining the modified Rankin score reduced assessment time
from 5 minutes for a regular questionnaire to 1 minute and 40 seconds
[41]; interobserver agreement was good with a Cohen’s kappa of 0.72.
Glasgow Outcome Scale [136]: The scale is very similar to the Modified
Rankin Scale. This scale scores a patient from 1 to 5 based on disability.
5: No significant disability, 4: disabled but independent, 3: conscious
but disabled, 2: persistent vegetative state, 1: patient is deceased. This
scale combines the lowest two categories of the Modified Rankin Scale
and is focused on simple, broad categories. This can allow it to be used
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faster and to a similar effect as the Modified Rankin Scale.
Barthel Index [52, 108, 184, 195]: The Barthel index measures the pa-
tient‘s independence after having a stroke. A number of activities are
scored on a scale and then the total score provides the impact of the
stroke on the patient. Activities include toilet use, bathing, feeding,
dressing, transfers (bed to chair), and stairs. None of these activities are
completed on site, but are instead discussed with the patient.
Berg Balance Scale [26, 27]: The Berg Balance Scale has a number of mo-
tor activities that are completed under the supervision of the clinician.
These include actions involving standing, sitting, reaching down or for-
ward, and turning around. These are scored between 0 and 4 and then
summed. The final score is interpreted into three categories: wheelchair
bound, walking with assistance, and independent.
Lawton IADL Scale [174]: Instrumental Activities of Daily Living (IADL)
is a high level set of categories for the mental and physical capacity of
the patient. It measures the functional impact of emotional, cognitive,
and physical impairments. There are eight areas that are discussed with
the patient: the ability to use a telephone, shopping, food preparation,
housekeeping, laundry, transportation, medication, and finance manage-
ment.
Stroke Specific Quality of Life Measure [299, 300]: This measure focuses
on the patient’s interactions with their environment as well as their own
abilities. These topics are discussed rather than tested in the clinical set-
ting. Categories of questions cover energy, family roles and social roles,
but also language, mobility, and self care. Personality, mood, and pro-
ductivity are also discussed. This makes this measure one of the most
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comprehensive outcome assessments for stroke and needs post-stroke.
Other assessments of note that do not fit into the above categories are
the Mathew Stroke Scale [198] which is a combination of other tests and
physical and mental assignments, the Oxfordshire Community Stroke Project
Classification (Bamford) [18, 201] that uses a broad set of patient symptoms
to determine the size/severity of the stroke, the Action Research Arm Test
[45, 62, 68, 187] — a short assessment looking at the arm and hand actions
of the patient. It is used at various stages of recovery to quantify the recov-
ery rate, although does not quantify stroke symptoms beyond the arms and
hands. The test consists of grasp, pinch, grip, and gross movement of the hand
or arm. The Hachinski Ischaemia Score [116, 209] examines the speed of onset
and progress of symptoms as well as the history of a patient to find the stroke’s
impact and risk.
4.5 Datasets
Ie use data from three previous studies on patients with suspected stroke:
ATTEST [131], POSH [190], and WYETH [292] (detailed below) provided by
the Institute of Neuroscience and Psychology, University of Glasgow, Southern
General Hospital. Specifically, I made use of the NCCT volumes, radiology
reports, and ASPECTS for 156 patients. The NCCT scans were taken within
6 hours of symptom onset. The ASPECTS provided by these studies represents
the professional standard.
Ground truth was collected on the NCCT scans using manual segmentation
with the program 3D Slicer (4.5.0) [89] by an internal clinical expert (see
Section 4.6) on a per-slice voxel-level basis.
ATTEST [131] (Alteplase versus Tenecteplase for Thrombolysis af-
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ter ischaemic Stroke) The aim of this study was to comparatively
assess two drugs: alteplase and tenecteplase. These can be used to
treat acute ischemic stroke. Patients eligible for intravenous thromboly-
sis within 4.5 hours of stroke onset were recruited. The outcome of this
study showed that of the 71 patients (35 assigned tenecteplase and 36
assigned alteplase) no significant difference was found in terms of the
efficacy and safety of the treatments.
POSH [190] (Post Stroke Hyperglycemia) This study investigated whether
post stroke hyperglycaemia has an impact on the infarct growth and
brain arterial patency. The patients recruited for this study presented
with acute ischemic stoke (within 6 hours of stroke onset) and were di-
vided into three groups: 17 normoglycaemic patients at all time, 59
patients hyperglycaemic on admission and 32 patients that became hy-
perglycaemic 6 or more hours after admission. Findings suggested that
the patient hyperglycaemic on admission tended to have larger infarct
volumes at the 24-48 hour stage than normoglycaemic and late hyper-
glycaemic patients [189] .
WYETH [292] This study verified the predictive value of perfusion and an-
giographic imaging for clinical outcomes. 83 patients with potentially
disabling stroke were recruited in three stroke centres. Two sets of imag-
ing took place. First 76% were imaged with CT and 24% with MRI
within 6 hours from the stroke onset. Second, 72 hours later, they were
imaged with the same modality again. Researchers found that recanali-
sation at 72 hours on the angiography volumes predicted clinical outcome
more directly than tissue reperfusion.
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4.6 Scoring Methods
Further to the ASPECTS I have calculated the score via three other means,
described below, leading to four overall methods of determining the ASPECTS
for each patient:
1. From clinical studies, as taken from the datasets (defined in Section 4.5)
themselves.
2. From the manual segmentation of ischemic and non-ischemic regions by
an expert.
3. From visual inspection of the NCCT volumes by an expert.
4. From an automatic segmentation using a CNN algorithm.
Clinical Score: These scores were generated as part of the aforementioned
studies (Section 4.5). ASPECTS was calculated by two clinicians review-
ing the data independently. A third clinician resolved discrepancies. The
experience and background of the reviewers varied.
Ground Truth Score: At my host company there is an in-house member of
staff, who I will refer to as the clinical expert throughout, with 16 hours
of training in detecting stroke signs. They segmented regions of acute
ischemia in the NCCT volumes under the supervision of an experienced
neuroradiologist. The clinical expert additionally created an atlas volume
of the twenty ASPECTS territories (refer to Section 4.3) on a patient
whose regions were clearly defined and otherwise unremarkable. These
two tasks were completed in the program 3D Slicer (version 4.5.0) [89]
at the slice level.
The atlas is rigidly aligned to each ground truth volume via landmark
registration using automatic landmarks [65] to identify the territories for
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that patient. Rigid alignment is chosen to prevent non-rigid distortions
of the atlas creating artifacts that could undermine clinical validity. How-
ever, rigid alignment does introduce an error in the boundary locations
of the ASPECTS territories.
To convert the ground truth to ASPECTS two rules are applied. These
rules are based on work by Kosior et al. [157] in the absence of an
accepted standard for calculating ASPECTS.
1. The first rule – which I call the 5% rule – states that any territory
with ground truth ischemia present in more than 5% of its volume
is classified as ischemic. This is defined mathematically in Equation
4.2.









where D is the set of voxels in a territory and GTi is the ground
truth label for voxel i.
2. The second rule - the small volume rule - is applied only if no
territories meet the 5% rule but there is ground truth ischemia
present in at least one territory. This rule states that the territory
with the highest volume of ischemia ground truth present in it,
and only this territory, is classified as ischemic. This results in an
ASPECTS of 9. The total volume of the territory is not taken into
account – only the volume of ischemia ground truth in each territory
is used. Equation 4.3 demonstrates this.
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To explain: The first line checks to see if any territories meet the
5% rule (in which case Equation 4.2 is used), the second line checks
for the set of voxels in all territories (Dall) if any ground truth above
zero is present, and if so, the third line says the territory with the
highest total value of ground truth is classed as having ischemia
present.
Observed Score: Six months after the completion of the ground truth seg-
mentations, the clinical expert visually examined each of the data vol-
umes by using 5 mm slabbed slices and noted which territories presented
acute ischemia. The ASPECTS came directly from the number of af-
fected territories.
CNN Score: A CNN architecture based on previous work by Lisowska et
al. [180, 179] is used to produce a voxel-level confidence mask of early
ischemic change in each volume. The CNN features two identical inten-
sity channels consisting of a series of three orthogonal 1D convolutions
with kernel size of 5 x 1 x 1 , 1 x 5 x 1 , and 1 x 1 x 5 and 16 kernels. The
two channels then merge, and atlas coordinates are input. The set of
convolutions is repeated with two kernels. Figure 4.3 demonstrates the
design. The use of the left hemisphere and right hemisphere channels
provides a hemispherical (bilateral) comparison, which is used by clini-
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cians to diagnose stroke — stroke usually affects only a single hemisphere
due to the brain’s major blood vessels each only connecting to a single
hemisphere. This comparison helps rule out false positives caused by
age-related changes in the brain. These changes exhibit a high degree of
symmetry.
I use samples of approximately 20 million voxels from folded slices. Vox-
els are given positive confidences if ischemia is suspected by the CNN,
and negative confidences if no ischemia is suspected. There is no upper
or lower bound on the confidence values.
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Figure 4.3: A) Schematic of the CNN showing the filter sizes and the number
of layers. Pairs of contralateral 3D image intensity patches are input to the
network at training time. Atlas coordinate inputs are then fused at the merge
point of the intensity channels. B) Application of the network at test time.
Whole folded slices are input to the network, but predictions are generated
separately for each hemisphere. Modified from [180].
The ground truth segmentations are used to train and validate the CNN
with five-fold cross-validation. For each fold 40% of the training data
is kept separate as a validation set. The ASPECTS atlas is aligned to
the voxel confidence masks in an identical manner to the Ground Truth
Score. Figure 4.4 shows an example detection with ground truth and the
atlas.
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Figure 4.4: Left: NCCT volume axial slice of a dataset showing the M4 to
M6 regions of the MCA. Centre and Right: The ASPECTS atlas for the
shown NCCT slice with the M4-M6 territories marked for each hemisphere.
The brighter regions in the left of the images show segmented ground truth
ischemia by the clinical expert (Centre) or suspected ischemic voxels from the
CNN (Right) for that slice. A-P refers to the Anterior to Posterior axis; R-L
references the Right to Left axis.
The voxel confidences are converted into ischemic territories via Equation
4.4, which averages across the suspected ischemic (positive) voxels in a
territory and applies a threshold to determine if this average is sufficient
for the region to be classed as ischemic. The threshold is selected by
receiver operating characteristic (ROC) curve analysis to balance false
positives with false negatives relative to the ground truth in the training
set, resulting in a score that is unbiased across a large number of datasets.









where D represents the set of voxels comprising the region, ci is the
confidence score of voxel i, and t is the threshold.
I dichotomise the four method scores at ≥7. A dichotomised ASPECTS can
be clinically useful to weight treatment decisions and the use of a dichotomised
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score is increasingly common in clinical trials [233]. For all the methods except
the Clinical score I also have a territory breakdown. This level of detail was
not provided with the Clinical score. I refer to this as the territory data.
Figure 4.5: A high level overview of how each of the scores are arrived at
from the original volume and the different interpretation levels each step exists
within.
4.7 Evaluation Procedure
I cannot take any of these methods as a definitive gold standard, however the
clinical score can be accepted as the closest. Statistical measures are required
to compare the overall accuracy of each method to the clinical score and to
each other. I apply two measures: Cohen’s kappa [51, 103, 271] and STAPLE
[294]. Each measure is applied to pairs of methods at a time for all possible
pairings for the dichotomised ASPECTS and the territory results.
Cohen’s kappa is a statistic to measure agreement between two sets of
data while taking into account the probability of random chance agreement —
therefore accounting for class imbalance. Cohen’s kappa is defined as




where po is the observed agreement among methods, and pe is the proba-






(TP + FN) ∗ (TP + FP ) + (TN + FN) ∗ (TN + FP )
n2
(4.7)
where n is the number of patients or regions in the data and TP, FN, FP,
and TN are the number of True Positives, False Negatives, False Positives,
and True Negatives respectively.
STAPLE is an algorithm that compares the performance of two or more
results, in this case my four methods, with each other. STAPLE is an extension
of the expectation-maximisation algorithm [211]. It does this by estimating a
true score for each patient based on the score from each expert (the methods)
and the perceived ability of each expert. The algorithm then calculates the
performance of each expert against the true score, which gives the sensitivity
and specificity of each expert. The process then repeats from the first stage
until convergence.
The sensitivity is the fraction of positive cases correctly identified as being
positive. The term positive here refers to an ASPECTS on the “more severe”
side of the dichotomised scale (i.e. ASPECTS< 7 ) in the case of the patient-
level evaluation, or to an ischemic territory in the case of the territory-level












I use all available data from the studies (156 patients) and for each patient
I collect the ASPECTS via the four methods at the patient level using the
conversions explained in Section 4.6, and three methods at the territory level
— the Clinical Score did not provide a territory-level break down. This is
because it was not scored by the hospitals involved.
Figure 4.6 illustrates the distribution of the scores for each method. From
the 156 patients, 52 of these reported a Clinical Score of 10, however our clinical
expert recorded an ASPECTS of 10 in 62 cases (Observed Score), and there
were 66 cases of such in the Ground Truth Score. Each method generally tails
off towards the lower scores, but there are notable exceptions. The Clinical
Score features a clustering of patients around the central scores (particularly
scores 4–7) that the other methods do not exhibit. The Ground Truth score
has a peak at 9 that is 33% larger than the method with the next highest bar
of that score (CNN Score) and almost three times that of the clinical standard
(Clinical Score). The CNN Score is the most likely to predict no ischemia
within the territories.
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Figure 4.6: The distribution of the raw ASPECTS for each method.
At the patient level, the fraction of patients above the threshold for throm-
bolysis treatment (≥7) varies between the methods: 70% of the Clinical Scores,
92% of the Ground Truth Scores, 86% of the Observed Scores, and 90% of the
CNN Scores.
A total of 3120 (156 x 20) ASPECTS territories were scored by each of
the three methods (Ground Truth, Observed, and CNN scores) as presenting
ischemic signs or not. I calculated Cohen’s kappa coefficient between pairs
of the dichotomised scores and each pair of the territory scores. Figure 4.7
displays these values. The highest correlation is seen between the Ground
Truth and CNN dichotomised scores, while the lowest set of correlations at the
dichotomised level are the three comparisons with the Clinical Score. At the
territory level there is a modest correlation between the territories calculated
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as ischemic between the Ground Truth and the Observed methods, while a































Clinical vs Ground Truth
Clinical vs Observed
Clinical vs CNN
Ground Truth vs Observed
Ground Truth vs CNN
Observed vs CNN
Figure 4.7: Cohen’s kappa coefficient between pairs of ASPECTS methods for
the dichotomised per-patient data and territory data.
For the voxel-level masks (CNN method) I evaluated these against the
ground truth segmentations in terms of Area Under Curve (AUC) for the
Receiver Operating Characteristic (ROC) curve and the Precision-Recall (PR)
curve to get ROC AUC = 0.94 and PR AUC = 0.41.
The STAPLE algorithm determines the sensitivity and specificity of each
of the methods at the dichotomised and territory levels.
Table 4.2 shows these values. Further to the evaluation against the STA-
PLE true score, each of the methods are evaluated against each other to pro-
duce sensitivity and specificity for each. Table 4.3 shows the evaluation at the
dichotomised level, while Table 4.4 displays it at the territory level. In both
cases the assumed true class is on the left and the assumed predicted class is
Chapter 4. ASPECTS For Ischemic Stroke 149
along the top. Sensitivity for methods evaluated against the Clinical score is
low in all cases, but specificity is high. Specificity is expected to be high due to
the large number of true negatives in the data relative to true positives. This
means any false positives only have a minimal effect on the specificity each.
On the other hand, the sensitivity is more prone to false negatives due to the
low number of true positives in the data relative to true negatives.
The most likely regions to be disagreed between methods (i.e. where one
method claims they are affected territories and another does not) are the small
central ASPECTS territories: Caudate, Lentiform Nucleus, Insula, and the
Internal Capsule. I believe this disagreement comes from the small size, close
proximity, and irregular and variable shaping of these territories making them





Dichotomised Sensitivity 0.87 0.72 0.48 0.50
Dichotomised Specificity 0.82 0.98 1.00 0.97
Territory Sensitivity N/A 0.84 0.72 0.49
Territory Specificity N/A 0.98 0.99 0.97
Table 4.2: The sensitivity and specificity from binary STAPLE analysis on the
dichotomised and territory data.






Sensitivity: 0.37 0.28 0.28










Table 4.3: The sensitivity and specificity between pairs of scores at the di-
chotomised patient level.










Table 4.4: The sensitivity and specificity between pairs of scores at the territory
level.
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4.9 Discussion
I present results from two statistical measures applied to methods of scor-
ing ASPECTS to compare three methods of determining ASPECTS to the
professional standard and to explore the methods against each other. I use
Cohen’s kappa as a method resilient to dataset imbalance to compare the cor-
relation between pairs of methods, and STAPLE to determine the sensitivity
and specificity of each method relative to the others.
4.9.1 Comparison of Score Methods
This section describes and constrasts the score methods.
CNN Score: At the patient level, the CNN Score correlates the strongest
with the Ground Truth Score, which is expected as the CNN is trained
on the ground truth. The similarity between the CNN and Ground Truth
Scores is influenced by the choice of the CNN Score threshold, which
exists to balance false positives and false negatives, and thus minimise
the bias between the two scores. The quality of the ground truth provides
an upper bound on the ability of the CNN. At the territory level the
performance of these methods diverge. A STAPLE sensitivity of 0.5 for
the CNN Score indicates that there are as many false negatives as true
positives.
Ground Truth Score and Observed Score: The Kappa coefficient of 0.6
between the Ground Truth territory scores and the Observed territory
scores is low given that both were marked by the same clinical expert.
It can be reasonably assumed that the clinical expert will have chosen
similar territories for both methods, however the Observed territories are
identified directly the clinical expert, while the Ground Truth territories
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came from an indirect route through manual segmentation, atlas align-
ment, and thresholding rules. There are associated errors with these
processing steps such as ground truth segmentation accuracy, atlas ac-
curacy and misalignment, threshold rules inconsistently applied due to
human judgement, and different tools being available at the time of the
method - namely the availability of a slabbing tool which was used for
the Observed Scores, but was not available for the Ground Truth Scores.
Slabbing makes the identification of ischemic stroke signs easier by im-
proving contrast, so should result in a lower ASPECTS. This is observed
in Figure 4.6, although with the number of other sources of error here I
cannot conclude that the lower ASPECTS is caused by slabbing alone.
The high frequency for the Ground Truth Score at an ASPECTS of 9
in Figure 4.6 is an indication that the small volume rule could be being
applied too regularly or inconsistently with the clinical expert’s manual
observations. This could be due to the 5% threshold being set too high,
which in turn may be due to underestimating the extent of ischemia due
to the absence of a slabbing tool when marking.
Clinical Score: The Clinical Score returns the lowest STAPLE specificity of
all the methods. Figure 4.6 shows this method is biased towards lower
scores, which leads to a lower specificity. The Cohen’s kappa between the
Clinical Score and each of the other methods is poor. A possible reason
for this is that the hospital clinicians assigning the score may have been
able to see subtle signs due to their expertise level and use of clinical
tools.
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4.10 Conclusion
Stroke is a serious condition and is becoming more common in developed coun-
tries. This chapter examined the reliability of ASPECTS obtained from four
observers at two levels of interpretation: the ASPECTS territory level, and
patient level. I showed how a voxel-level output from a CNN can be distilled
into these levels and how comparable these results were to other observers.
My results show the CNN is an effective means of determining stroke sever-
ity; however it is most closely correlated to its ground truth rather than to the
professional standard. This is because my ground truth does not capture the
level of detail visible to expert clinicians, which leads to a higher average AS-
PECTS. The performance of the CNN is similar to the ground truth itself
when interpreted at the patient level, but the performance diverges at the ter-
ritory level due to my rules on converting the voxel predictions to territory
score being applied broadly.
4.10.1 Future Work
In the future it will be possible to improve the ground truth used in my ex-
periments. If an ensemble of experienced radiologists could mark accurately
the affected regions, my ground truth quality would be improved and would
match the professional standard better. This would lead to a CNN that can
predict closer to the professional standard. However radiologists often lack the
free time to complete this exercise.
A simpler improvement could come from an improved atlas and registra-
tion to better align the territory scores from the CNN to the observed scores.
Brains are unique with variations due to age, historical pathology, and head
shape, among other factors, affecting the scan. The atlas, especially rigidly
aligned, does not approximate well to every brain. Improving this approxi-
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mation through the use of better landmarking, the use of different atlases for
different ages/pathologies/heads, or careful non-rigid alignment of the atlas
are areas for future research.
Improvements may also be made to the CNN by slabbing training data to
provide additional context that clinicians already have access to. Similarly,
the follow-up scan data taken for surviving stroke patients could be used to
add context, as could scans taken in other modalities. While these data could
be used for training, they cannot be available in practice, so the CNN must
only use it as an additional ground truth aid and not as an input.
Next Steps: With distillation explored for ischemic stroke in CT, I move
on to the final problem of federation where I train a neural network within a




Federated learning is an approach that allows a machine learning model, such
as a neural network, to train on two or more isolated datasets without any
data samples transferring between these datasets. Instead, the model exists as
a copy for each dataset that trains locally and returns their trained parameters
to a central location, where they are aggregated to form a new model. This
new model is then copied to each dataset and replaces the previous copy. The
cycle then repeats.
Federated learning has uses in domains where data privacy or sensitivity
are concerns, such as in the medical domain. In addition to this conventional
form described, I present a novel evolution called soft federated learning which
accounts for covariate shift between the isolated datasets to yield specialised
model aggregation for each model copy.
To analyse these two federated learning algorithms, I use three baseline
implementations: Global Pooling where all datasets are pooled together and
trained on; Local where a model copy is trained and tested within each dataset
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(no model aggregation stage); and Ensemble in which the models from the
Local method are evaluated on every dataset and the average prediction for a
dataset is taken.
I use two datasets to evaluate the performance of these algorithms and the
baselines. First is the MNIST dataset introduced earlier in this thesis, which
consists of handwritten digits, but for this chapter I divide it into a series
of subsets to represent distinct datasets. Each of these subsets may have an
additional transformation applied to simulate inter-dataset differences. These
transformations consist of a range of affine transformations and varying levels
of noise. Sample level classification accuracy forms my evaluation.
The second dataset is the BraTS medical imaging dataset, which are MRI
scans of brain glioma from multiple institutions. Each institution forms an
isolated dataset. I evaluate using the Dice coefficient on slicewise pixel-level
segmentations.
The aim of my experiments is to evaluate conventional federated learn-
ing against its soft counterpart and to compare these against the baselines.
My results show soft federated learning is more effective than its convential
counterpart at accounting for differences in the data domains.
5.2 Chapter Overview
To finish the thesis I tackle the issue of federation for machine learning in the
medical domain. Federated techniques seek to bypass the need to move data
around, allowing training across multiple cohorts. They do this by sending
copies of model parameters between data providers, such as hospitals. In this
chapter I introduce federated learning in its most popular form currently used
in industry, and later develop soft federated learning, which is a new federated
technique that addresses some of the weaknesses of the current form.
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Federated learning is a model-agnostic means of training using data that are
divided between distinct locations called institutions without any data sam-
ples being transferred between institutions. An institution has some number
of data samples contained within. In the most popular form currently used
commercially [17, 135], federated learning achieves this by training a model
at each institution and then transferring trained model parameters to some
central location where they are synchronised and aggregated to form a new
model. The new model then replaces the model used in each institution and
the cycle repeats. The aggregated model can be considered to have learned on
all data present despite not directly observing any data.
After introducing this form of federated learning, which I will refer to as
Conventional Federated Learning (CFL), I describe the difficulties this algo-
rithm faces when dealing with domain shift between institutions — a common
issue. I then introduce a novel development called Soft Federated Learning
(SFL). SFL addresses the issues of CFL by modifying the model aggregation
stage based on the relative differences between data in different institutions.
It also removes the need for a central location, which while not an issue in
itself, is a potential point of failure or attack.
Federated learning (both CFL and SFL) is useful in situations where I
want to learn from a large amount of data, but this data cannot be pooled
into a central location because of, for example, costs, technical barriers, legal
concerns (privacy, data protection, consent, etc.), and so on. For these reasons
the data must remain in their respective institutions and not be transferred
from them. Medical data are one of the most protected forms of data and
transferring it is often costly or unfeasible. This makes it a prime area for
federated learning.
This chapter starts with a short reference list of the mathematical nota-
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tion used throughout this chapter (Section 5.3). I then move into a technical
description of CFL detailing the algorithm and its strengths and weaknesses
(Section 5.4), and provide a literature review on this topic (Section 5.5). The
results of a survey on clinical staff for federated learning for a clinical decision
support application are examined in Section 5.6.
In Section 5.7 I describe the novel evolution of this algorithm, SFL, that
addresses the major issues with federated learning. CFL and SFL are com-
prehensively compared against each other and a series of baseline results on
simple problems involving the MNIST dataset and a multi-institutional medi-
cal dataset known as BraTS to emphasise their differences. The datasets used
are described in Section 5.8, experiment design in Section 5.9, model training
and evaluation in Section 5.10, an explanation of the baseline measures Sec-
tion 5.11, and results in Section 5.12. Discussions and conclusions finish this
chapter in Sections 5.13 and 5.14 respectively.
The programs used in the experiments in this chapter were written from
scratch in Python 3.6 [93]. There now exists a framework for (conventional)
federated learning using TensorFlow [105], but this was not available at the
time of this research.
The SFL algorithm has been filed as a Canon patent [67].
5.3 Notation
Here I define the mathematical notation I will be using throughout this chapter.
This acts as a reference list that the reader may refer back to throughout this
chapter.
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Symbol Definition
NI
The total number of data institutions. This does not count the
central server used in CFL.
NC The total number of classes across all institutions.
Nd,i The number of data samples at institution i.
ND
The total number of data samples across all institutions
(= ΣNIi=0Nd,i).
di
The dataset within institution i. A dataset is made up of






A data sample. x ∈ Rdim where dim is the number of
dimensions in the data — the number of features (such as
pixels or voxels), not the number of spatial dimensions.
y
A class. y ∈ N+ with, for example, MNIST being the set
{0, ..., 9}. ypred refers to the predicted class, ygt refers to the
true class (ground truth), and yc is the correct class c of a
data sample.
D
The set of all data across all institutions. D = (x,y) where
x = {x1, . . . ,xi}, y = {y1, . . . ,yi}. xi = {x1, . . . , xNd,i},
yi = {y1, . . . , yNd,i} This can also be expressed as D = ∪idi
where ∪ is the set union.
T The number of cycles for a given experiment run.
t The current cycle in the experiment run.
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M ti
A neural network model (at cycle t and within institution i)
The model consists of a set of weights (w) and biases (b)
M ti = (bi,wi) where bi = {b1, . . . , bj,i} and wi = {w1, . . . , wk,i}
where j is the number of biases in the model and k is the
number of weights. M t=0 is the initial model state.
Ii
An institution. i can take the values {1, . . . , NI} An




A special institution called the central server or central
location.
Table 5.1: Definitions of the symbols used in this chapter.
5.3.1 General Model Training
Here I define model training mathematically for a general case. A cycle of
training takes a model, M t to M t+1:
M t+1i ← SGD(M ti , L(M ti , dtraini )) (5.1)






where ypred in this case is the probability of that class prediction.
Expanding, I get:
M t+1i ←M ti − αL(M ti , dtraini ) (5.3)
The optimisation function (SGD) and loss function (cross-entropy) can be
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trivially substituted by any other corresponding function. In my work on the
MNIST data I use the above functions, while for the BraTS data I use a custom
loss function (Section 5.10.2) and the Adam optimiser [151].
5.3.2 General Model Evaluation
Now for the evaluation, I take the class predictions generated by applying the
model, M , to each data sample in the test dataset, xtest:
P (y|xtest,M) = {P (y0|x,M), . . . , P (ymax|x,M)} (5.4)
and then I take the class with the highest probability to be the class prediction:
ypred = arg max
c
P (yc|x) (5.5)
with the predicted class contained within NC .
To calculate the accuracy of an evaluation at an institution, i, I count the









1, if ypred = ygt0, otherwise (5.7)
The evaluation function can be trivially substituted for another. In my
BraTS work I use the Dice score [74] instead of simple accuracy (see Section
5.10.2, Equation 5.15) as it is a better suited evaluation method for image
segmentation tasks.
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5.4 An Introduction to Federated Learning
Federated learning is a model-agnostic approach to training a machine learning
model, in this case a neural network, across two or more distinct institutions
without there being any transfer of data samples between the institutions. The
collection of institutions is called the federation.
Federated learning is generally inferior in terms of achievable accuracy to
the traditional model training technique of pooling all available data in a cen-
tral location and training on this pooled data. It falls behind in terms of time,
performance, resource usage (memory and network), and computational com-
plexity — experiments later in this chapter confirm this. This is because the
added complexity of federated aggregation and fitting error of training on sub-
sets of the total data reduce the performance of federated learning. However,
pooling data is not always easy or possible to do. For example, in the medical
domain, a hospital is a location that is generating data (through taking scans
of patients, for instance), but I cannot simply remove these data from the hos-
pital. To obtain data in such a case I require contractual agreements, patient
consent, plenty of time (often months), and financial payment, and even if the
data are obtained, there will likely be restrictions on their use. These issues
make it difficult to develop a central pooled resource of medical data for model
training.
Federated learning overcomes this by removing the need for any transfer of
sensitive data. Federated learning generally operates under four key assump-
tions about the data [156, 200].
1. The data are sensitive and cannot leave their institution.
2. The data at each institution have some degree of “similarity”. That
is, a model trained on a dataset at one institution will learn something
Chapter 5. Federated Learning 163
applicable to a dataset at a different institution.
3. However, the datasets are not independently and identically distributed.
This means each institution’s data may not be representative of the
global distribution.
4. The datasets are class unbalanced both within themselves and between
each other. This means some classes occur much more frequently than
others and some institutions do not have all of the classes of other insti-
tutions. An example would be a particularly rare pathology label that
is only observed at a minority of institutions.
5.4.1 The CFL Algorithm
Here I introduce the CFL algorithm, which is the most popular federated
learning algorithm currently used in commercial applications [17, 135].
I start with one of two options. Either a model that has been pre-trained on
a task similar to what I expect to see in the institutions, or an untrained (ran-
domly initialised) model. The model is chosen to be suitable for the desired
task. Using a pre-trained model accelerates convergence to good performance
within the institutions and ensures that the first few iterations have an ac-
ceptable performance. Using an untrained model leads to a slower training
but convergence is still reached.
With this model I create a copy of it for each institution. Within these
institutions the model then trains locally on the data present in the usual way.
After some set amount of time or number of epochs the models send their
parameters (their “model”) — for example, the bias and weights of neurons in
a neural network — to some central location. This may be the location where
the model originally came from, or any other secure and accessible location.
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The time before parameter return must be long enough for the models to
specialise to the local features of their data, but not too long that the models
substantially diverge from each other. Federated learning requires that the
models remain somewhat synchronised, otherwise aggregating the parameters
can result in a nonsensical model.
Depending on the resources available, a subset or all of the institutions
can return their models — in my work I always return all of the models. If
a federation is very large (lots of clients), it may be applicable to return a
random subset of models under the assumption that the models in this subset
will approximate the models in the full federation. This improves the time
efficiency of the algorithm.
The returned parameters are aggregated with a weighting equal to the
amount of data each was trained on — Equation 5.8. The new model is then
copied to each institution, replacing the previous version, and the cycle repeats
for the lifetime of the software. See Algorithm 5 for pseudocode of CFL using











The models at the institutions can be used for evaluation of local data once
their performance is deemed good enough by some defined metric.
Figure 5.1 shows non-federated data transfer where data from a number of
institutions (sometimes only one) are transferred to a central location. Figure
5.2 shows the CFL approach where the data is not transferred (remains within
each red ring), but the model parameters are passed back and forth between
the central location and each institution. Finally, Figure 5.3 shows an overview
of a cycle of CFL at a single institution.
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CFL essentially allows knowledge transfer between institutions without any
raw data leaking out, especially when this knowledge is encrypted. Knowledge
here refers to the patterns and mappings implicitly learned in the parameters
of the models. The models are essentially learning on all data without any
data being directly moved into or out of an institution. It achieves this by
each model being an encoding of the data it trained on and these abstract
data encodings (the models) are transferred across institution boundaries.
Figure 5.1: An overview of a traditional (non-federated) setup showing a cen-
tral location (central server) where data from numerous institutions are trans-
ferred to (red arrows) and pooled. A model is then trained at the research
centre on the pooled data. Any number of data institutions may be used.
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Figure 5.2: An overview of a federated learning setup showing a central location
(central server) connected to numerous data institutions. The data do not leave
their respective institutions (as indicated by the dashed rings), but instead the
model parameters are passed back and forth (blue arrows). To utilise the CFL
algorithm, at least two institutions are needed.
Figure 5.3: A cycle of federated learning at a single institution. Starting from
the central server and going to the right a model is copied to each institution.
The model learns locally and is returned. On the left of the figure a series of
learned models are averaged to form a new model. The cycle then loops back
to the first step.
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Algorithm 5 Conventional Federated Learning Pseudocode
// Randomly initialise and then pre-train the global model:
M t=0cent ← rand init(Mg)
M t=1cent ← SGD(M tcent, L(M t=0cent, dtraincent ))
// For each cycle of federated learning
while t ≤ T do
For each institution
for i in 1 to NI do
// Copy the central model to the institution
M ti ←M tcent
// Train locally
M t+1i ← SGD(M ti , L(M ti , dtraini ))
// Parameter feedback and weighted averaging.
// The parameters of each institution’s model are weighted based on the










5.4.2 Issues with CFL
Federated learning works well if the data within each institution are represen-
tative of the whole population. This means any knowledge learned within one
institution can be directly applied to all other institutions.
Unfortunately, this is rarely the case. Each institution will have its own
characteristics which may or may not leave its data similar to those in other
institutions. These characteristics can be placed into two categories:
Data Acquisition: These are differences in how the data are collected. In the
medical domain a hospital, for instance, that is collecting CT data may
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have a different CT scanner make, model, and age, or may use different
scanner settings, or scan protocol to another hospital. There can also be
differences between how clinicians record data. These differences affect
the data samples that in turn affect what a model at that institution
learns.
Population Sampling: This forms differences in which data are observed at
a hospital, rather than within the data themselves. Some hospitals, such
as specialist clinics, or hospitals in specific geographical locations, may
see a much higher number of a certain type of pathology than other,
more general, hospitals. This leads to a shift in the class balance which
means the model will focus on different features between institutions.
Furthermore, institutions may see a different volume of data: a large
hospital is likely to generate more data than a small hospital. The model
is at risk of overfitting on the smaller hospital’s data — where it trains
for an extended period on a few data samples — leading to non-useful
parameters being learned. Meanwhile, the larger hospital is less likely
to overfit and more likely to learn good general parameters, but its new
model at a new cycle will be influenced by the overfitted one from the
small institution, thereby weakening its ability.
Finally, federated learning is at risk of compromised institutions. When
deployed to a large number of institutions around the world, there is a risk of
an institution malfunctioning, or being attacked in such a way that its data
becomes invalid or the model returned is maliciously modified to weaken the
federation during aggregation. One can imagine a scenario where an institution
is compromised and its model is designed to perform poorly on the task by, for
example in the medical domain, always returning negative (healthy) labels for
pathology. If this compromised model is sent to the central location alongside
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a parameter saying it has been trained on a very large number of datasets,
then it will dominate the aggregation (see Equation 5.8) and thus result in a
compromised aggregated model that is then sent to every institution, thereby
rendering the entire system useless.
Later in this chapter (Section 5.7) I detail my new algorithm, SFL, to solve
these issues:
1. SFL factors in overfitting when deciding how much a model should be
weighted during aggregation.
2. SFL also factors in the differences between institutional data cohorts
when weighting models, and it does this for every pair of institutions.
3. SFL is able to recognise outlier models (such as from rogue institutions)
and weaken their influence in the federation (potentially to zero).
4. SFL removes the need for a central location.
5.5 Previous Work
In recent years there have been substantial advances in the computational
abilities of graphical and computational processing units for machine learn-
ing. This has allowed higher complexity models to be trained [69], which offer
improved performance. Performance on ImageNet — an image classification
challenge used as a benchmark for machine learning [72] — continues to im-
prove every year. With these advances, one of the largest constraints in the
field is now a lack of data. Sun et al. showed (empirically) that there is a
logarithmic improvement achieved in model performance with increasing data
[278]. As such, finding new ways to obtain data and reduce the difficulty of
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collecting large sets together is important to continue improving model perfor-
mance. Federated learning is one way this is being addressed [199]. McMahan
et al. developed federated learning and found ways of efficiently communicat-
ing between many datasets [200] and showed that there are diminishing returns
with the number of institutions used in each update. Bonawitz et al. discuss
some of the key challenges with high-level federated learning design [32], some
of which will be discussed below.
Attempts have been made to create open-source advanced federated learn-
ing technology, such as OpenMined [226], which started in 2017 [307]. Closed-
source federated learning systems include WedGLORE [137] and EXPLORER
[290] that enable privacy-preserving construction of a global logistic regression
model from distributed sensitive datasets, GWAS [53] specifically for federated
genomic datasets, and WebDISCO [186] for patient survival data.
Bogdanov et al. discuss how secure multi-party computation can be used
as a privacy-enhancing technology, and they provide a detailed description of
the solution [31]. Kamm et al. — in a paper that shares several authors
with the previous reference — explain privacy enhancing in the context of
genome data using secret values to obscure the data during processing [143].
Pihur et al. use their “draw and discard” method that maintains a number of
versions of a model on a server, then selects one at random to update using
data from an institution. They then use this to randomly replace one of the
instances on the server, thus gradually progressing the models using data from
multiple institutions [234]. Nishio and Yonetani develop a means of selecting
institutions for carrying out model updates at using the computational resource
limits of these institutions and the timeframe the update must be completed
in to select the institutions that give the most efficient update [222] — they do
not factor in the data domain differences between institutions when deciding
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which to select however.
Data anonymisation via de-identification methods have also been put for-
ward, such as k-anonymity [279], l-diversity [191], and differential privacy [80];
which enable easier use of the data including the possibility of transfer. How-
ever, these methods remove information that may be useful for machine learn-
ing purposes.
Smith et al. look at multi-task learning — where a model learns to solve
multiple tasks by taking advantage of similarities between the tasks — but
in a federated setting [273]. Multi-task learning is a substantial field in itself
that will not be covered in detail in this thesis, but the following provide a
good starting point: [8, 10, 11, 87, 166, 310]. Essentially, multi-task learning
involves learning a single model that can be applied to two or more different
tasks. By doing so, the learning acts as a regularisation method making the
model less likely to overfit than a single-task model. This has some similarities
to federated learning, but operates on the assumption that the data can be
communicated and avoids model parameter averaging.
Kamp et al. explore how the institution models diverge over time as they
fit to their local data [145]. This divergence harms the aggregation stage of
federated learning. They employ a new algorithm called Dynamic Averaging
[146], which modifies the federated learning algorithm by monitoring the di-
vergence of each model over time. When a set have diverged beyond some
defined threshold, model averaging occurs to pull these diverged models back
together.
5.5.1 Previous Work with Medical Data
A federated learning system was tested in 2016: euroCAT by Deist et al. [70].
They took five radiation clinics across three countries (Belgium, Germany, and
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the Netherlands) and used a support vector machine and Bayesian network as
their models to federate. Their results show successful learning of the models
for dyspnea (shortage of breath) [139], thus acting as a proof-of-concept that
federated learning can be used in the medical domain. However, Konecny et
al. have found that federated learning can train very slowly in the presence of
a large number of institutions [156].
In 2018, Sheller et al. used federated learning on a U-Net model — a type
of deep neural network that downsamples an input through convolutions and
downsampling layers before upsampling through transpose convolutions and
upsampling layers [245] — to show how federated learning can be used on
the medical dataset BraTS (an MRI brain tumour dataset) [268]. The BraTS
dataset is described in detail later in this chapter (Section 5.8.2) and used in
one of my experiments (Section 5.12.5). Also in 2018, another research group
— Brisimi et al. — used a support vector machine for federated learning on
patient electronic health records [38].
Recently, Roy et al. in 2019 developed BrainTorrent, a version of federated
learning aimed at medical applications [250]. It removes the central server from
the federated system by enabling peer-to-peer sharing of the models. At each
cycle a random institution checks the model version at all other institutions
and then aggregates the models that are new locally before training the new
model on its own data. This shares some similarities with part of my SFL
method (see Section 5.7), but the authors do not take into account the domain
shift between institutions in their calculations (Section 5.7.1). Domain shift
between institutions is a significant issue for any federated learning system
and may be due to different treatment guidelines [71], technological differences
[192], or variations between clinician’s interpretations [246].
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5.6 Clinician’s Opinions
To gain insight into the opinions of the target user base of a medical federated
learning system and the desire to have such a system, I created a survey aimed
at clinical staff of all backgrounds. Such a system could be deployed in a
wide variety of situations, so I aimed for responses from a wide background,
although I did not reveal the technical details of federated learning during the
survey.
I received 15 responses from a variety of backgrounds and experience levels
from consultant radiologists to doctors, and from professors to students. How-
ever, all responses were from the United Kingdom1. Therefore the applicability
of these results outside of the United Kingdom is limited.
The responses showed most (60%) are not aware of a clinical decision
support application at their institution that continually improves. The re-
spondents that were aware reference a voice activation reporting software that
learns continually as reports are dictated.
The respondents generally agreed that they would trust the software ven-
dor (i.e. Canon) to validate updates. They also wanted to be able to compare,
revise, or undo updates to the system if they did not believe they were bene-
ficial, and wished to be notified when the system updates. Overall, there was
a strong desire to implement continuous learning in systems currently in use.
Respondents have a varied opinion on the frequency of updates with the
most populat options being weekly or quarterly (every three months). This
would be frequent enough to keep the systems in the federation synchronised.
As for where the updates should come from, everyone believes that their own
institution and large regional institutions should be involved. Opinions fall
1I sent the survey to many international partners of Canon Medical Research Europe,
but failed to receive any responses.
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gradually from regional institutions to national to international, with only
47% wanting all institutions worldwide offering updates. This captures the
concerns that data that are less local to an institution may be less useful.
Despite this risk of non-useful data, 67% of respondents are happy for
all users of the system to contribute to system learning, with the remaining
respondents seeking an accreditation process before a user can contribute. This
could reflect the need for the system to be used in a wide variety of scenarios
by a range of users, so the system should be trained to be suitable for any
realistic possibility.
In the final comments at the end of the survey concerns are raised about
how one person’s improvement can be another person’s problem and how I
could measure the performance of the system over time and offer the ability
for expert review of tricky cases before the system learns on them. These could
be addressed by the system adapting to each user via some degree of additional
fitting to the core model, and for users uncertain of how to review a tricky case
to seek expert advice within their institution than attempt it themselves.
The survey questions in full along with all responses and extended analysis
can be found in Appendix A.
5.7 Soft Federated Learning
SFL is a novel advancement to CFL that accounts for weaknesses in the original
algorithm. It modifies CFL in the following ways:
Before starting: I calculate a novel quantity I call influence between every
pair of institutions including pairings of institutions with themselves.
The influence is a measure of similarity between two datasets that also
factors in the sizes of the datasets. Section 5.7.1 explains the process in
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detail, while here I provide a high level overview. Within each pair, the
influence is calculated both ways as it is not a symmetric quantity, so
the influence of IA on IB may not be the same as IB on IA. I refer to the
two institutions as the giving and receiving institution — I explain why
in the next step. The influences are normalised to sum to one on a per
institution basis. Table 5.2 shows an artificial example of what a table
of influences may look like for three institutions. The influence values
are used during the aggregation step in a cycle of federated learning.
Influence derives from the ability of an institution’s model to perform
well on the data the aggregated model will be used on. The model used
for the influence has the same architecture as the model used later during






I1 0.7 0.1 0.2
I2 0.3 0.6 0.1
I3 0.0 0.1 0.9
Table 5.2: An artificial example of three institutions showing the influence the
receiving institution gets from the giving institution. The influence for each
receiving institution sums to one. The Receiving Institution is taking in the
models from other institutions to aggregate them. The aggregation uses the
influence from the Giving Institution as the weighting of that model.
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Figure 5.4: SFL removes the central institution and instead connects every
institution directly to every other institution for model transfer. Additionally,
an asymmetric weighting (not shown) modifies each model transfer based on
the similarity between a pair of institutions. Like CFL, this requires at least
two institutions. Refer to Figure 5.2 for the equivalent figure for CFL.
During cycles: Influence, explained simply, is a weighting used during model
aggregation in a cycle. An institution with a higher influence receives a
higher weighting on its model when aggregated, and thus influences the
final model more. Referring to Table 5.2, in this case for I1 as the receiv-
ing institution the values are 0.7, 0.2, 0.1 and so it will generate its new
model from a 70% weighting of its previous model (I1), 10% weighting of
the model at I2, and a 20% weighting of I3’s model. These three institu-
tions are the giving institutions, which have the potential to contribute
to the receiving institution’s model. Each institution creates a unique
model in this way. There is no central location now; the aggregation
happens at each institution instead.
SFL does not explicitly factor in the amount of training data a model has
seen when performing the aggregation, unlike CFL. Instead, the dataset
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sizes naturally forming part of the influence calculation.
SFL’s differences to CFL are summed up as follows:
1. In SFL there is no central location for aggregating the models. Instead,
the aggregation takes place within each institution with the aggregation
being specific to that institution. See Figure 5.4
2. The institutions do not all contribute equally to the newly aggregated
models. Instead, each institution performs the aggregation with differ-
ent weightings in relation to its calculated influence on the institutions
involved. This weighting is derived from the performance of a test model
on other institutions at the start of SFL (explained in Section 5.7.1). See
Figures 5.5 and 5.6.
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Figure 5.5: A comparison of CFL to SFL in similarity space. Each small cir-
cle represents an institution, and the axes represent some notion of similarity
space onto which the institutions’ data are projected. The distance between
institutions represents (inversely) the degree of similarity between those insti-
tutions’ data. Top: In CFL an extra central location is added (large circle) to
which each institution is connected. The relative positions of the institutions
in this space are not used. Bottom: In SFL there is no central location, but
each institution is connected to each other by some weighting (represented by
the thickness of the connecting lines). More similar (closer) institutions receive
a higher weighting from each other, while dissimilar (distant) institutions can
have a zero weighting (indicated by a missing connection between two institu-
tions). The weighting between pairs is not symmetric as it factors in the size
of each institution as well as their similarity, but I do not show this asymmetry
on this image.
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Figure 5.6: A comparison of CFL to SFL in solution space. The parabolic
curves each represent the loss function for an institution’s data. The lateral
position represents the current solution as a projection onto a 1D axis, such
that the current solution will be providing some value of loss for each institu-
tion. The aim of federated learning is to minimise the overall loss. The dots
along the top represent the solution found in consecutive cycles, starting from
the centre. Top: In CFL the solution will move to the average of all losses
to minimise the average loss. Bottom: In SFL each institution has its own
solution, which seeks to minimise its own loss function. Outlying institutions
have less of an effect here.
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5.7.1 Calculation of the Influence
The influence is calculated through an empirical means to provide the weight-
ing for each model during the aggregation step of federated learning. This
calculation takes a pair of institutions with one being the giving institution,
Igive, and one being the receiving institution, Ireceive. It then determines how
much influence Ireceive should receive from Igive. That is, it is the weighting of
Igive’s model to use when aggregating at Ireceive. Both institutions may be the
same to calculate self influence (i.e Igive = Ireceive), or they may be different
(Igive 6= Ireceive). The influence calculation must be done for every permutation
of every possible pairing of institutions including self-pairings. This is due to
its asymmetric behaviour.
All influences are first calculated before the federated learning cycles begin.
They may then be re-calculated periodically to account for data drift over
time2. There are four stages to calculating the influence values.
The data at each institution is divided into a training set and a testing set
at a 2:1 ratio. During the calculation of the influence, only the training set is
used. This is to avoid biasing the influences with test data. The testing set is
used only during the federated learning itself to evaluate model performance.
Stage 1 – Model Training: I train n models at each institution, where n is
any integer ≥ 2. This represents the number of folds used. I use three
folds in my experiments. These models use the same architecture and
hyperparameters as the models to be used during the federated learning,
but are entirely separate from them. The models are trained to a good
fit in an n-fold manner on the training data present in the institution.
2Data drift over time is when the data generated by an institution changes over time. For
instance, a hospital gets a new scanner, or modifies its protocols, and this slightly changes
the data it produces. SFL relies on the influences being accurate enough to improve the
aggregation.
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I have an additional constraint that each fold must have at least one
example of each class3. The fold left out is used in the model evaluation
in Stage 2. Only the training data is used to ensure the test dataset
remains unseen for when I perform the federated learning.
Stage 2 – Model Evaluation: I now take pairs of institutions, and these
pairs may be self-pairing or different. For the pair I take the models
trained at Igive and test them at Ireceive. Each model is tested on the fold
not used for training, so for a three-fold evaluation the model trained
on folds 1 and 2 at Igive is tested on fold 3 at Ireceive for example. This
involves the transfer of model parameters but not of any data samples.
The accuracy, between 0 and 1 representing 0% and 100% accuracy,
of the models is noted and averaged between the folds. I refer to this
average value as an accuracy value.
If the two institutions have similar data and the data are plentiful, the
models trained at one institution should perform well on the other. This
is known in literature as the system having a low covariate shift [269] – the
inputs (data) change little between institutions while the outputs (class
definitions) remain the same. On the other hand, if the data between
institutions diverge greatly, the performance of one model on another
will be low (high covariate shift). A third option is if the institutions are
similar (low covariate shift) but one institution has plentiful data, while
the other has very limited data. In this case a model trained on the larger
dataset, it should generalise well to the smaller one, but a model trained
on the limited dataset may overfit4 locally to the data and perform less
3This is a realistic scenario as even the rarest pathologies get several measurements taken
- i.e. generate several data samples.
4Overfit rather than underfit as I will have a model that is relatively complex compared
to the amount of data it is seeing in this data-sparse institution. This is due to it needing
the same architecture as all other models, such as those used on more complex institutions.
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well on the large dataset.
Refer to Figure 5.7 for a schematic of Stages 1 and 2 for two institutions
with different sizes (four possible pairings), which results in four accuracy
values. Self-pairings are shown as well as the training/testing sizes for
each pairing. Three folds are used for training.
Figure 5.7: Visual representation of all four possible pairings of the influence
calculation for a pair of institutions (triangles) — one with 900 training cases,
and one with 30 - these numbers were chosen partially arbitraily and partially
for convenience of example. Each arrow represents a model being trained and
tested. The arrow’s origin marks the training institution (Igive) and points to-
wards the testing institution (I(receive)). I perform three-fold cross-validation,
which results in three train/tests for each possible pair. The numbers next to
the arrows show the number of training and testing cases. E.g. 3 * 600/10 is
three-fold cross-validation with each fold having 600 training examples and 10
testing examples. All data samples used in the influence calculations (training
and testing) come from the institutions’ training cases.
Stage 3 – Conversion to Influence: Next, I calculate a value called trivial
chance accuracy from the class balance present in the training data of
The model is likely to fit perfectly to the training data (overfit), and so not generalise well.
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Ireceive, where the models were tested. I do this by assuming a “dumb”
model is evaluating on the test dataset and giving the same class output
for all samples where this class is the most common class. For instance,
in MNIST there are ten classes with an approximately equal number
of samples each. Therefore a dumb model can achieve about a 10%
accuracy by predicting any of the classes for all samples, so 0.1 is the
trivial chance accuracy. Likewise, in a binary class task where 70% of the
class labels are the same value, a model predicting this class for all labels
would achieve a 70% accuracy, so 0.7 is the trivial chance accuracy.
The trivial chance accuracy is subtracted from the accuracy values from
Stage 2 to give accuracy above trivial chance. This may be negative in
the case of a poorly performing model, in which case I clamp it at 0.
These values are then normalised to be between 0 and 1 by dividing
by the max range from trivial chance accuracy to 100% accuracy – see
Equation 5.9 where Influence is the influence value, A is the accuracy
value (between 0 and 1), and T is the trivial chance accuracy. A− T is




1−T if A− T > 0
0 otherwise
(5.9)
Stage 4 – Institution Normalisation: Once all possible pairings and per-
mutations have been evaluated, I have the full set of influence values. I
then take the influence values for each institution and normalise them
to 1. This normalisation ensures that the total influence from all models
when aggregating sums to 1, and therefore the parameters do not ex-
plode or grow slowly. Table 5.4 previously showed an example of the full
set of influence value for three fictional institutions.
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The influence values are essentially a measure of how useful one insti-
tution’s model is for another. It can be seen as a measure of similarity,
but it also factors in the size of the dataset naturally in the way a model
may overfit to a small set of data, leading to low performance, and hence
reducing the influence from this institution to others.
Algorithm 6 captures these steps in pseudocode and shows how the influ-
ence ties into the aggregation step.
The influence values are re-calculated periodically to factor in drift of the
institutions. This re-calculation happens on a longer time scale than a cycle of
federated learning and this time scale is chosen according to the task needing to
be solved. For a typical medical application, I might re-calculate the influences
on a yearly basis. I do not re-calculate them for every cycle of federated
learning due to the computational cost of the previous stages.
Chapter 5. Federated Learning 185
Algorithm 6 Soft Federated Learning Pseudocode
// Randomly initialise and train a model at each institution:
for n in f = 1 to f = number of folds do
for i in i = 1 to i = NI do
Mi,f ← SGD(Mi,f , L(Mi,f , dtraini,f ))
// Test trained model at all institutions
// Select institution to test models at:
for j in j = 1 to j = NI do
// Select institution to bring trained model from:
for k in k = 1 to k = NI do
// Find the predictions for each class for each fold
for n in f = 1 to f = number of folds do
P (y|xtestj ,Mk,f ) = {P (y0|xj,Mk,f ), . . . , P (ymax|xj,Mk,f )}
// Take the maximum predicted class
ypred = maximizercP (yc|x)











// Convert to accuracy above trivial chance (refer to Equation 5.9)
Final Acc← Average Acc−Trivial
1−Trivial if Average Acc− Trivial > 0 else 0
// Normalise the Final Accuracies to 1
Summed Accuracies←∑r=NIr=1 Final Accr
// Find influence for each final accuracy value
for r in r = 1 to r = NI do
Influencer ← Final AccrSummed Accuracies
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// Randomly initialise and then pre-train an initial model:
M t=0init ← rand init(Mg)
M t=1init ← SGD(M tinit, L(M t=0init , dtraininit ))
// For each institution
for i in i = 1 to i = NI do
// Copy the initial model to the institution to begin
M ti ←M tinit
// For each cycle of federated learning
while t ≤ T do
// For each institution
for i in i = 1 to i = NI do
// Train locally
M t+1i ← SGD(M ti , L(M ti , dtraini ))
// Parameter feedback and weighted averaging.




j=1 ((bi,wi) ∗ influencei)
5.7.2 Shortcomings of SFL over CFL
SFL is more computational complex than CFL largely due to the influence
calculation.
SFL’s influence calculation, when done for every pairing, has a computa-
tional complexity of O(NI) during Stage 1 where NI is the number of institu-
tions due to needing to train a model at every institution, but during Stage
2 it has O(N2I ) complexity because every model (NI models) is tested at ev-
ery institution (NI institutions). However, this computational cost is spread
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between NI institutions in both cases. CFL does not feature an influence
calculation phase, so this computational cost is entirely extra.
My proposal also features a O(NI) cost during the aggregation part of feder-
ated learning due to the aggregation happening at every institution. However
this SFL cost is again spread between all institutions, leading to an effectively
O(1) cost in time. This matches the time cost for CFL.
The total network usage of SFL is O(N2I ) because every every pair of insti-
tutions transfer a model across. This compares to O(1) for CFL (the model is
sent back and forth along a single connection). The SFL cost is spread between
all institutions, so the network usage per institution is O(NI).
The running of SFL, like CFL, happens in the background using spare
compute power and network bandwidth for the systems in question.
5.7.3 Benefits of Removing the Central Location
In CFL there is some central location, typically owned by the research centre
or business that deployed the algorithm, which is used for model aggregation
and communication. SFL does not feature any central location. This gives the
benefits of control and privacy over CFL. Namely:
No risk of downtime or malfunction: CFL relies entirely on the server at
this central location functioning correctly over long periods of time. This
server may be owned by a third party.
Control over computation: The computation of a new model happens on-
site with SFL, meaning the users themselves have more control over any
issues faced than if the aggregation happened off-site at an unknown
location.
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One fewer exposed points: With no central server, SFL has one fewer lo-
cations at which a security breach is a concern.
5.7.4 Dealing with Compromised Institutions
Unlike CFL, SFL has an inherent resistance to compromised institutions.
When calculating the influence between institutions, an institution that has
been compromised and is no longer providing a correct model or whose data
are no longer valid, will have very little influence from and to other institutions.
This leads to it becoming effectively disconnected from the federation.
The influence calculation must be repeated on a regular basis to ensure any
drift between institutions or sudden change in an institution’s performance is
captured readily. It might also be possible to have metrics available at each
institution that could determine when an institution has changed sufficiently
to warrant re-calculation of the influences. For example, a separate set of vali-
dation data chosen when the influences are calculated and on which the model
must achieve a certain accuracy, otherwise it is considered to have diverged.
This validation data is taken from the institution being validated.
5.7.5 Adding and Removing Institutions
The federation is a flexible structure where institutions may be added or re-
moved at any time. Here I describe how I do these two tasks.
Adding an institution: I must first run the influence method on all connec-
tions from this new institution to every other institution and to itself,
such that set of influence values now includes the new institution. I then
use these influences to aggregate an initial model for this institution. I
do not use the influence of the new institution to itself, as the institution
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does not have a previous model to use – instead I use the normalised
influences from all other institutions to this new institution. Finally,
this model is trained locally for some period of time before it is used for
evaluation. This new institution now acts as any other institution in the
federation.
In the unlikely scenario that a new institution does not have any influence
to or from other institutions due to differences in the datasets, then this
institution cannot join the federation because the federation can neither
help it nor receive help from it. Training an uninitialised model locally
at this institution may be a suitable alternative.
Removing an institution: To remove an institution from the federation I
set all influences to and from it to be zero with the exception of the
influence to itself, which now becomes 1. It now has no influence to the
rest of the federation and the rest of the federation has no influence to
it. The model will learn locally (wholly influenced by itself) as it goes
forwards.
In exceptional cases the removal of an institution may also disconnect
other institutions from the federation. An institution whose only other
non-zero influencing institution is the one removed now has no influence
to or from the rest of the federation. This disconnected institution may
reconnect later when a new institution is added that bridges the gap
between it and the federation.
Removing all trace of an institution: A challenge arises if an institution
desires to be fully removed from the federation. I define this as any trace
of that institution being part of the federation being removed. An insti-
tution may wish to do this for privacy reasons. The model parameters,
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the knowledge, learned on the data at this institution will have diffused
gradually through the federation with each cycle. The interactions of
knowledge transfer and mixing between institutions is complex and this
learned knowledge cannot be easily separated out for any particular in-
stitution.
As a possible solution, I could keep a complete history of every model in
every institution for every cycle and all data used and influences. If such
historical data were available, I could recalculate every cycle of federated
learning from when the removed institution joined, but exclude influences
from this removed institution. This would result in new models at each
institution that have no trace of the removed institution. However this
is impractical over the time scales a federated model may be deployed
for in terms of the storage capacity and cost needed for data that will be
rarely used, and for computational cost of re-running the entire federated
from cycle zero. Further, such full removal may lead to a step change
in performance of a model at an institution, which when dealing with
medical patient data is undesirable and has inherent risks.
5.7.6 Other Data-Comparative Techniques
I use model training/testing to measure the similarity between two datasets,
however this is a rich area with many other techniques available when the
datasets are modelled as probability distributions. In this section I state the
more prominent methods. I have not used these methods as they require
transferring the data (or some aspect of it) between institutions or only offer
a symmetric relationship.
f-divergence: The f-divergence is a measure of the divergence of two prob-
ability distributions (P , Q) using the odds ratio [280] and a weighting
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function, f [6, 63, 212]:







The function (f) takes one of several forms depending on the desired
properties. Specific examples can be found in Table 5.3.
Divergence Corresponding f(x)
KL-divergence [164, 165, 96] x log x
Reverse KL-divergence − log x
Hellinger Distance [125, 221, 95] (
√
x− 1)2, 2(1−√x)
Total Variation Distance [99] 1
2
|x− 1|
Pearson χ2-divergence [220] (x− 1)2, x2 − 1, x2 − x





Table 5.3: Some examples of the f-divergence function [177].
Jensen-Shannon divergence: A symmetrised and smoothed version of the
KL-divergence. Essentially the average KL-divergence of distribution 1
given distribution 2, and distribution 2 given distribution 1 [178].
Bhattacharyya distance: A symmetric measure of the “distance” between
two probability distributions via a measure of the amount of overlap [30]:
DB(p, q) = −ln(BC(p, q)) (5.11)
where DB is the Bhattacharyya distance, p and q are the probability
distributions, and BC is the Bhattacharyya coefficient, which has two
closely related definitions depending on if the probability distributions
are discrete or continuous.







with x being a sample.








Kolmogorov–Smirnov: A non-parametric test for equality of two one-dimensional
probability distributions via sampling of the cumulative probability [155,
272]. The statistic is the maximum difference between the cumulative
distributions.
5.8 Datasets
In my experiments in this chapter I use two datasets. For the first dataset
I take the MNIST digits — 70 000 2D 28 x 28 pixel handwritten digits —
introduced previously in Chapter 2 (Section 2.9) and transform these with
affine transformations or noise to form the first dataset (Sections 5.8.1). For
the second I use the BraTS dataset, which is a set of 3D brain volume scans
(Section 5.8.2).
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5.8.1 MNIST
To simulate institutions I divide the MNIST data into disjoint subsets (in-
stitutions) and apply affine transformations or add noise to the samples to
represent differences between institution’s. Each institution is constructed to
have a random subset of the MNIST data, however I have a restriction of a
minimum of three data samples for each of the ten classes for the SFL influence
three-fold training.
MNIST Transformations
I have four affine transforms and four noise transforms that can be applied to
each MNIST sample: rotation, translation, scaling up (magnification), shear-
ing, salt & pepper noise, Gaussian noise, intensity inversion, and gradient
noise. These are detailed in Table 5.4 and shown in Figure 5.8. For institu-
tions with a transform applied, this transform is applied consistently to each
data sample in that institution.
The transformations provide challenging datasets with some of the trans-
formations resulting in part of the digit being outside the view (see Figure
5.8). This challenge is intentional to put the federated learning systems under
stress and emphasise the difference between SFL and CFL.
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Transform Definition
Rotation
A random rotation is applied around the
central point of the digit with zeros padding
new pixels.
Translation
The digit is translated along both axes with
zeros padding new pixels.
Scaling Up
The digit is zoomed in around its central
point.
Shearing
The digit is sheared — pixels are translated as
a function of their position along each axis.
Zeros pad new pixels.
Salt & Pepper
Noise
Random pixels are set to the minimum or
maximum intensity of all samples.
Gaussian Noise
Every pixel value has a value added to or
subtracted from it with this value sampled
from a Gaussian distribution for every pixel.
Inversion Every pixel value is multiplied by -1.
Intensity Gradient
An amount is added to every pixel depending
on the pixel’s position along each axis.
Table 5.4: Definitions of the transforms used for the MNIST data. See Figure
5.8 for visual examples.




Salt & Pepper Noise Gaussian Noise
Inversion Intensity Gradient
Figure 5.8: Visual examples of the transformations used. Two digits are shown:
a one and a two. These are in their original form at the top, and then each pair
shows a transformation from this initial state with the transformation noted
below each pair. Refer to Table 5.4 for transform definitions.
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5.8.2 BRaTS
I use the volumetric imaging data from the Multimodal Brain Tumor Segemen-
tation Challenge 2018 dataset (BraTS)[265] — a multi-institutional medical
dataset that consist of 285 patients with brain glioma (a type of cancerous brain
tumour). Each patient has four scan modalities: MRI T1, Contrast-Enhanced
MRI T1 , MRI T2, and MRI Flair — these modalities were introduced pre-
viously in this thesis (Chapter 1 — Section 1.1.2), as well as ground truth
segmentation of the background (BG), gadolinium-enhancing tumour (ET),
peritumoral edema (ED), and the necrotic (fluid-filled) & non-ehancing (solid)
tumour (under a single ground truth label — NCR/NET) [205].
Due to the four imaging modalities providing similar data for the model,
in the interest of a runtime that does not slow the clinical decision process,
I only use the contrast enhanced T1 which provides a good contrast between
the tumour regions. Each scan consists of 155 slices of 240 x 240 pixels and
come from one of 14 institutions. As spatially adjacent slices are similar, I
subsample every tenth slice leading to 16 slices per patient. Table 5.5 details
the amount of data from each institution and Figure 5.9 shows an example
slice of contrast-enhanced T1 and ground truth.
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Figure 5.9: An example BraTS slice with Top: Contrast-enhanced T1 MRI
and Bottom: Ground truth segmentation for the glioma.







HGG2013 20 320 224/96 (14/6) Y
HGGCBICA 88 1408 992/416 (62/26) Y
HGGTCIA01 22 352 240/112 (15/7) Y
HGGTCIA02 34 544 384/160 (24/10) Y
HGGTCIA03 12 192 128/64 (8/4) Y
HGGTCIA04 8 128 96/32 (6/2) N
HGGTCIA05 4 64 48/16 (3/1) N
HGGTCIA06 8 128 96/32 (6/2) N
HGGTCIA08 14 224 160/64 (10/4) Y
LGG2013 10 160 112/48 (7/3) Y
LGGTCIA09 11 176 128/48 (8/3) Y
LGGTCIA10 35 560 384/176 (24/11) Y
LGGTCIA12 6 96 64/32 (4/2) N
LGGTCIA13 13 208 144/64 (9/4) Y
Table 5.5: The number of patients, total number of slices per modality (16
slices per patient), and the size of the training and testing dataset in terms
of number of slices and in brackets the number of patients these slices came
from for each institution within the BraTS dataset. I also note if I include the
institution in my experiments (Y=yes, N=no).
I exclude institutions with fewer than 10 patient scans as I believe the
variability these small datasets contribute to the federation exceeds the benefit
of including them. Some institutions are prefixed with HGG or LGG. These
stand for High-Grade Glioma and Low-Grade Glioma respectively, which refers
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to the type of glioma in the patient data. High grade is the faster growing
and more aggressive form of glioma but can mimic LGG in MRI scans [1]
(often a surgical sample is required to differentiate the two types). I divide the
patients into a training and testing dataset within each institution with 70%
contributing to training and 30% to test — this split is frequently used for
neural network training, although I also explored similar divisions and found
no significant accuracy difference. This division is done at a patient level, so
all slices from a single patient appear in either the training or testing dataset.
The proportion of each class in the training and testing datasets for the used
institutions can be found in Table 5.6. The classes are strongly biased towards
the background class.
5.9 Experiment Design
I detail five experiments chosen to highlight the behaviour of SFL and contrast
it with CFL. The first four experiments use the MNIST dataset with transforms
for simplicity to allow for focus on the behaviour of the algorithms. The
final experiment uses the BraTS medical dataset. The experiments are run
for 50 cycles with three cross-fold validation to quantify noise-induced error
boundaries. I return and update all model parameters in SFL and CFL at each
cycle. 50 cycles is chosen as prior experiments (not shown in this thesis) showed
that around 30 cycles achieves accuracy convergence, and the additional 20 act
as a buffer for experiments that converge more slowly due to uncontrollable
factors.
My evaluation on MNIST occurs at the sample level — classification of
whole samples to one of ten digits. For BraTS I evaluate at a pixel level and
use Dice as the evaluation metric. Model training and evaluation is explained
in detail in Section 5.10.
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5.9.1 Experiment 1 - Knowledge Transfer Test
This experiment has three institutions. Two have normal MNIST digits (no
transform), while the third uses a strong shear transform to make it different
to the other institutions. Figure 5.10 demonstrates this transform. The first
of the normal institutions (I1) has a small dataset (30 training samples) while
the other (I2) is large (3000 training samples). The third institution (I3) has
3000 training samples.
The purpose of this experiment is two-fold. First, it aims to show how the
influence from the large normal institution to the small institution is larger
than from the other way around due to the size of the datasets alone. Sec-
ond, the third institution should then both give to and receive from the other
institutions an almost-zero influence due to the data transform.
Initial State Sheared
Figure 5.10: Visual examples of the shear transformation used in Experiment
1. A 0 and a 3 are shown on the left as non-transformed MNIST digits, and
on the right with the shear transform applied.
5.9.2 Experiment 2 - Noisy Institutions
I use nine institutions in this experiment. At the first institution I have 30
training samples of non-transformed MNIST digits, but at the other eight I
do not use MNIST digits — I instead generate Gaussian noise samples for the
data and assign a random class label to each. Figure 5.11 shows an example
sample. The noise is normalised so it matches the intensity range of MNIST
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digits. There are 30 samples with no signal at each of these eight institutions.
The digit labels 0–9 are assigned in equal proportions. The choice of 30 samples
here is a trade-off against speed and reliability of the final results. As only one
model (institution) is training on MNIST data, little data are needed to train
successfully. Adding further samples did not produce any increase in accuracy
in my tests. The choice of 30 samples for the noisy institutions is to match the
number of samples in the first institution to ensure that CFL uses an equal
weighting from all institutions during model aggregation.
Figure 5.11: An image of MNIST size (28 x 28 pixels) consisting of Gaussian
noise only (no digit present).
This experiment aims to demonstrate how SFL learns to ignore these signal-
less institutions and focuses on maximising accuracy at the signal institution,
while CFL fails to do so and thus performs worse than SFL at the signal
institution.
5.9.3 Experiment 3 - Identical Institutions
Here I use three institutions, each with 100 training samples with no trans-
forms. The choice of 100 samples ensures a balanace against speed and accu-
racy. I carried out experiments not shown here showing an increase in samples
does not affect the results.
I expect this to show how SFL approximates to CFL when the domains and
dataset sizes are identical as the influences will be approximately identical.
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5.9.4 Experiment 4 - 50 Institutions
I have 50 institutions, each with 100 training samples, and each institution
has a random transform at a random intensity within a sensible range. The
transforms are selected from Table 5.4. The 100 samples is to match Exper-
iment 3 in training parameters, and the 50 institutions was chosen partially
arbitraily as a large number to challenge the algorithms without being unre-
alistic. My experiments took around six days to finish, which I considered to
be an acceptable balance between waiting and attaining results.
This experiment stresses the SFL algorithm to explore its ability to operate
at scale and find strong influences between similar institutions in a very mixed
scene.
5.9.5 Experiment 5 - BraTS Data
I train on ten BraTS institutions (see Table 5.5) each containing a different
amount of data ranging from 112 training slices to 992. Each institution has
data from a different real world institution. I run for 30 cycles to see the
performance of SFL and CFL in this realistic scenario. Further details about
the data are in Section 5.8.2.
5.10 Model Training and Evaluation
I use two models, one for the MNIST data (Experiments 1-4) and one for
BraTS (Experiment 5).
5.10.1 MNIST Model
The MNIST model (Figure 5.12) uses a series of convolutional and pooling
layers, with fully-connected dense layers at the end that condense the output
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down to ten classes, which are each given a probability value. The class with
the highest probability is chosen as the predicted label (as per Equation 5.5).
Rectified linear unit activations are used throughout the model except for the
final layer, which uses Softmax to deliver probability values.
The MNIST model is pre-trained using 1000 raw MNIST digits that are
randomly selected but not used in any of the institutions. There are 1000
test samples at each institution for evaluation regardless of how many training
samples are used. The experiments are run for 50 cycles each. Accuracy of the
class predictions vs ground truth classes for samples is used as the evaluation
metric.
Figure 5.12: The model for the MNIST experiments. The number of kernels
used for the four convolutional layers from start to end are: 32, 16, 8, 16.
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5.10.2 BraTS Model
My BraTS model (Figure 5.13) is based on the U-Net by Ronneberger et al.
[245], which has shown to be one of the most successful architectures for the
BraTS data [144]. The U-Net uses a series of convolutional and pooling layers
in the first half of the model to reduce the dimensionality and focus informa-
tion; it then uses a form of upsampling — in my case transpose convolutions —
and further convolutions to expand the data back up and continue processing
it. Skip connections are used to concatenate the layers in the first half of the
model to the second half.
Figure 5.13: The model for the BraTS experiment. Note the convolution ar-
rows represent two convolutional operations, while the other types are a single
operation. The number of kernels is 16 for the highest level (least reduced),
and doubles with every level going down: 32, 64, and then 128 for the lowest
(most reduced) level. The number of kernels then halves going back up.
My model is a smaller and simpler version of the U-Net due to the com-
putational cost of training a full U-Net. I have reduced the “depth” (number
of pooling/transpose convolution layers) and reduced the number of kernels
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used. This reduced model has a weaker performance than the full U-Net, yet
is sufficient for my comparative purpose. I tested with a range of depths and
convolutions and found this one to be both quick and capable of detecting
the glioma to a sufficiently high accuracy to show the differences between the
algorithms.
After the final layer, a (1,1) kernel size convolutional layer with softmax
activation and four kernels is used to generate the probability maps for the four
classes. Rectified linear units are used for the activation function elsewhere.
I pre-trained my model on the data not used in the selected institutions
(refer back to Table 5.5).
A custom loss function adjusts the weight of the classes based on the in-
verse proportion of the class in the dataset is used for training. Referring to
Table 5.6, the background class is weighted very lowly, while the other classes
— particularly the ET class — have high weightings. This reweighting is stan-
dard practice to avoid the network finding the trivial solution by assigning
every pixel to the background class. Figure 5.14 shows an example of my pre-
dictions and the ground truth for two classes in a typical sample evaluation.
My experiment with this model runs for 30 cycles.
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Figure 5.14: Predictions (left) and ground truth (right) segmentations for an
example slice of BraTS data showing the NCR/NET class on top and the ED
class beneath.
During the evaluation stage I apply a three pixel morphological closing
operation to remove boundary complexity believed not to be significant. Per-
forming the same effect on the predictions ensures a fair evaluation. This
processing led to a minor improvement in my performance for all methods.
The Dice score [74], on a per class basis and averaged, is used for the evalua-
tion metric. Dice is a measure of the overlap of two regions and scores from
0 to 1 with 1 representing a perfect overlap. In terms of the number of True




2TP + FP + FN
(5.15)
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5.11 Baseline Measures
In addition to CFL and SFL, I employ three further methods as baseline
performance measures:
Global Pooling: I take the data in all institutions and pool it in a new lo-
cation (separate to all institutions). A model is trained and evaluated
on this pooled dataset. This non-federated baseline provides an upper-
bound performance.
Local: I train and evaluate a model at each institution. There is no transfer
of models or data. Clearly, federated methods must exceed this trivial
baseline to warrant the added complexity.
Ensemble: This is the same as the Local method during training, however
during evaluation the set of all models are evaluated at each institution
and the average accuracy of the models gives the performance. This
method can be seen as a halfway between Local and federated learning.
In CFL and SFL I average the models from all institutions, but with the
Ensemble method I do not average, I simply evaluate them all individ-
ually and average the results. The models the Ensemble method trains
will naturally diverge from each other throughout the cycles since they
are not tied together. This answers the question “How does model aggre-
gation affect the performance compared to using an ensemble method?”
Formally, the ensemble and local methods have the same training function:
M t+1i ← SGD(M ti , L(M ti , dtraini ))∀i ∈ {1, . . . , NI} (5.16)
with notation defined previously in Section 5.3.
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The global pooling uses a notion of some central location:
M t+1cent ← SGD(M tcent, L(M tcent, Dtrain)) (5.17)
The ensemble method also has a more advanced evaluation procedure than
what was define previously (Section 5.3.2) to factor in the ensemble of models:
ME = {Mi=1, . . . ,Mi=NI} (5.18)
An ensemble of models, ME, is formed from the set of all models.
I calculate the set of class probabilities using this ensemble of models:
P (y|xtest,ME) = {P (y0|x,ME), . . . , P (ymax|x,ME)} (5.19)
where





which is the average class predictions for a given class, y, by the ensemble.
5.12 Results
Here I detail the results to the experiments described in Section 5.9. Through-
out this section I will show three types of graphs. The first are the influence
heatmaps, which display the amount of influence a each institution receives
from the other institutions.
The second type of graph seen in this section are the result graphs. These
show a plot for each institution and within each plot are five lines showing
the five evaluation methods: global pooling, the ensemble method, the local
method, CFL, and SFL. These figures should be viewed in colour. The x-
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axis shows the cycle number, which is synonymous to the number of training
loops the models have gone through. The y-axis is the performance of the
models on the (unseen) testing data at that institution. The global pooling
method is identical for each institution as it has been calculated separately
and superimposed onto each figure as a reference.
The third type of graph are the accuracy graphs that give the accuracy of
each method at each institution at 50 cycles. They can be considered a cross-
section through the corresponding result graph at cycle 50. These figures also
display the average accuracy across the institutions.
The purpose of the influence heatmaps is to provide insight into the SFL
method, the result graphs show training performance over time, and the accu-
racy graphs show the final accuracy performance.
All experiments were conducted three times with the results averaged. The
shaded regions on the result graphs and the error bars on the accuracy graphs
show one standard deviation from the mean.
I shorten institution names from here throughout the remainder of the
chapter from, for example, “Institution 1” to “I1”.
5.12.1 Experiment 1 - Knowledge Transfer Test
I have three institutions. Two (I1 and I2) from the same domain while the
third is from a very different domain, and two (I2 and I3) with plenty of data
while I1 have few.
In Figure 5.15 I observe that I1 receives a higher influence from I2 than
from itself. It also receives no influence from the third institution. I2 is in-
fluenced predominantly by itself with a small influence from I1 and a minimal
amount from I3. I3 on the other hand is almost entirely influenced by itself
and recognises the other two institutions as outliers relative to itself.
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The evaluation in Figure 5.16 show that for I1 the local accuracy is the
weakest method, with CFL and the ensemble method next, SFL closely after,
and the global pooling method on top. In I2 CFL outperforms the ensemble
method, followed by SFL, local, and pooling. The ensemble method has a
similar performance in I1 and I2. Finally, in I3, the pooling, local, and SFL
methods have the highest accuracy, but CFL approaches their performance in
later cycles. The ensemble method is 66% accurate.
Overall, from Figure 5.17, SFL, CFL, and pooling are the highest accu-
racy methods at around 96 – 97% average accuracy, local is next at 92%, and
ensemble is the poorest with 85%.
Figure 5.15: The influence heatmap for Experiment 1 (Knowledge Transfer).
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Figure 5.16: The result graphs for Experiment 1 (Knowledge Transfer). Each
plot represents an institution showing the performance of the five evaluation
metrics (y-axis) across 50 cycles (x-axis). The colors are: Yellow - SFL, Blue
- CFL, Purple - Ensemble, Green - Local, and Red - Global Pooling. The
shaded region is the error at one standard deviation from the mean for the
three-fold experiments. The institutions are numbered from the left starting
at I1.
Figure 5.17: The accuracy of each of the three institutions in Experiment 1
(Knowledge Transfer) at 50 cycles for the five evaluation methods. The error
bars are one standard deviation from the mean for the three-fold experiments
The institutions are displayed starting from I1 on the left. The number on
each set of bars is the average accuracy for that evaluation method.
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5.12.2 Experiment 2 - Noisy Institutions
I have one institution (I1) with normal MNIST digits, and eight institutions
(I2 – I9) with no signal, but Gaussian noise in the shape of an MNIST digit
instead. In Figure 5.19 the pooling method performs weakly on this data, but
does perform above random chance accuracy (20%). The evaluation methods
on I2 – I9 show no learning, with all performances at the random chance level
(about 10% as there are ten classes).
I1 has a good performance with all methods. The ensemble method per-
forms around 40% with substantial errors (10-15% absolute error each way),
CFL reaches 95% but does not appear to have plateaued by 50 cycles. The
local method and SFL are at 98% (Figure 5.20). SFL shows I1 receives al-
most zero influence from the other institutions (Figure 5.18) and the other
institutions have a pattern of influences that is noisy. The number of training
samples in each fold of the influence function is 10 (30 samples between three
folds).
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Figure 5.18: The influence heatmap for Experiment 2 (Noisy Institutions).
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Figure 5.19: The result graphs for Experiment 2 (Noisy Institutions). Each
plot represents an institution showing the performance of the five evaluation
metrics (y-axis) across 50 cycles (x-axis). The colors are: Yellow - SFL, Blue
- CFL, Purple - Ensemble, Green - Local, and Red - Global Pooling. The
shaded regions are the error at one standard deviation from the mean for the
three-fold experiments. The institutions are numbered from the left along then
down starting at I1.
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Figure 5.20: The accuracy of I1 (normal MNIST data) in Experiment 2 (Noisy
Institutions) at 50 cycles for the five evaluation methods. The error bars are
one standard deviation from the mean for the three-fold experiments. The
number on each bar is the accuracy for that evaluation method.
5.12.3 Experiment 3 - Identical Institutions
This experiment uses three identical institutions with limited training data (30
samples). The evaluation methods have comparable accuracies between insti-
tutions (Figure 5.22) with the local method having the lowest overall accuracy,
and pooling and the ensemble method having the highest performance. SFL
and CFL are the next highest (Figure 5.23). The influences between institu-
tions are approximately equal (Figure 5.21)
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Figure 5.21: The influence heatmap for Experiment 3 (Identical Institutions).
Figure 5.22: The result graphs for Experiment 3 (Identical Institutions). Each
plot represents an institution showing the performance of the five evaluation
metrics (y-axis) across 50 cycles (x-axis). The colors are: Yellow - SFL, Blue
- CFL, Purple - Ensemble, Green - Local, and Red - Global Pooling. The
shaded regions are the error at one standard deviation from the mean for the
three-fold experiments. The institutions are numbered from the left starting
at I1.
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Figure 5.23: The accuracy of each of the three institutions in Experiment 3
(Identical Institutions) at 50 cycles for the five evaluation methods. The error
bars are one standard deviation from the mean for the three-fold experiments.
The institutions are displayed starting from I1 on the left. The number on
each set of bars is the average accuracy for that evaluation method.
5.12.4 Experiment 4 - 50 Institutions
This experiment has 50 unique institutions each with 100 training samples.
The institutions have a data domain sampled randomly from Table 5.4 with
random parameter settings in a sensible range. The results show that institu-
tions with the inverse transform, such as I3 in Figure 5.24, get their influences
from other inverse institutions, with a minor level of noise from the other
institutions. The transforms rotation, Gaussian noise, salt & pepper noise,
and intensity gradient in particular receive a high level of influence from non-
rotation or non-Gaussian noise institutions respectively. Often they receive
the highest influence from their own institution.
Figure 5.25 shows these institution’s result graphs and Figure 5.26 the
overall accuracies but divided into the different transforms.
The overall accuracy figure for each method when averaged across the trans-
form sets (i.e. taking the values in Figure 5.26 and averaging) and averaged
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across individual institutions is displayed in Table 5.7.
Figure 5.24: The influence heatmap for Experiment 4. Note the scale has been
adjusted to improve visualisation.
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Figure 5.25: A selection of result graphs for Experiment 4. Each plot rep-
resents an institution showing the performance of the five evaluation metrics
(y-axis) across 50 cycles (x-axis). The colors are: Yellow - SFL, Blue - CFL,
Purple - Ensemble, Green - Local, and Red - Global Pooling. The shaded re-
gions are the error at one standard deviation from the mean for the three-fold
experiments. The institutions are numbered from the left along then down as
institutions 3 (inversion), 5 (intensity gradient), 8 (rotation), 9 (rotation), 16
(salt & pepper noise), 22 (scaling up), 39 (intensity gradient), 42 (translation),
and 44 (Gaussian noise).
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Figure 5.26: The accuracy of each of the 50 institutions at 50 cycles in Exper-
iment 4 divided into figures according to the transform used. The error bars
are one standard deviation from the mean for the three-fold experiments. The
number on each set of bars is the average accuracy.
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Table 5.7: The average accuracy for Experiment 4 for each method when
averaged across transform sets and across institutions.
5.12.5 Experiment 5 - BraTS Data
I train for 30 cycles at ten institutions each with their own varying quantities
of MRI medical data for brain glioma. The influence graphs (Figure 5.27)
show some institutions (1, 2, 4, 5, 9, 10) receiving the most influence from
themselves, but overall the influences are variable. The results and accuracies
of the methods in Figures 5.28 and 5.29 show the ensemble method performing
the poorest at 0.12 Dice at 30 cycles, the local method next at 0.27 although
with great variation between the institutions, SFL and CFL are next around
0.45, and global pooling achieves 0.54. In some cases the SFL, CFL, and local
methods exceed the pooling method by a small margin.
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Figure 5.27: The influence heatmap for Experiment 5 (BraTS Data).
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Figure 5.28: The result graphs for Experiment 5 (BraTS Data). Each plot
represents an institution showing the performance of the five evaluation metrics
(y-axis) across 30 cycles (x-axis). The colors are: Yellow - SFL, Blue - CFL,
Purple - Ensemble, Green - Local, and Red - Global Pooling. The shaded
regions are the error at one standard deviation from the mean for the three-
fold experiments. The institutions are numbered from the left starting at I1.
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Figure 5.29: The accuracy (Dice coefficient) of each of the ten institutions in
Experiment 5 (BraTS Data) at 10 cycles (Top) or 30 cycles (Bottom) for the
five evaluation methods. The error bars are one standard deviation from the
mean for the three-fold experiments. The institutions are displayed starting
from I1 on the left. The number on each set of bars is the average accuracy
for that evaluation method.
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5.13 Discussion
5.13.1 Experiment 1 - Knowledge Transfer Test
This experiment demonstrates a number of key principles surrounding the
functioning of federated learning.
1. A lack of training data in I1 leads to a lower local accuracy here with all
other methods outperforming by a margin of around 10-15%.
2. The similarity of the data in I1 and I2 leads the ensemble method to
perform similarly between these institutions; but the uniqueness of I3
causes difficulty for this method. This is because two of the ensemble
models are evaluating I3’s data using I1’s or I2’s training data, which
is different, and this is out-voting the ensemble model from I3. The
ensemble method does not factor in the relative usefulness of each model
for the institution I am evaluating at.
3. Pooling performance is weakened by the variety of data, although the
model is still able to learn to classify the mixed data well. In I2 all
methods apart from the ensemble method are more accurate than pool-
ing.
4. The CFL method is able to operate well on mixed institutions despite a
small decrease in accuracy in I3 due to the different data present. This
shows that the models at each institution are learning features that are
useful at all institutions, which may be edges and shapes. When the
models are averaged they remain useful.
5. The SFL method is able to learn faster than CFL as it discovers a useful
influence weighting for aggregation. This effect is most noticeable in I1
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around cycles 5 – 10 (Figure 5.16) and is caused by the large influence
received from I2 effectively accelerating the training by providing addi-
tional (useful) training samples. The accuracy of CFL approaches that
of SFL at a high number of cycles, but remains hindered by I3.
5.13.2 Experiment 2 - Noisy Institutions
As expected, the global pooling method fails here as much of the data has no
signal — only noise. The 0.21 accuracy figure comes about from it achieving a
high accuracy on the samples with signal, which make up 11% of the total data,
and achieving a random chance accuracy of around 10% (one in ten classes)
on the other 89% of the samples. Overall this should provide an accuracy
of around 0.20 and Figure 5.19 shows the global pooling method near this
accuracy across the cycles.
The ensemble method performs around 40%. This is because eight insti-
tutions (I2 – I9) are voting for random classes due to their random training,
and so the deciding vote goes to I1 if these eight decisions are all different.
From the local method I know the I1 model will make a correct guess about
80% of the time. However sometimes by random chance the eight noise insti-
tutions may vote together for an incorrect class in a way that outweighs I1.
This is why the performance of the ensemble method fails to reach that of the
local method. The random chance element in the voting leads to a variable
performance, hence the large error.
I1 receives minimal influences from I2 – I9. The models learned at the noise
institutions are random, but this leads to these models sometimes performing
slightly above trivial chance when tested on I1. This leads to the small influ-
ences seen in Figure 5.18. These weak influences do not appear to have an
impact on SFL performance, which outperforms the other methods.
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CFL on the other hand receives noise from these models during model
aggregation, leading to a significant reduction in performance. The average of
the noisy updates from I2 – I8 will be approximately a model with zero-value
parameters. Therefore when aggregating with I1 the new model will be I1’s
model with its parameter values shifted by 8/9ths towards zero. Due to the
way neural networks work, if all parameters within the network are multiplied
by the same amount, the performance of the network will not change as it is
the relative differences between parameters that define a network’s ability.
The observed drop in performance is due to the average of I2 – I8 being a
model that is not zero everywhere. Some parameters will be slightly above
zero, and some slightly below. This may lead to the relative differences in I1’s
new model changing, resulting in a small fall in accuracy.
5.13.3 Experiment 3 - Identical Institutions
As I expect, the institutions all perform similarly to each other. Local accuracy
is the lowest due to a lack of training data available locally. The pooling and
ensemble methods have the strongest accuracy because they operate on the
assumption that all data is sampled from the same distribution, which is a
valid assumption here. The small reduction in performance for SFL and CFL
relative to pooling and ensemble could be due to the nature of the model
aggregation. Useful parameters may average out in this stage, which slows the
training speed of these methods compared to non-model averaging techniques
such as the pooling and ensemble methods.
The almost identical influences between the three institutions show that
SFL approximates CFL in cases where there are no distribution shifts between
institution. CFL is identical to SFL when all influences are equal and all
training set sizes are the same.
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The general conclusion here is that if the insitutions’ data domains in a
federation are identical (or highly similar), then there is no need to carry out
the relatively expensive SFL algorithm since CFL will perform fine in this case.
5.13.4 Experiment 4 - 50 Institutions
This experiment shows the advantages of SFL on a highly mixed set of insti-
tutions. In some cases, such as with institutions with the rotation transform,
SFL performs significantly better than CFL due to the influences focusing on
their own institution here. This is due to each rotation providing a largely
unique data domain. The local performance here however is much stronger
than SFL as SFL has been unable to recognise that isolating the institutions
from the federation provide the best outcome — instead the small amount
of influence noise from all other institutions has greatly weakened the useful
signal (see Figure 5.24). For all other transforms SFL achieves comparable
performance to CFL.
The global pooling method features the highest accuracy, which means
that pooling data from these different domains and training on the whole set
provides the best model for generalising. The performance being higher than
the local method indicates two things. First the amount of training data (100
samples) is insufficient to train the best models — this is especially apparent
in the salt & pepper and Gaussian noise institutions where the performance
of the local method is 0.73±0.03 and 0.70±0.05 respectively — the lowest of
the transform sets. The random noise component of these two transforms lead
to more training data being needed. Second, the model itself has sufficient
capacity when working on the pooled data to train on the varied training data
and fit well. The institutions must have some useful general knowledge that
can be pooled (the higher CFL performance confirms this), and the global
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pooling model has been able to generalise to all transforms.
This experiment also shows the strengths and weaknesses of the ensemble
method, which performs the second best (behind global pooling) on the salt
& pepper and Gaussian noise institutions due to its ability to average out
the noise with the ensemble’s models, but it finds in particular the rotation
transform challenging as the parameters learned on other transforms cannot
be easily applied here.
5.13.5 Experiment 5 - BraTS Data
This successful experiment showed that federated learning can be used on med-
ical data and that SFL is able to recognise (to limited extent) the differences
between institutions that see high-grade glioma and ones that see low-grade.
The first six institutions have high-grade brain glioma, while the remaining
have low-grade. This is reflected in the influences (Figure 5.27) where the
first six receive considerably more influence from themselves than from the
final four. Likewise, in these low-grade institutions, the influences from the
high-grade appear subdued.
However, there is little difference between SFL and CFL at each institution
(Figure 5.29). The influences are similar across all institutions, which indicates
that there is not enough domain shift in this dataset for SFL to improve the
performance.
The ensemble method is weak at all institutions, showing a slow rate of im-
provement at some over time. The local performances are also weak, with the
exception of I2 which has much more training data than the other institutions.
I8 is an interesting case as no method is able to perform particularly well
(see Figure 5.28). The data at that institution appears similar to the other
institutions at first glance, however the influence for I8 from itself is one of the
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lowest influences it receives, implying that a local model is unable to perform
well on its own data. Upon inspection of its data, I see that it features many
narrow pathology regions. These are not as common in the other datasets.
Due to the small size of I8 (11 patient datasets), this will be affecting training.
The local method will be struggling to learn, while the models in the ensemble
are trained on more rounded regions. The convolutional and downsampling
layers will further shrink the data, potentially reducing the narrow regions
further.
5.14 Conclusion
I have shown that SFL has several potential use cases where it can outperform
other algorithms. In this section I capture key insights into federated learning
and the SFL algorithm.
5.14.1 Soft Influences
SFL and CFL represent different ends of a spectrum. At one end, SFL can
isolate an institution from the federation if their data domain is unique, and
modify the influences in other cases, while at the other end CFL does not
perform any localisation. SFL acts like CFL when all the influences are equal.
Between these two extremes there is a middle ground where the influences are
calculated as in the SFL case, but then they are weighted by some amount
towards all being equal (= 1
NI
), which is the CFL case. I will refer to this CFL
case as the equality level. This softens the influence values. While it is not
clear that using this weighting will improve model accuracy, it does enable the
federation to become better connected relative to the SFL case and this may
be useful when adding or removing institutions (see Section 5.7.5) to provide
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more models for aggregation at a new institution or keeping the institutions
connected when removing an institution.
An example scenario where this may be useful is when there is a federation
consisting of a set of hospitals and SFL has been used to calculate the influences
on some set of recent cases in the hospitals. Now there are two obvious cases
which could invalidate the influence values. The first is the event of a disease
outbreak — the hospitals start seeing more of one type of pathology (one
class). As the data, which will be used for model training, have now changed,
the influence values are no longer accurate and without softening them, they
may damage the federation.
The second case is when a hospital changes its data acquisition protocol,
for example changing the way data are collected or upgrading a scanner. This
shifts the data domain and leaves the hospital out of sync with the original
influence values. As re-calculating the influences can be costly (Section 5.7.2),
I do not want to be doing this frequently. With softer influences, the impacts
of this scenario are reduced.
5.14.2 Drifting Influences
An alternative to using fixed influences is to have influences change over time.
For instance, after they are initially calculated using SFL, they begin to soften
over time, drifting towards the equality level, reducing at a rate proportional
to their strength. This works under the assumption that the data domains of
the institutions will drift over time, thereby invalidating the influences, but
since I may not be able to afford to re-calculate them often due to computa-
tional resource constraints, softening them over time works as an alternative to
minimise the impact of this drift. A softer set of influences leads to increased
coherence between the models, which in turn leads to more stability since each
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institution is less isolated than in the case of the initial influences.
I can also switch this around and instead of softening the influences, I
proportionally strengthen influence signals to reduce the noise from weaker
institutions. Such a technique may have been useful in Experiment 4 (Section
5.12.4) to help isolate the different transforms. This is discussed below in
Further Work.
5.14.3 Sparse Influences
For large federations where calculating the influences is prohibitive, it may be
possible to calculate them sparsely — on a subset of pairs of institutions — to
reduce the time and computational cost. For pairs where it is not calculated,
it defaults to the CFL influence level (equality level) and then is normalised
to 1. The aim here is to shift the CFL performance towards SFL at a lower
time and computational cost than running SFL fully. An important note here
is every institution must have the influence calculated to itself (self-pairing) as
part of the pairings, as this is usually the strongest influence value. If this is
not done, institutions will lack the localisation to themselves and so will fail
to perform well in institutions with relatively unique data domains.
5.14.4 Further Work
I would like to explore the SFL algorithm on further medical datasets, par-
ticularly ones featuring domains more varied than seen in the BraTS data. I
believe SFL will perform well in these cases as my earlier experiments showed
it works for varied MNIST institutions.
There are also several routes available for further development of the SFL
algorithm. Ideas that I would like to trial in the future include:
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Soft influences: As described above. The influence values could be softened
either initially or over time to better connect the federation and reduce
the impact of domain drift.
Favouring self influences: I give a slight boost to self influence values and
reduce the other influences. This helps to favour institutions’ own model
when there are a large number of other institutions factored in, thereby
helping the model stay focused on its own institution. The amount of
boost/reduction that works best may be case dependent and is an area
for further research.
Specialised model heads: This idea derives from the field of multi-task
learning — refer back to Section 5.5 for an overview of relevant literature.
I take a base model and train it using CFL. The base model is designed
to be capable of learning generally useful features. Then, within each
institution, I remove the final classification layer of the base model, add a
few additional model layers to the end of the model, such as the addition
of convolutional and upsampling layers, as well as a new classification
layer. I call these layers the model head. The base model’s parameters
are then frozen (or otherwise have inertia added, which reduces learning
rate) and the entire model is trained locally on the institution’s data.
This will focus training on the model head, aiming to specialise it by
taking the embeddings from the base model and using these as the inputs
to the specialised head, which then seeks to fit to the local nuances of
the data.
This should improve the performance within an institution. The base
model learns generally useful features, while the specialised model heads
learn how to convert these features into a high-accuracy prediction.
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It is not clear how the useful parameters learned within one head can be
transferred to another model’s head (at a different institution). Using
the notion of influence described in Section 5.7.1 I may be able to use
the SFL algorithm to transfer only the model heads between institutions
and use these to form the new model heads with each cycle.
Reducing influences that are below the average influence: One idea
to improve the signal achieved from strong influence links is to set all
influences that are below the equality level to zero (before normalising
the influences to one). This means a more sparsely connected federation.
This sparsity would also reduce computation time.
The issue with this sparsity is now each model is aggregated from fewer
models, which increases overfitting risks. This may only be suitable for
federations of many institutions.
A different threshold could be used rather than the equality level, but
this choice would be arbitrary.
Another way is to emphasise the differences between institutions. One
way of doing this is to square the influences (and then normalise). This
increases the influence at high levels while reducing it at low levels. This
may have been beneficial in Experiment 4 for the Rotation transform
institutions (Section 5.12.4). However the choice of how to emphasise
the differences is again arbitrary and a single choice may not be suitable
for all tasks or federations.
To scale with the number of institutions, I could also divide the SFL
influences by the equality level to provide a final quantity that is nor-
malised against the number of institutions.
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5.14.5 An (almost) Infinite Federation
An interesting thought experiment arises when I take soft federated learning
to the extreme. What would happen if I took every dataset in existence (re-
gardless of the data within it) and calculated the influences? This is of course
impractical, but offers interesting outcomes.
It is common knowledge that different tasks require different model archi-
tectures to achieve high performance. For example, the type of model used for
imaging data is very different to that used for time series data. While data
embedding techniques can (theoretically5) be used to reduce all data into a
format suitable for a single model architecture, or additional specialised layers
or pre-processing at the start of a model could make the data consistent, it
remains unlikely that a single model architecture would be adequate for all
datasets. Concepts from the field of multi-task learning could be extended
here. But let us assume some solution to this problem exists and I can feed
very different data into a single learning model.
It is likely that most, if not all, of the datasets will be linked to one another
in this extremely large federation. There will be clusters within the federation
of closely linked datasets that share similar data — for instance hospitals may
form a cluster — and these clusters will be linked to other related clusters.
There may also be weak links to a number of other datasets as Experiment 4
showed that quite different datasets can still feature small influences between
them (Section 5.12.4). Within each cluster there are likely subclusters for more
specific types of data, and these themselves may also have more subclusters,
and so on going down into smaller and smaller subclusters.
Now imagine a randomly initialised model being copied to every dataset
5In practice this would be very difficult as trying to capture the information within
datasets of different features into some common size for a neural network (for instance) is
not a straightforward task.
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and being trained and then aggregated using the SFL algorithm. The models
for very different datasets will diverge across cycles as there are no (or little)
influence connections between them, while for similar datasets, and even be-
tween similar clusters, the models stay reasonably tied together. All models
are tied to each other by the influences somehow, but ones connected through
a long series of other institutions will have more flexibility to diverge.
These models are now effectively learning on all data in existence with a
focus on similar data. They are localising to a specific dataset (and specific
task) while using context from similar tasks to improve their performance.
The need to pool the data into a central location is gone too. It also does not
require an (extremely) high capacity model to capture all the information in
the data, while if the data were pooled like in the global pooling method case,
a high capacity model would be needed.
It is unclear if SFL would be able to train the models in practice, or if the
task performances would be good. There are also practicality issues such as
gaining access to all of the data and having sufficient computational resources.





As the global population ages and the shortage of clinicians worsen, it be-
comes ever more urgent for AI to aid the roles of human clinicians. The topics
studied in this thesis — novelty, distillation, and federation — are three im-
portant areas in machine learning for medical imaging that bridge the gap
between where we are today and where we need to be. The next generation of
intelligent healthcare methods must be able to detect diseases and anomalies
never seen during training (novelty), must be understandable at the patient
level (distilled), and will need to be trained on large amounts of data without
transferring sensitive data (federated), especially in the face of ever-tightening
data laws.
Chapter 2 outlined the novelty forest, an efficient abnormality detection
method that aims to operate at a lower computational cost to existing ab-
normality methods while offering admissible accuracy performance. An ab-
normality detection method is one that seeks to classify outliers through the
analysis of inliers in the raw data or an embedding of it. Efficiency is especially
238
Chapter 6. Conclusions 239
important in high dimensional datasets, such as in the medical imaging do-
main, where the number of dimensions often slows other methods, even after
applying embedding techniques.
The novelty forest’s performance in terms of speed and accuracy was con-
trasted with a number of other simple novelty methods on interstitial lung
disease data under a number of embeddings in Chapter 3. The results showed
that the novelty forest is fast with good general accuracy, but another method
— the one-class support vector machine — gave the highest accuracy in a
quicker time by using principal component analysis to embed the data.
Next I examined distillation for the analysis of ischemic stroke patients
(Chapter 4). I took non-contrast CT data and used a bespoke neural network
to analyse and contrast the brain hemispheres to provide a voxel-level proba-
bility map of early ischemic change. The challenge here was to translate this
3D volume probability map into a clinically meaningful, easily interpretable,
and reliable quantity that could aid clinical decision making.
I achieved this by using an established scoring method — ASPECTS —
which scores ischemic stroke severity by the number of affected regions in the
most affected hemisphere. I crafted an ASPECTS atlas — a volumetric map
of brain regions supplied by the middle cerebral artery — and aligned this
to the probability maps. Then, using rules that converted the probabilities
into ischemic presence/absence in each ASPECTS region and dichotomising
the final score, I delivered a single value that aids the clinician in the choice
of patient treatment. It is clinically accepted and easily interpretable, and I
demonstrated it had good reliability with other means of scoring ASPECTS.
To finish I looked at federated learning in Chapter 5, which I demonstrated
on the task of brain tumour segmentation to prove its feasibility within the
medical field. I introduced a novel evolution called soft federated learning that
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performed favourably to its conventional form in a series of carefully designed
experiments. This soft version allows for a wider and more varied federation
of institutions, which enables more hospitals to join the federation without
damaging the average accuracy performance.
My results showed that while soft federated learning can be used to recog-
nise and adapt to different domains, it weakens when there are a large number
of institutions due to the each institution taking a small amount of the influ-
ence. I was unable to show a significant difference with conventional federated
learning on medical data, but no negative performance was noted. Further
research is needed.
6.2 The Present
The field of machine learning for medical imaging is advancing rapidly. The
number of research publications have grown by an order of magnitude every
decade over the past 30 years. The use of machine learning has been welcomed
in the field, although regulatory restraints have slowed the progress. The new
field of federated learning, introduced in its current form in 2017, has opened
new opportunities in the data-restrictive world of medical image analysis. Fed-
erated learning is generally accepted by clinicians, but there is an inherent risk
with a system that changes its behaviour over time, especially when dealing
with human life and wellbeing. We must take care to ensure our new systems
are reliable, consistent, and able to compete with existing talent.
This research in this thesis helps in many ways to deal with these risks
by showing how my machine learning methods compare to other methods out
there and can be used for abnormality detection (novelty), can be interpreted
easily and reliably despite their complexity (distillation), and can be used
despite the transfer restrictions faced by data today (federation).
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6.3 Going Forward
Detailed suggestions for future work are given at the end of each chapter, but
here I capture the most promising ideas and summarise what I have learned.
6.3.1 Novelty
The novelty forest offered a means of abnormality detection with minimal time
cost, especially when dealing with a large number of dimensions. I showed it
performed reasonably against other simple abnormality detection methods,
but also that it has a weakness in the way it utilises a minority of features and
thus may miss features that are important in the test data but not present in
the training data. In this way it could struggle to build a successful model of
normality because the abnormal data may be different in ways not checked by
the novelty forest.
To improve the novelty forest’s accuracy without reducing speed I could
explore new information functions for node divisions, and employ more intel-
ligent searching over the features to try to maximise the variety of features
checked. Exactly how this would be done remains a research area for the
future.
6.3.2 Distillation
In my distillation work, I learned that it is possible to convert a neural net-
work’s probabilistic voxel output to a single meaningful value, however this
value is only as reliable as its ground truth. The conversion rules, use of the
atlas, and dichotomisation threshold were logical choices to distill the data,
but the weakness of the ground truthing limited the final performance.
Future work takes two routes. I could improve the ground truth in the
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context of how clinicians use the CT scan to better match my output to theirs
to develop a highly reliable and thus deployable commercial tool for this use
case. The second route could be to use distillation for a wider range of medical
problems to show how it could be used in very different contexts. The distilla-
tion method I developed is specific to ischemic stroke in CT brain and cannot
be directly applied to any other form of data or pathology.
6.3.3 Federation
With federated learning I described where it is useful and demonstrated its
weakness on carefully crafted data. My soft federated learning algorithm aims
to overcome these weaknesses, although it also featured weaknesses of its own.
For example, federations of many institutions diluted the influence values that
provide the power behind soft federated learning. This is an issue when soft
federated learning is designed to work with large and varied federations.
Despite this, I believe federated learning will be a key technique for learning
on medical data in the future. My soft federated learning provides insight into
how this area could be developed going forward. If the influence function
was more resilient at telling apart useful (similar) and not useful (dissimilar)
institutions, especially when the federation is large, or the way similarity is
calculated is improved, then soft federated learning or a technique derived
from it could exceed the accuracy of conventional federated learning.
6.4 Closing Remarks
Medical image analysis with machine learning is an extensive, varied, and
challenging area. Pathology is greatly varied and in some cases very rare,
the machine learning algorithms are complicated with complex outputs while
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clinicians need understandable and interpretable outputs, and medical data is
difficult to collate in a single location.
This thesis showed a variety of techniques and experiments to aid in these
challenges. However, the use of novelty, distillation, and federation extends
beyond medical image analysis and are each applicable in many cases in the
field of machine learning. I hope the new concepts and methods introduced in





Learning — Full Analysis
To understand the opinions of the potential user base of a federated learning
system, I created a survey aimed at clinical staff of all backgrounds to gather
their insights into a clinical decision support application that improves during
use. Such a system could be deployed in a wide variety of situations, so I
desired to receive responses from a wide background. I did not reveal the
technical details of federated learning during the survey.
A total of 15 responses were received.
The questions and the raw responses follow. Analysis and discussion of
these responses are in Section A.2.
A.1 Survey Questions and Responses
1. What is your current job title and how many years of experience
do you have in this role?
Respondent #1: Consultant Neuroradiologist, 4 years
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Respondent #2: Consultant Radiologist, 11 years
Respondent #3: Consultant Radiologist, 4 years
Respondent #4: Consultant Radiologist, (did not state years of expe-
rience)
Respondent #5: Cardiothoracic Radiologist, 19 years
Respondent #6: Forensic Pathologist, 11 years
Respondent #7: Clinical Director, (did not state years of experience)
Respondent #8: Clinical Lead (Electronic Patient Records), 7 years
Respondent #9: Doctor, 23 years
Respondent #10: Professor of Radiology, 6 years; (previously: radiolo-
gist, 23 years)
Respondent #11: Clinical Scientist, 20 years
Respondent #12: Clinical Research Fellow, 3.5 years
Respondent #13: Clinical Research Fellow, 2 years
Respondent #14: Specialist Trainee in Radiology, (did not state years
of experience)
Respondent #15: PhD Student, 1.5 years
2. Which country do you work in?
United Kingdom - 15 (100%) (5 stated Scotland (33%), 10 stated United
Kingdom (67%))
3. Do any clinical decision support applications at your institu-
tion continually improve? If yes, please describe briefly the
system(s) you are aware of.
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Yes - 1 (7%)
No - 9 (60%)
Not Sure - 5 (33%)
Additional comment by the Yes respondent: “We use dragon voice
recognition software. It supposedly continually learns from the re-
ports being dictated. It does not do this well - in fact I would
suggest the way it has been set up means it does not do it at all.”
Additional comment by a Not Sure respondent: “Our voice activation
reporting software learns continually but is not a clinical decision
support application”
4. Please indicate your level of agreement with each statement:
a. I trust the software vendor to validate any updates.
Strongly Disagree - 1 (7%)
Disagree - 1 (7%)
Undecided - 3 (20%)
Agree - 9 (60%)
Strongly Agree - 1 (7%)
b. I must be able to compare the performance of a new system with
the previous version.
Strongly Disagree - 0 (0%)
Disagree - 1 (7%)
Undecided - 5 (33%)
Agree - 7 (46%)
Strongly Agree - 2 (13%)
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c. I must be notified when my system updates.
Strongly Disagree - 0 (0%)
Disagree - 2 (13%)
Undecided - 3 (20%)
Agree - 4 (27%)
Strongly Agree - 6 (40%)
d. I must be able to undo a system update if I deem it to have made
the system worse.
Strongly Disagree - 0 (0%)
Disagree - 2 (13%)
Undecided - 0 (0%)
Agree - 9 (60%)
Strongly Agree - 4 (27%)
e. I am willing to record discrepancies as I use a system to help improve
it.
Strongly Disagree - 0 (0%)
Disagree - 1 (7%)
Undecided - 1 (7%)
Agree - 9 (60%)
Strongly Agree - 4 (27%)
f. I want systems I use to continually improve.
Strongly Disagree - 1 (7%)
Disagree - 0 (0%)
Undecided - 0 (0%)
Agree - 8 (53%)
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Strongly Agree - 6 (40%)
5. How regularly would you like your system to update? (i.e. to
receive improvements).
Daily - 0 (0%)
Weekly - 5 (33%)
Monthly - 5 (33%)
Quarterly - 4 (27%)
Annual - 1 (7%)
Never - 0 (0%)
6. From where would you like contributions to the system im-
provements to come from? (Check all that apply).
My Institution - 15 (100%)
Large Regional Institutions - 15 (100%)
All Regional Institutions - 11 (73%)
Large National Institutions - 12 (80%)
All National Institutions - 8 (53%)
Renowned International Institutions - 9 (60%)
All Institutions Worldwide - 7 (47%)
I do not want any system improvements - 0 (0%)
7. Whose input would you like to contribute to system improve-
ments?
Only mine - 0 (0%)
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All users above a particular grade - 0 (0%)
All users who have completed an accreditation process - 5 (33%)
All users of the system - 10 (67%)
8. Do you have any final comments, ideas, or concerns about any-
thing in this survey?
Response #1 - “For me much would depend on the way the software
worked. In terms of global reach, this should be tempered by re-
gional variations in risk and healthcare provision, but it should
be possible to identify relevant data to inform particular ‘improve-
ments’. Also, one person’s improvement is another person’s prob-
lem. I would like to see improvements assessed in terms of a mea-
surable output, which could be an audited comparison of diagnostic
performance against another standard, or might be an ongoing sur-
vey of ease of use.”
Response #2 - “Channels should be adapted where users can give feed-
back and suggestions which can be reviewed by an expert group and
then prioritised as a change. Change and improvements would need
dedicated testing and validation which would need to be funded as
part of the existing license. Users should get feedback with regards
changes.”
A.2 Survey Analysis and Discussion
From Q1 I observe a wide range of professions and levels of experience within
the respondents, however as Q2 reveals, despite my best efforts to reach an
international community, all respondents were from the UK with many being
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from Scotland. This limits the applicability of my results to locations outside
of the UK.
Q3 revealed that most (60%) of respondents were not aware of any con-
tinually improving clinical decision support applications at their institution,
but 33% were not sure. Both additional comments refer to voice recognition
software, although one of them says that the software is not learning. Voice
recognition software pools the data it learns on to enhance development of
a suitable model. This is possible because voice data are not as sensitive as
medical data and can be sent off-site. This is different to federated learning
where data cannot be sent off-site.
For Q4 I compute an average score for each question for better analysis.
This score is calculated as
Average Score =
0 ∗ SD + 0.25 ∗D + 0.5 ∗ U + 0.75 ∗ A + 1 ∗ SA
n
(A.1)
with SD, D, U, A, SA referring to the number of respondents for each
answer category: Strongly Disagree, Disagree, Undecided, Agree, and Strongly
Agree respectively; and n being the number of respondents (15). This score
will be between 0 and 1 with 0 representing complete strong disagreement, 1
being full strong agreement, and 0.5 being an undecided or balanced opinion
response.
Using Equation A.1 I get the following scores:
4a. 0.63 (weak agreement with “I trust the software vendor to validate any
updates”).
4b. 0.67 (weak agreement with “I must be able to compare the performance
of a new system with the previous version”).
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4c. 0.73 (general agreement with “I must be notified when my system up-
dates”).
4d. 0.75 (general agreement with “I must be able to undo a system update if
I deem it to have made the system worse”).
4e. 0.77 (general agreement with “I am willing to record discrepancies as I
use a system to help improve it”).
4f. 0.80 (strong agreement with “I want systems I use to continually im-
prove.”)
As most responses were either in agreement or undecided, I highlight the
respondents who disagreed for each question:
4a. Strong Disagreement by Respondent 7 (Clinical Director), and Disagree-
ment by Respondent 8 (Clinical Lead).
4b. Disagreement by Respondent 10 (Professor of Radiology).
4c. Disagreement by Respondent 10 (Professor of Radiology) and Respondent
2 (Consultant Radiologist).
4d. Disagreement by Respondent 10 (Professor of Radiology) and Respondent
12 (Clinical Research Fellow).
4e. Disagreement by Respondent 11 (Clinical Scientist)
4f. Strong Disagreement by Respondent 11 (Clinical Scientist)
I note that two senior roles (Clinical Director and Clinical Lead) do not
believe the software vendor will validate updates correctly. Most other roles did
believe in this. The Professor of Radiology disagrees with 4b to 4d, indicating
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that they did not desire to compare the performance of system updates, be
notified when an update happens, or undo updates. This could be because
they trust the software vendor to get it right, or they could be too busy to
wish to be notified of these items or have to act on them. The Clinical Research
Fellow also disagreed with being able to undo system updates. Only one of
the three consultant radiologists did not want to be notified when the system
updates.
The Clinical Scientist is the only respondent to disagree with the last two
statements, and they disagreed strongly with the final one. While it is promis-
ing to see most respondents agreeable to these systems and willing to donate
their time to recording discrepancies to help the system improve, the Clin-
ical Scientist did not want to help the system learn and is strongly against
working with a system that continually improves. This may be due to the
job of a scientist where repeatability is of critical importance. Working with
a system whose output is constantly in flux is not compatible with this goal.
Alternatively the Clinical Scientist may not feel medically qualified to provide
corrections for the system.
Q5 asked how regularly the respondent would like their system to up-
date. Despite the Strong Disagreement by the Clinical Scientist in the pre-
vious question, they and everyone else were open to updates: no respondent
selected Never. The responses are largely divided between Weekly, Monthly,
and Quarterly. As federated learning requires frequent updates to keep the
models converged, Weekly would be the best option for a deployed system.
In Q6 every respondent desired for their own institutions and large regional
institutions to be included in the training. This could be due to the similarities
between these institutions, so the training data is less diverse and so catalyses
a better model. There is a drop of 27% when asked about All Regional In-
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stitutions, indicating that small regional institutions aren’t as desirable in the
federation, possibly because their data are of lower quality than larger insti-
tutions. A similar drop to 80% is seen for Large National Institutions, again
possibly due to differences at the regional and national level. This is an effect
seen in the UK where different nations may have different protocols for data
collection. Around half of respondents wanted All National Institutions. 60%
wanted Renowned International Institutions. This could be because of the
high standards at these institutions and a desire to learn from them for one’s
own institution. Support for using all institutions worldwide was under half
(47%). This is a split opinion with some respondents perhaps believing that
using more data would mean better local performance, while others believe
more diverse data would harm the local performance.
Finally, in Q7, most respondents were willing to let all users of the sys-
tem contribute to learning (67%) while the remainder desired an accreditation
process (33%). No respondents selected the Users Above a Particular Grade
option, indicating that grade is not as relevant as specific accreditation. The
openness to allowing all respondents to contribute to system learning could be
due to the high level of training respondents have before they enter a hospital
environment to use a machine like this, and thus mistakes will be rare and dam-
age to the learning because of these mistakes will be low and outweighed by
more positive responses. Someone lacking confidence is also unlikely to mark
discrepancies between their work and the model’s output, so this reduces the
risk of poor training data further.
At the end of the survey two further comments were made. Response #1
mentioned the variation between regions and healthcare provisions, which is
a problem I am aware of. They also mention how improvements should be
measurable against some audited task. However, there is no way to know
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if the performance against this task is applicable to every institution in the
federation. An audited task for each institution would be a suitable alternative.
Response #2 discusses modifying the importance of the training data, such
that some data are more important and prioritised above other data. The re-
sponse suggests an expert group can do this prioritisation. This comment is
useful, as some training data is more valuable to a model that others (e.g.
edge cases or difficult cases), but as processing is cheap (i.e. happens in the
background), I have no concerns about using all of the data present and not
prioritising changes. Also, what one institution decides is important, may not
be what another institution declares important, so there is an added compli-
cation if this was to go ahead.
A.3 Additional Discussion Topics
This section details the common questions I have received while presenting
about federated learning at technical talks. I detail my response to each ques-
tion.
1. How much of a footprint in hospitals will this take? Does it
need a server room, or can it run in the background on the
tasks that come in? How about for the network usage?
I hope that the final system will train silently in the background of an
installed system at a hospital, such as on a CT scanner. This is in-line
with other deployed or soon-to-be-deployed AI systems in hospitals. The
training may need to operate on a low number of resources, and as such
may be slow, but this is acceptable as we run the federated system over
a long period of time (months, years). Data pre-processing in particular
may slow down training and require a substantial use of resources. Hence
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this should be kept to a minimum. A federated learning system should,
as much as possible, be able to work on raw input data, or data that
has undergone a low amount of pre-processing or utilises only quick pre-
processing methods.
Network usage will be low. As we will only be sending model parameters
(megabytes worth of data) and this will not be continuous but rather
infrequent, in the region of once a week or month, and certainly no more
often than once a day. This leads to network usage being insignificant.
Even at the central institution’s end, where a large number (tens or
hundreds or potentially more) could arrive and require processing, this
is not expected to be difficult, especially if time is not a critical factor in
this situation.
2. Will patients need to consent to have a model trained on their
data sent off-site and used within a federated system?
This is a grey area that it beyond a technical exercise. In the UK it
isn’t clear if patients need to consent to having their data used by an AI
that is an integral part of a piece of hardware. Having a model learned
from their data transmitted around the world is a different category of
problem and consent may be required in this case. When working with a
federated system that could span many countries and continents, guide-
lines and laws surrounding this novel technology become increasingly
vague. Further guidance must be sought from legal professionals before
a federated learning system can be deployed in practice.
3. How can hospital staff, especially those without technical knowl-
edge on the workings of the system in question, know that no
sensitive data is being sent off-site? How can they trust the
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system?
It would be possible to describe the data being sent off-site to the clinical
staff before it is allowed to leave, such that is can be reviewed to ensure no
sensitive information is leaving. This is possible if the dataset is small
and sent off-site infrequently. Exactly how this is done is a topic for
future research as unfortunately the network’s parameters are themselves
a series of incoherent numbers and arrays that are not human readable.
Finding ways to display this information graphically or in some way that
can be understood will help. Other than these factors, it may be down
to an issue of trust with the clinical staff and the AI.
4. Data is constantly being pulled in and sent away using the
system. Is there some way to be certain of the quality of the
incoming or outgoing data?
The models being sent away should be validated to ensure they aren’t
corrupt or haven’t trained on incorrect data (either data that is corrupt,
or incorrectly labelled, or simply irrelevant – for example, from a different
system). Likewise, models being sent into a hospital should be validated,
either at the central institution or at the hospital, so that its ability shows
no significant failures. A significant failure in this case is defined as when
a human could notice a mistake in the output of the AI model that was
not there previously. Validating a model could consist of running test
cases through it with results compared to the previous cycle of the model
to ensure no major (negative) differences have taken place.
5. Will the system be compatible with the current software used
within hospitals around the world and is it future-proof, such
that it can always be used – at least until a superior technology
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renders it obsolete? Would it be easy to replace in this case?
An AI system is a special case. It naturally forgets old cases as new
cases come in, leading to adaption over time. To assist in this, data
should not be retained for training/evaluation for a long period of time.
It is assumed that improvements in hardware will lead to improvements
in the data quality. If data quality was to suddenly change, the model
could perform poorly on the new data for a while until it learns how
to accurately process this change. This is especially true if no other
institution within the federation is using this style of data. In this case,
it may be beneficial detecting the drop in performance and taking this
hospital out of the federation to prevent it affecting the performance
at other institutions. The model at this hospital can train locally until
such a time that performance has returned, and then it can re-join the
federation. When a new federated model is returned to that institution,
its model parameters could be shifted towards its previous iteration to
prevent issues around needing to relearn the new style of data again.
6. Training the model may require data to be kept for an ex-
tended period of time for repeated training (appearing in mul-
tiple epochs or across multiple cycles) or as an example to use
for future reference (i.e. a test sample). How long can data be
retained for?
The amount of time we can store data for is bounded by the data laws in
the regions we are operating the federation in, and by storage allowances
for the data, but where possible data should be kept until the point where
it is no longer useful. Exactly when this is is an area for future research.
7. How will clinical staff know the system is getting better with
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each update? What if the system becomes better than they
are, such that they claim the system is getting worse because
it is making claims that increasingly diverge from their own
opinion, even if the system is more accurate?
Model validation, as discussed in point 4, should allow clinical staff to
know a model is not getting worse. If the test performance improves, it
is likely to be the case that the model has improved, especially if the test
cases represent the full range of cases the algorithm will see.
In response to the second part of this question, this is moving towards
a new question of trust. How can I trust an AI model to make the right
decisions when its decisions differ from our own and yet are believed to
be better than our own?
Part of the answer may be blind trust. This is like how we trust a
calculator to provide the correct answer to some complicated sum that
would take a human some time to work out. AI is more complicated than
a mathematical calculation, although it can be seen as a very advanced
calculator and treated as one. I know and accept that a regular calculator
is faster than us and makes fewer mistakes. Could I also accept the same
from an AI?
The other part of the answer goes down the path of explainability. An AI
model should be able to explain why it came to a decision on a particular
task in a way that a human can understand and can even learn from.
This way, the AI is seen as a tool to aid in the understanding of a task
rather than a mysterious black box system that “just gives answers”.
There is active research into AI explainability [2, 77, 114, 129].
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